≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

Endpoint Browser PheWeb

C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C22
  • Hospital discharge: ICD-9 — 155
  • Hospital discharge: ICD-8 — 155
  • Cause of death: ICD-10 — C22
  • Cause of death: ICD-9 — 155
  • Cause of death: ICD-8 — 155
  • Cancer registry: Topography ICD-O-3 — C22
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

2117

4. Check minimum number of events

None

2117

5. Include endpoints

None

2117

6. Filter based on genotype QC (FinnGen only)

2034

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 2034 576 1458
Unadjusted period prevalence (%) 0.54 0.20 0.67
Median age at first event (years) 72.05 71.20 72.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2117
Matched controls
21169
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
29.3
316.0
214
81
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
939
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
307.7
601
*
H02AB02
ATC
dexamethasone; systemic
45.9
307.7
391
104
R18
ICD-10 Finland
Ascites
22.7
307.7
255
127
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
6985.7
307.7
539
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
10.5
307.7
630
821
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
677
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
29.8
307.7
338
134
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
1160
*
Z51.5
ICD-10 Finland
Palliative care
25.6
307.7
863
554
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
32.4
307.7
229
79
A04AA01
ATC
ondansetron; systemic, rectal
18.2
307.7
296
187
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
307.7
309
*
N02AA05
ATC
oxycodone; systemic
8.2
307.7
997
2078
JN4CD
NOMESCO Finland
Very extensive body CT
31.2
307.7
301
112
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
24.6
307.7
247
113
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
150.3
307.7
641
61
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
157.6
307.7
670
62
A03FA01
ATC
metoclopramide; systemic, rectal
12.5
307.7
878
1132
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
20.5
307.7
269
149
JN4AD
NOMESCO Finland
Body CT examination
11.0
307.7
578
699
A04AA02
ATC
granisetron; systemic, transdermal
671.3
301.2
291
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.7
299.9
246
148
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
24.3
298.9
217
99
JN4BD
NOMESCO Finland
Extensive body CT
9.4
291.0
382
483
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.0
280.7
250
176
WF002
NOMESCO Finland
Radical radiotherapy
105.4
267.8
138
14
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2668.5
261.9
248
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.2
260.8
275
256
K83.1
ICD-10 Finland
Obstruction of bile duct
29.6
248.9
167
61
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
247.9
233
*
198
Kela drug reimbursment
Sorafenib
+∞
245.7
231
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
242.5
228
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
234.3
580
1394
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
229.4
216
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
18.9
222.0
179
103
L01BC06
ATC
capecitabine; oral
+∞
211.0
199
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
34.8
206.1
131
40
JN3AD
NOMESCO Finland
Abdominal CT examination
5.0
205.1
535
1332
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
17.8
195.8
162
98
WZC00
NOMESCO Finland
Treatment plan or consultation
3.8
191.1
898
3429
UJK02
NOMESCO Finland
ERCP
9.9
177.8
214
238
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
177.5
323
577
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
170.1
161
*
K83.0
ICD-10 Finland
Cholangitis
14.1
168.8
158
120
C61
ICD-10 Finland
Malignant neoplasm of prostate
358.6
167.7
167
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
441.0
166.0
164
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
67.1
164.1
90
14
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
24.2
163.0
117
51
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.0
154.0
198
239
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
71.9
153.0
83
12
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
1500.5
144.5
139
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
31.7
144.1
94
31
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.1
142.9
89
25
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
134.7
237
406
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
25.6
132.5
93
38
L01XE05
ATC
[U] sorafenib
+∞
131.6
125
*
323
Kela drug reimbursment
Sorafenib
+∞
130.6
124
*
127
Kela drug reimbursment
Transplant complication
17.1
130.2
109
67
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
12.0
129.7
134
119
WF049
NOMESCO Finland
Radiotherapy of metastasis
667.5
128.9
126
*
C03DA01
ATC
spironolactone; oral
3.4
127.5
579
2084
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
127.4
121
*
WW500
NOMESCO Finland
Blood transfusion
9.8
127.4
152
166
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
127.0
909
4262
A05AA02
ATC
ursodeoxycholic acid; oral
16.9
124.9
105
65
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
122.1
116
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
45.9
120.2
71
16
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
48.2
119.8
70
15
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
116.8
111
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
112.5
107
*
A06AH03
ATC
naloxegol; oral
22.4
108.5
80
37
A07AA11
ATC
rifaximin; oral
36.4
107.0
67
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
106.5
334
930
Z94.4
ICD-10 Finland
Liver transplant status
130.1
104.1
111
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
102.6
207
402
WZC30
NOMESCO Finland
Teaching
3.5
101.6
426
1440
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
44.1
100.6
60
14
D77
ICPC
Malignant digestive neopl other/NOS
516.7
100.4
99
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
34.1
98.9
63
19
116
Kela drug reimbursment
Prostate cancer
+∞
92.4
88
*
L04AD02
ATC
tacrolimus; systemic
17.5
92.2
76
45
A06AD11
ATC
lactulose; oral
2.9
91.5
578
2463
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
91.3
87
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
916.3
90.5
88
*
I81
ICD-10 Finland
Portal vein thrombosis
27.3
89.1
61
23
K76.9
ICD-10 Finland
Liver disease, unspecified
11.1
88.5
95
89
3019
Kela drug reimbursment
Lenvatinib
+∞
88.1
84
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
190.0
88.0
91
5
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
20.3
87.2
67
34
L01EX02
ATC
sorafenib; oral
+∞
87.1
83
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
18.1
86.4
70
40
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
872.8
86.2
84
*
1508
Kela drug reimbursment
Lenvatinib
+∞
86.0
82
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
86.0
82
*
L01EX08
ATC
lenvatinib; oral
+∞
86.0
82
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
85.3
1078
6352
L04AA06
ATC
mycophenolic acid; systemic
9.7
85.1
101
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
84.4
418
1550
B01AB10
ATC
tinzaparin; parenteral
3.8
84.4
286
835
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
12.5
83.5
83
69
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
8.2
80.0
109
140
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.1
78.1
97
111
D97
ICPC
Liver disease NOS
21.3
77.1
58
28
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
75.5
72
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
74.4
71
*
A79
ICPC
Malignancy NOS
196.9
73.6
76
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
15.2
73.5
65
44
A04AA55
ATC
palonosetron, combinations; systemic
+∞
73.4
70
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
73.3
590
2798
D13.4
ICD-10 Finland
Benign neoplasm: Liver
26.9
72.7
50
19
C03CA01
ATC
furosemide; systemic
2.2
71.4
1058
6515
L03AA02
ATC
filgrastim; parenteral
114.1
71.4
77
7
ZX120
NOMESCO Finland
Intravenous
3.7
70.7
249
743
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
68.1
65
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
237.6
67.6
69
*
J01MA12
ATC
levofloxacin; systemic
2.5
67.4
531
2480
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
67.0
880
5124
B01AB05
ATC
enoxaparin; parenteral
2.3
64.3
712
3853
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
18.6
63.9
51
28
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
63.8
344
1324
R50.9
ICD-10 Finland
Fever, unspecified
2.7
63.2
414
1763
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
61.8
59
*
L03AA13
ATC
pegfilgrastim; parenteral
322.1
61.7
62
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
6.1
61.6
110
189
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
60.7
1158
7700
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
212.8
60.4
62
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
19.2
59.7
47
25
WX402
NOMESCO Finland
General anaesthesia
2.5
58.4
435
1965
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
57.6
55
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
57.6
55
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
57.5
796
4666
A10BA02
ATC
metformin; oral
2.1
56.2
872
5324
A10AE04
ATC
insulin glargine; parenteral
2.7
55.9
348
1438
UJF32
NOMESCO Finland
Coloscopy
2.2
55.9
638
3461
PC2SC
NOMESCO Finland
Liver angiography with X-ray
562.4
55.8
55
*
WF004
NOMESCO Finland
Palliative radiotherapy
562.4
55.8
55
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
55.5
53
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
72.0
55.4
63
9
A10AB05
ATC
insulin aspart; parenteral
3.0
55.3
274
1002
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
54.5
707
4024
XX2RW, ,
NOMESCO Finland
14.4
52.9
48
34
176
Kela drug reimbursment
Regorafenib
+∞
52.3
50
*
PJA12
NOMESCO Finland
Sentinel node biopsy
520.3
51.7
51
*
115
Kela drug reimbursment
Breast cancer
+∞
51.2
49
*
R4110
NOMESCO Finland
Physiotherapy
2.1
51.1
627
3478
K92.0
ICD-10 Finland
Haematemesis
4.6
50.9
126
289
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.1
50.8
89
150
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
21.5
50.7
38
18
JAH00
NOMESCO Finland
Laparotomy
5.4
50.6
103
200
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
17.1
50.6
42
25
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
50.4
95
172
C24.00
ICD-10 Finland
Hepatic duct
+∞
50.2
48
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
50.2
48
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
499.2
49.6
49
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
499.2
49.6
49
*
N02AA01
ATC
morphine; systemic, rectal
6.5
49.3
82
131
A02BC02
ATC
pantoprazole; systemic
2.0
49.2
1450
10915
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.0
48.7
47
37
R4190
NOMESCO Finland
Nutritional therapy
5.3
48.4
99
193
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
48.4
515
2694
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.9
48.2
49
42
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
16.1
47.8
41
26
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
167.1
47.0
49
*
L02AE02
ATC
leuprorelin; implant, parenteral
61.5
46.5
54
9
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
46.0
44
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.4
45.9
67
93
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.9
44.9
139
377
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
446.8
44.4
44
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
43.9
42
*
T90
ICPC
Diabetes non-insulin dependent
2.0
43.6
695
4198
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
14.7
43.4
39
27
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
42.9
41
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
42.9
41
*
B01AB04
ATC
dalteparin; parenteral
3.6
42.7
145
419
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
80.2
42.0
47
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
10.4
41.4
46
45
JJB30
NOMESCO Finland
Excision of two segments of liver
415.4
41.3
41
*
L04AD01
ATC
ciclosporin; systemic
6.9
41.3
64
95
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
41.2
121
316
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
40.8
39
*
369
Kela drug reimbursment
Regorafenib
+∞
40.8
39
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
208.9
40.0
41
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
208.9
40.0
41
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
39.7
38
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
39.6
136
396
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
384.1
38.2
38
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
135.8
37.8
40
*
A10BB12
ATC
glimepiride; oral
2.4
37.8
285
1277
J01MA02
ATC
ciprofloxacin; systemic
1.8
37.1
895
6101
SPAT1262
SPAT
Handing over of treatment supplies
2.0
37.0
468
2584
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
193.4
36.9
38
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
36.6
35
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.0
36.5
79
162
TJA10
NOMESCO Finland
Laparocentesis
99.3
35.8
39
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
35.5
34
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
35.5
34
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
35.3
320
1551
JJB71
NOMESCO Finland
Laparoscopic resection of liver
352.9
35.0
35
*
A10BH01
ATC
sitagliptin; oral
2.3
34.6
299
1420
JKA20
NOMESCO Finland
Cholecystectomy
3.8
34.5
106
286
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
34.5
33
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
34.5
33
*
L02BB03
ATC
bicalutamide; oral
+∞
34.5
33
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
34.5
33
*
A04AD12
ATC
aprepitant; systemic
+∞
33.4
32
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
33.4
32
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
33.4
32
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
332.1
33.0
33
*
JJA20
NOMESCO Finland
Open biopsy of liver
49.6
32.6
39
8
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
10.4
32.5
36
35
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.1
32.5
92
234
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
32.4
31
*
L01EX05
ATC
regorafenib; oral
+∞
32.4
31
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
321.7
31.9
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
321.7
31.9
32
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
321.7
31.9
32
*
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
5.0
31.5
68
139
160
Kela drug reimbursment
exenatide
4.4
31.0
78
181
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
31.0
469
2736
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
30.3
29
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
30.3
29
*
A10BX07
ATC
[U] liraglutide
5.7
30.3
57
103
WW200, ,
SPAT
0.4
30.0
226
4501
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
29.5
434
2503
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
29.2
28
*
C07AG02
ATC
carvedilol; oral
2.5
29.1
205
887
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
40.7
29.0
36
9
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
295.9
28.8
29
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
295.9
28.8
29
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
28.7
298
1517
Y77
ICPC
Malignant neoplasm prostate
104.9
28.7
31
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
28.2
173
701
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
28.2
27
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
27.8
370
2061
ZX090
NOMESCO Finland
Other technic of radiotherapy
47.8
27.5
33
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
27.3
667
4469
K72.1
ICD-10 Finland
Chronic hepatic failure
30.5
27.2
36
12
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
54.1
27.2
32
6
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
27.2
353
1947
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
27.1
26
*
A10AE05
ATC
insulin detemir; parenteral
2.6
27.1
160
636
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
274.4
26.8
27
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
98.0
26.7
29
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
141.8
26.7
28
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
6.3
26.2
44
71
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
26.1
25
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
26.1
25
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
31.4
25.9
34
11
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
263.7
25.7
26
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.4
25.7
36
15
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
25.0
24
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
25.0
24
*
JAH01
NOMESCO Finland
Laparoscopy
3.9
24.9
74
195
K92.1
ICD-10 Finland
Melaena
2.5
24.8
170
725
JJ5AT, ,
NOMESCO Finland
253.0
24.7
25
*
A41.8
ICD-10 Finland
Other specified sepsis
3.8
24.5
75
202
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.4
24.4
90
274
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
48.9
24.3
29
6
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
24.3
82
236
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
24.2
175
3585
WPB10
NOMESCO Finland
Making a convalescent care decision
29.5
24.1
32
11
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
24.0
23
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
24.0
23
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
23.9
315
1741
K75.0
ICD-10 Finland
Abscess of liver
20.9
23.9
35
17
HAC20
NOMESCO Finland
Total mastectomy
87.8
23.7
26
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
8.7
23.7
30
35
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
23.5
38
59
K70.1
ICD-10 Finland
Alcoholic hepatitis
6.9
23.4
36
53
ZX050
NOMESCO Finland
Stereotactic radiotherapy
54.6
23.1
27
5
L02BG04
ATC
letrozole; oral
25.0
23.1
32
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
18.7
23.0
35
19
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
23.0
22
*
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
+∞
23.0
22
*
C24.02
ICD-10 Finland
Common bile duct
+∞
23.0
22
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
23.0
22
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
23.0
22
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.4
22.9
82
245
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
7.4
22.9
33
45
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.6
22.7
54
120
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
232.4
22.7
23
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
232.4
22.7
23
*
162
Kela drug reimbursment
liraglutide
5.1
22.6
47
93
JLC30
NOMESCO Finland
Pancreatoduodenectomy
121.3
22.6
24
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
21.9
21
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
21.9
21
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
21.9
21
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
21.9
340
1980
ZZR00
NOMESCO Finland
Flap of skin
8.2
21.8
29
36
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
21.6
210
1038
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
7.9
21.3
29
37
NK6AN
NOMESCO Finland
Total body bone isotope imaging
23.4
21.3
30
13
A10AC01
ATC
insulin (human); parenteral
2.1
21.2
229
1178
TK800
NOMESCO Finland
Hemodialysis
3.6
21.0
69
195
Z2446
NOMESCO Finland
Social worker
2.5
20.9
132
542
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
20.9
20
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
20.9
20
*
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
20.9
20
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
20.9
20
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
20.9
20
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
20.9
20
*
L01XE21
ATC
[U] regorafenib
+∞
20.9
20
*
N05CF01
ATC
zopiclone; oral
1.6
20.8
677
4812
ZX070
NOMESCO Finland
Intensity modified radiotherapy
77.6
20.7
23
*
Z3231
NOMESCO Finland
Registered nurse
1.7
20.6
523
3495
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
212.0
20.6
21
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.4
20.2
51
119
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
20.0
146
640
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
23.6
20.0
28
12
WVA20
NOMESCO Finland
Medicine administration
3.6
19.8
67
193
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
19.8
19
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
19.8
19
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
19.8
19
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
19.8
19
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
19.8
706
5114
K72.9
ICD-10 Finland
Hepatic failure, unspecified
6.5
19.7
32
50
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
8.2
19.6
26
32
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
19.2
250
1371
WX002
NOMESCO Finland
Sedation and analgesia
1.7
19.2
387
2427
ZXE00
NOMESCO Finland
One hour or less
1.6
19.1
690
5002
ZX108
NOMESCO Finland
Inhalation
7.6
19.1
27
36
Z2221
NOMESCO Finland
Medical doctor
1.7
19.0
476
3163
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
18.8
18
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
18.8
18
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
18.8
18
*
M04AA01
ATC
allopurinol; systemic
1.7
18.7
376
2354
XX4BW, ,
NOMESCO Finland
28.1
18.7
25
9
H01CB02
ATC
octreotide; parenteral
70.5
18.7
21
*
A10BG03
ATC
pioglitazone; oral
3.0
18.7
85
294
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
23.9
18.6
26
11
SPAT1255
SPAT
Intravenous administration of medicine
2.2
18.6
166
793
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
18.4
108
428
205
Kela drug reimbursment
Chronic hypertension
1.5
18.4
750
5577
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
18.3
293
1716
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
18.3
134
589
JFB30
NOMESCO Finland
Right hemicolectomy
7.5
18.2
26
35
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
18.2
104
407
C10AA07
ATC
rosuvastatin; oral
0.6
18.1
340
5231
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.2
18.1
31
51
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.9
18.0
86
306
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
18.0
95
357
JN6AD
NOMESCO Finland
CT of torso and neck
7.0
17.8
27
39
HA1AA
NOMESCO Finland
X-ray mammography
3.6
17.8
59
168
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
17.7
17
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
17.7
17
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
17.7
17
*
B03XA02
ATC
darbepoetin alfa; parenteral
3.8
17.6
53
141
C20
ICD-10 Finland
Malignant neoplasm of rectum
181.5
17.5
18
*
C07AA05
ATC
propranolol; systemic
1.7
17.5
327
2003
Z3226
NOMESCO Finland
Physiotherapist
1.7
17.3
344
2143
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.7
17.3
32
57
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.2
17.2
29
47
A10BX04
ATC
[U] exenatide
4.7
17.1
39
84
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
17.0
105
427
WX892
NOMESCO Finland
Monitored bed care
2.1
16.9
179
912
K29.6
ICD-10 Finland
Other gastritis
4.4
16.9
42
97
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
16.9
196
1033
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.8
16.9
52
141
K76.89
ICD-10 Finland
Other specified diseases of liver
22.0
16.9
24
11
ZXC40
NOMESCO Finland
Use of ultrasound
14.2
16.8
28
20
SPAT1109
SPAT
Analgesia with portable analgesic pump
14.2
16.8
28
20
A10BH05
ATC
linagliptin; oral
2.1
16.8
156
757
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
16.7
16
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
16.7
16
*
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
16.7
16
*
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
16.7
16
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
5.5
16.7
32
59
N06DX01
ATC
memantine; oral
0.3
16.4
62
1701
E66.00
ICD-10 Finland
Metabolic syndrome
2.3
16.3
128
579
RS220, ,
NOMESCO Finland
4.9
16.2
35
72
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.5
16.1
39
88
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
16.1
200
1078
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
16.1
46
118
C10AA05
ATC
atorvastatin; oral
0.7
16.1
597
7909
ZX112
NOMESCO Finland
Subcutaneous
6.0
16.1
28
47
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
16.0
47
123
WPA13
NOMESCO Finland
Palliative consultation
14.6
15.8
26
18
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
60.5
15.8
18
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
15.6
15
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
15.6
15
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
15.6
15
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
15.6
15
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
15.6
15
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.6
15
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
15.6
15
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.6
15
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
161.1
15.5
16
*
H02AB06
ATC
prednisolone; systemic
1.5
15.4
917
7287
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
38.3
15.4
19
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
15.4
60
190
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
15.4
102
429
EB1VA, ,
NOMESCO Finland
0.4
15.3
85
1965
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.7
15.3
48
132
C10AX09
ATC
ezetimibe; oral
0.5
15.3
146
2756
K76.7
ICD-10 Finland
Hepatorenal syndrome
16.2
15.2
24
15
WZC15, ,
NOMESCO Finland
28.8
15.2
20
7
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.0
15.1
43
110
ZXD05
NOMESCO Finland
Urgent procedure
1.5
15.1
579
4211
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
31.9
14.8
19
6
L02BA01
ATC
tamoxifen; oral
57.1
14.8
17
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
14.6
82
318
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
14.6
14
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
14.6
14
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
14.6
14
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
14.6
14
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
14.6
14
*
L04AA10
ATC
[U] sirolimus
80.7
14.6
16
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
14.5
157
807
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
14.4
183
993
A10BJ02
ATC
liraglutide; parenteral
2.9
14.4
67
235
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
14.4
597
4406
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
15.5
14.4
23
15
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.3
14.3
36
84
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
14.3
112
507
WPA43, ,
SPAT
27.4
14.3
19
7
EB4VA, ,
NOMESCO Finland
0.3
14.0
51
1424
N02AA03
ATC
hydromorphone; systemic, rectal
30.2
13.9
18
6
A98
ICPC
Health maint/preventive medicine
0.7
13.8
1509
16633
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
13.8
127
614
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.3
13.7
27
51
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
13.7
102
452
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
75.6
13.6
15
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
13.6
13
*
L01XE29
ATC
[U] lenvatinib
+∞
13.6
13
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
13.6
13
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
13.6
13
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
13.6
13
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
13.6
13
*
YJ3VG
NOMESCO Finland
MRI examination of abdomen with high intesity magnet for dose design of radiotherapy
+∞
13.6
13
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
13.6
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.6
13
*
L02AE04
ATC
triptorelin; parenteral
+∞
13.6
13
*
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
13.6
13
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
21.3
13.3
19
9
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
13.2
223
1323
R10.0
ICD-10 Finland
Acute abdomen
2.7
13.0
69
260
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
28.5
13.0
17
6
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
9.7
12.7
25
26
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
12.7
80
329
R11
ICD-10 Finland
Nausea and vomiting
1.9
12.7
154
824
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
12.6
73
288
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
70.3
12.6
14
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
70.3
12.6
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
12.6
619
4702
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
32.2
12.6
16
5
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
12.5
12
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
12.5
12
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
12.5
12
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
12.5
12
*
C24.01
ICD-10 Finland
Cystic duct
+∞
12.5
12
*
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
+∞
12.5
12
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
12.5
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
12.5
12
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
12.5
154
828
Z51.0
ICD-10 Finland
Radiotherapy session
130.8
12.4
13
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
130.8
12.4
13
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
130.8
12.4
13
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
9.0
12.2
25
28
J94.8
ICD-10 Finland
Other specified pleural conditions
3.4
12.1
43
129
D75
ICPC
Malignant neoplasm colon/rectum
26.8
12.0
16
6
J01DB01
ATC
cefalexin; oral
1.4
12.0
1511
13454
P20
ICPC
Memory disturbance
0.6
12.0
163
2779
WPA11
NOMESCO Finland
Developing a plan for palliative care
21.4
12.0
17
8
ZZA00
NOMESCO Finland
Split skin graft
2.8
11.9
58
209
R94.5
ICD-10 Finland
Abnormal results of liver function studies
4.4
11.9
29
66
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
11.8
196
3164
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
14.7
11.8
19
13
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.3
11.7
92
417
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
11.7
86
379
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
11.6
400
5474
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.4
11.6
80
343
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
65.3
11.6
13
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
11.5
11
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
11.5
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
11.5
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.5
11
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
11.5
11
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
11.5
11
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
11.5
11
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
11.5
11
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
11.5
11
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
11.5
11
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
120.6
11.4
12
*
E34.0
ICD-10 Finland
Carcinoid syndrome
120.6
11.4
12
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
120.6
11.4
12
*
X76
ICPC
Malignant neoplasm breast female
120.6
11.4
12
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
11.4
31
77
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.5
11.4
72
297
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.9
11.3
32
82
358
Kela drug reimbursment
liraglutide
5.2
11.3
23
45
P15
ICPC
Chronic alcohol abuse
2.6
11.2
64
251
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.5
11.2
27
61
A10BD07
ATC
metformin and sitagliptin; systemic
2.1
11.1
109
540
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.2
11.1
29
70
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.6
11.1
63
247
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
14.0
11.0
18
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
11.0
549
4167
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
10.9
89
411
E0000UV, ,
ATC
1.4
10.9
707
5612
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
10.9
55
1327
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.4
10.9
21
39
N05AX08
ATC
risperidone; systemic
0.4
10.9
64
1450
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.9
634
4942
L04AX01
ATC
azathioprine; systemic
2.3
10.9
78
341
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.9
10.8
22
25
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
17.9
10.7
16
9
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
10.7
116
597
XF612
NOMESCO Finland
Measurement of central venous pressure
21.6
10.7
15
7
C10AC01
ATC
colestyramine; oral
2.8
10.6
53
194
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
10.6
136
742
G93.4
ICD-10 Finland
Encephalopathy, unspecified
8.5
10.5
22
26
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
10.5
120
629
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
110.6
10.4
11
*
H01CB03
ATC
lanreotide; parenteral
110.6
10.4
11
*
L04AA18
ATC
[U] everolimus
110.6
10.4
11
*
L01AX03
ATC
temozolomide; systemic
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
10.4
10
*
L01CB01
ATC
etoposide; systemic
+∞
10.4
10
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
10.4
10
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
10.4
10
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
10.4
10
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
10.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
10.4
10
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
10.4
10
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
10.4
10
*
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
10.4
10
*
J01FF01
ATC
clindamycin; systemic
1.4
10.4
480
3585
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
7.7
10.4
23
30
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
10.3
204
3160
A10BB01
ATC
glibenclamide; oral
1.8
10.3
157
904
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
9.6
10.3
20
21
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
23.5
10.2
14
6
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.2
10.2
85
396
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.3
10.2
76
338
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.9
10.2
123
658
WX882
NOMESCO Finland
High dependency care
2.5
10.1
62
252
XQ902
NOMESCO Finland
Other photography
3.9
10.1
29
75
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.9
298
4214
K51.5
ICD-10 Finland
Left sided colitis
2.7
9.9
51
190
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.6
9.9
56
219
A10AD05
ATC
insulin aspart; parenteral
2.5
9.9
63
261
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.9
9.9
28
72
B01AF01
ATC
rivaroxaban; oral
0.5
9.8
108
1964
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.0
9.8
27
68
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.7
9.7
50
187
K83.3
ICD-10 Finland
Fistula of bile duct
55.2
9.6
11
*
D76
ICPC
Malignant neoplasm pancreas
55.2
9.6
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
55.2
9.6
11
*
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
11.4
9.6
17
15
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.5
9.6
23
52
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.6
9.5
155
2524
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
9.4
73
330
I85
ICD-10 Finland
Oesophageal varices
100.5
9.4
10
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
100.5
9.4
10
*
L04AH02
ATC
everolimus; oral
100.5
9.4
10
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
9.4
135
763
A06AH05
ATC
naldemedine; oral
30.2
9.4
12
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
9.4
97
491
WPA44
NOMESCO Finland
Nursing home for palliative care
17.6
9.4
14
8
D69.5
ICD-10 Finland
Secondary thrombocytopenia
17.6
9.4
14
8
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
9.4
181
2827
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
9.4
9
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
9.4
9
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
9.4
9
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
9.4
9
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
9.4
9
*
TQW20
NOMESCO Finland
Tatoe
+∞
9.4
9
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
9.4
9
*
YX9AW, ,
NOMESCO Finland
+∞
9.4
9
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.2
9.3
76
351
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.4
9.3
33
99
N06DA02
ATC
donepezil; oral
0.4
9.3
55
1243
B02AA02
ATC
tranexamic acid; systemic
1.7
9.1
161
967
SPAT1110
SPAT
Measurement of pain intensity
4.8
9.1
20
42
K74.0
ICD-10 Finland
Hepatic fibrosis
11.5
9.1
16
14
A07AA09
ATC
vancomycin; oral
3.2
9.1
35
111
A07AA02
ATC
nystatin; oral
1.9
9.1
105
554
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.8
9.0
43
154
R4110, ,
SPAT
0.5
9.0
90
1690
WX004
NOMESCO Finland
Patient-controlled sedation
9.1
9.0
18
20
WPA44, ,
SPAT
10.1
9.0
17
17
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
36.8
9.0
11
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
36.8
9.0
11
*
OAB43, ,
SPAT
0.5
9.0
68
1401
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
8.9
128
723
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.5
8.9
30
87
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.9
8.9
41
144
JFB00
NOMESCO Finland
Partial resection of small intestine
3.4
8.9
31
92
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.4
8.9
31
92
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.1
8.8
79
380
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
8.7
133
767
C50
ICD-10 Finland
Malignant neoplasm of breast
50.2
8.7
10
*
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.2
8.7
9
427
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
8.6
346
2509
N03AX16
ATC
[U] pregabalin
1.4
8.6
380
2806
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
8.5
90
460
K76.6
ICD-10 Finland
Portal hypertension
27.6
8.5
11
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.7
8.4
26
71
ZXC96
NOMESCO Finland
Robot assisted procedure
7.4
8.4
19
26
V03AF03
ATC
calcium folinate; systemic
90.4
8.4
9
*
A10BG02
ATC
rosiglitazone; oral
2.7
8.4
45
172
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
8.3
8
*
1551A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts
+∞
8.3
8
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
8.3
8
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
8.3
8
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
8.3
8
*
L02BX02
ATC
degarelix; parenteral
+∞
8.3
8
*
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
8.3
8
*
L01BC04
ATC
carmofur; oral
+∞
8.3
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
+∞
8.3
8
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.3
8
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
8.3
8
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
8.3
8
*
JK5ZT
NOMESCO Finland
Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic
+∞
8.3
8
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
8.3
8
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
8.3
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.3
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.3
834
7000
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
8.3
454
3480
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.8
8.2
125
719
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.2
8.2
31
97
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
8.2
412
3110
A28
ICPC
Limited function/disability NOS
1.4
8.2
427
3244
SPAT1088
SPAT
Blood transfusion
7.6
8.2
18
24
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.1
8.1
77
378
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.0
8.1
83
419
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.6
8.1
44
169
A10BD03
ATC
metformin and rosiglitazone; systemic
2.5
8.1
49
199
E83.50
ICD-10 Finland
Hypercalcemia
3.4
8.1
28
83
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
33.5
8.1
10
*
JCA20
NOMESCO Finland
Ligature of oesophageal varices
33.5
8.1
10
*
V03AE01
ATC
polystyrene sulfonate; oral
2.9
8.1
37
130
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
17.2
8.1
12
7
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
17.2
8.1
12
7
I86.4
ICD-10 Finland
Gastric varices
17.2
8.1
12
7
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
8.9
8.0
16
18
OAA67, ,
SPAT
0.4
8.0
35
899
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.1
8.0
21
51
Z94.0
ICD-10 Finland
Kidney transplant status
4.1
8.0
21
51
TDA90, ,
SPAT
0.4
8.0
40
968
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
8.0
107
593
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.9
8.0
106
586
KGH10
NOMESCO Finland
Operation for phimosis
2.1
7.9
69
328
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.3
7.9
20
47
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.0
7.9
78
389
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.9
62
283
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.8
7.9
17
22
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
7.8
185
1198
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
10.8
7.8
14
13
UJD02
NOMESCO Finland
Gastroscopy
1.9
7.8
101
554
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
7.8
68
324
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.0
7.8
33
111
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
9.4
7.8
15
16
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.8
7.7
104
577
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
45.1
7.7
9
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
7.7
49
204
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
7.7
309
2241
S77
ICPC
Malignant neoplasm of skin
18.4
7.6
11
6
SPAT1269
SPAT
Other puncture and/or drainage
6.7
7.6
18
27
JG1CG
NOMESCO Finland
Extensive MRI of rectum
25.1
7.6
10
*
WPA41
NOMESCO Finland
Psychosocial conversational support in palliative care
25.1
7.6
10
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
25.1
7.6
10
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.4
7.5
49
206
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
7.5
144
886
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.7
7.5
210
3027
WX419
NOMESCO Finland
Other general anesthesy
3.9
7.4
21
54
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
7.4
229
3241
T73
ICPC
Neoplasm endocrine other/unspecified
80.4
7.4
8
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
80.4
7.4
8
*
SPAT1122
SPAT
Ascites puncture
80.4
7.4
8
*
UJF92
NOMESCO Finland
Capsular endoscopy
2.7
7.4
39
148
N06DA03
ATC
rivastigmine; oral, transdermal
0.4
7.4
34
852
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.7
7.4
16
21
A10BH02
ATC
vildagliptin; oral
2.4
7.4
49
208
ZX121
NOMESCO Finland
Central venous catheter
13.4
7.4
12
9
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.0
7.3
20
50
AXX01, ,
SPAT
0.3
7.3
17
598
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
1552A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUM HEPATIS, PRIMARIUM ALIUD]
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
7.3
7
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
7.3
7
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
7.3
7
*
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
7.3
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
7.3
7
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
7.3
7
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
7.3
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
7.3
7
*
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
+∞
7.3
7
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
7.3
7
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
N05BA04
ATC
oxazepam; oral
1.4
7.3
453
3535
SPAT1111
SPAT
Planning of analgesia
3.2
7.3
27
84
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
7.2
201
1351
L15
ICPC
Knee symptom/complaint
0.7
7.2
233
3271
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
15.8
7.2
11
7
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
7.2
120
710
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.7
7.2
22
60
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
7.2
436
5501
WZC00, ,
SPAT
0.6
7.1
111
1834
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
7.1
89
484
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.2
7.1
58
270
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.0
7.0
29
96
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.4
6.9
37
869
L08
ICPC
Shoulder symptom/complaint
0.7
6.9
215
3040
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
7.5
6.9
15
20
WPA13, ,
SPAT
13.8
6.9
11
8
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.6
6.9
97
1645
A10BJ01
ATC
exenatide; parenteral
3.3
6.8
25
77
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.8
321
2391
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.7
6.8
16
24
C09BA02
ATC
enalapril and diuretics; systemic
1.5
6.8
189
1271
TPX15
NOMESCO Finland
Removal of vascular injection port
11.0
6.8
12
11
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
40.2
6.8
8
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
40.2
6.8
8
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
40.2
6.8
8
*
WPA43
NOMESCO Finland
A doctor's home visit to perform palliative care
40.2
6.8
8
*
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
16.7
6.7
10
6
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.4
6.7
29
747
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
6.7
19
49
L02AE03
ATC
goserelin; implant
22.6
6.7
9
*
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
6.6
75
394
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.9
6.6
29
100
T93
ICPC
Lipid disorder
0.4
6.6
40
892
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
6.6
21
622
RD210, ,
NOMESCO Finland
3.0
6.5
28
95
OAB42, ,
SPAT
0.6
6.5
95
1594
G04CB02
ATC
dutasteride; oral
0.6
6.5
99
1643
E83.1
ICD-10 Finland
Disorders of iron metabolism
5.7
6.4
17
30
H02
ICPC
Hearing complaint
0.6
6.4
160
2369
PJD99
NOMESCO Finland
Excision of other lymph nodes
70.1
6.4
7
*
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
7.4
6.4
14
19
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.2
6.4
49
222
KC1GB
NOMESCO Finland
Cystography with X-ray
14.3
6.4
10
7
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.5
6.4
38
154
D02AX
ATC
Other emollients and protectives
2.3
6.4
44
191
HAB99
NOMESCO Finland
Other partial excision of mammary gland
6.6
6.3
15
23
D64.8
ICD-10 Finland
Other specified anaemias
2.4
6.3
41
173
ZXE90
NOMESCO Finland
More than 22 hours
3.5
6.3
21
61
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
9.3
6.3
12
13
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.7
6.3
31
114
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.7
6.3
161
2367
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.3
6
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.3
6
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
6.3
6
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
6.3
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.3
6
*
8010/3-C22.1
ICD-O-3
Carcinoma, NOS, of intrahepatic bile duct
+∞
6.3
6
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
6.3
6
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
6.3
6
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
6.3
6
*
9120/3-C22.0
ICD-O-3
Hemangiosarcoma of liver
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.3
6
*
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
+∞
6.3
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.3
6
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
8180/3-C22.0
ICD-O-3
Combined hepatocellular carcinoma and cholangiocarcinoma of liver
+∞
6.3
6
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
6.3
6
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
6.3
6
*
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
6.3
6
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.0
6.2
26
87
D02AE01
ATC
carbamide; topical
1.7
6.2
104
617
QX9VV, ,
NOMESCO Finland
26.7
6.2
8
*
DAB10
NOMESCO Finland
Partial excision of auricle
26.7
6.2
8
*
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
26.7
6.2
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
6.2
132
834
ED1AA
NOMESCO Finland
Mandibular X-ray examination
7.0
6.2
14
20
XX9XW, ,
NOMESCO Finland
7.0
6.2
14
20
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.6
6.2
34
132
H02AB04
ATC
methylprednisolone; systemic
1.4
6.2
246
1778
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.7
6.2
32
121
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.6
6.1
80
1386
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
6.1
59
293
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.5
6.1
36
145
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.5
6.1
36
145
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
6.1
89
508
D01AC02
ATC
miconazole; topical
1.6
6.1
157
1040
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.9
6.0
27
94
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.9
6.0
75
407
H02AB09
ATC
hydrocortisone; systemic
2.5
6.0
36
146

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Other and unspecified cirrhosis of liver
K74.6 [45538546]
3.9e+00
4.7e+00
5.2e+00
—
5.7e+00
5.1e+00
4.5e+00
cases:5.60%
controls:0.12%
cases:7.02%
controls:0.07%
cases:4.89%
controls:0.03%
—
—
cases:6.66%
controls:0.02%
cases:12.02%
controls:0.08%
cases:14.84%
controls:0.20%
118
26
1989
21034
148
14
1959
21046
103
6
2004
21054
—
126
5
1766
20986
148
17
1083
20071
76
30
436
15093
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
3.6e+00
5.2e+00
—
1.0e+50
6.7e+00
6.5e+00
5.9e+00
cases:6.17%
controls:0.19%
cases:11.87%
controls:0.07%
—
—
cases:2.61%
controls:0.00%
cases:16.60%
controls:0.02%
cases:33.14%
controls:0.07%
cases:40.43%
controls:0.19%
130
39
1977
21021
250
15
1857
21045
—
55
0
2052
21060
314
5
1578
20986
408
15
823
20073
207
28
305
15095
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.7e+00
3.7e+00
6.5e+00
1.0e+50
6.2e+00
5.2e+00
4.1e+00
cases:6.41%
controls:1.20%
cases:12.72%
controls:0.38%
cases:24.25%
controls:0.05%
cases:3.13%
controls:0.00%
cases:22.52%
controls:0.06%
cases:39.72%
controls:0.38%
cases:44.73%
controls:1.30%
135
253
1972
20807
268
79
1839
20981
511
10
1596
21050
66
0
2041
21060
426
12
1466
20979
489
76
742
20012
229
197
283
14926
Alcoholic cirrhosis of liver
K70.3 [45596343]
3.6e+00
4.0e+00
4.7e+00
1.0e+50
5.1e+00
4.5e+00
4.2e+00
cases:5.41%
controls:0.15%
cases:5.89%
controls:0.12%
cases:4.60%
controls:0.04%
cases:4.27%
controls:0.00%
cases:5.34%
controls:0.03%
cases:10.32%
controls:0.13%
cases:12.11%
controls:0.20%
114
32
1993
21028
124
25
1983
21035
97
9
2010
21051
90
0
2017
21060
101
7
1791
20984
127
26
1104
20062
62
30
450
15093
Medical Oncology
90 [38004507]
4.3e+00
5.3e+00
—
1.0e+50
—
7.9e+00
6.7e+00
cases:7.17%
controls:0.10%
cases:7.40%
controls:0.04%
—
—
cases:9.40%
controls:0.00%
—
—
cases:58.49%
controls:0.05%
cases:51.76%
controls:0.13%
151
22
1956
21038
156
8
1951
21052
—
198
0
1909
21060
—
720
10
511
20078
265
20
247
15103
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
9.1e-01
2.0e+00
4.3e+00
6.5e+00
4.5e+00
3.4e+00
2.4e+00
cases:27.95%
controls:13.53%
cases:33.03%
controls:6.34%
cases:39.39%
controls:0.87%
cases:13.86%
controls:0.02%
cases:45.19%
controls:0.87%
cases:67.26%
controls:6.59%
cases:70.12%
controls:17.83%
589
2849
1518
18211
696
1336
1411
19724
830
183
1277
20877
292
5
1815
21055
855
183
1037
20808
828
1324
403
18764
359
2696
153
12427
Ascites
R18 [45548949]
2.9e+00
3.4e+00
4.2e+00
1.0e+50
4.1e+00
4.8e+00
3.3e+00
cases:1.71%
controls:0.09%
cases:1.90%
controls:0.07%
cases:1.85%
controls:0.03%
cases:0.85%
controls:0.00%
cases:1.43%
controls:0.02%
cases:4.96%
controls:0.04%
cases:4.30%
controls:0.17%
36
20
2071
21040
40
14
2067
21046
39
6
2068
21054
18
0
2089
21060
27
5
1865
20986
61
9
1170
20079
22
26
490
15097
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.9e+00
2.8e+00
5.1e+00
1.0e+50
4.6e+00
3.9e+00
3.2e+00
cases:10.58%
controls:1.72%
cases:11.44%
controls:0.75%
cases:12.06%
controls:0.09%
cases:2.28%
controls:0.00%
cases:11.21%
controls:0.12%
cases:27.29%
controls:0.73%
cases:35.55%
controls:2.29%
223
362
1884
20698
241
157
1866
20903
254
18
1853
21042
48
0
2059
21060
212
26
1680
20965
336
146
895
19942
182
347
330
14776
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
D37.6 [45586102]
4.2e+00
5.8e+00
—
1.0e+50
—
6.5e+00
4.9e+00
cases:1.90%
controls:0.03%
cases:8.35%
controls:0.03%
—
—
cases:10.25%
controls:0.00%
—
—
cases:14.05%
controls:0.02%
cases:7.81%
controls:0.07%
40
6
2067
21054
176
6
1931
21054
—
216
0
1891
21060
—
173
5
1058
20083
40
10
472
15113
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
1.7e+00
3.7e+00
—
1.0e+50
6.2e+00
5.2e+00
4.4e+00
cases:2.90%
controls:0.53%
cases:7.59%
controls:0.21%
—
—
cases:1.95%
controls:0.00%
cases:14.80%
controls:0.03%
cases:27.38%
controls:0.20%
cases:32.62%
controls:0.57%
61
111
2046
20949
160
44
1947
21016
—
41
0
2066
21060
280
7
1612
20984
337
41
894
20047
167
86
345
15037
Chronic viral hepatitis C
B18.2 [45590846]
3.2e+00
3.3e+00
3.4e+00
1.0e+50
3.9e+00
3.8e+00
3.7e+00
cases:2.09%
controls:0.09%
cases:1.66%
controls:0.06%
cases:0.95%
controls:0.03%
cases:1.23%
controls:0.00%
cases:1.16%
controls:0.02%
cases:2.03%
controls:0.04%
cases:2.34%
controls:0.06%
44
19
2063
21041
35
13
2072
21047
20
7
2087
21053
26
0
2081
21060
22
5
1870
20986
25
9
1206
20079
12
9
500
15114
Immunohistochemistry procedure
117617002 [4035726]
1.8e+00
2.6e+00
4.1e+00
1.0e+50
5.3e+00
3.7e+00
3.4e+00
cases:3.27%
controls:0.57%
cases:2.52%
controls:0.20%
cases:2.42%
controls:0.04%
cases:7.83%
controls:0.00%
cases:5.50%
controls:0.03%
cases:5.85%
controls:0.16%
cases:13.48%
controls:0.52%
69
119
2038
20941
53
42
2054
21018
51
9
2056
21051
165
0
1942
21060
104
6
1788
20985
72
32
1159
20056
69
79
443
15044
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.9e-01
1.6e+00
3.7e+00
4.9e+00
4.1e+00
3.0e+00
2.2e+00
cases:24.02%
controls:12.54%
cases:26.53%
controls:6.69%
cases:26.48%
controls:0.93%
cases:5.46%
controls:0.04%
cases:34.67%
controls:0.87%
cases:58.33%
controls:6.73%
cases:64.45%
controls:17.15%
506
2640
1601
18420
559
1408
1548
19652
558
195
1549
20865
115
9
1992
21051
656
182
1236
20809
718
1351
513
18737
330
2594
182
12529
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
1.2e+00
2.3e+00
4.9e+00
1.0e+50
5.0e+00
3.8e+00
2.8e+00
cases:8.31%
controls:2.55%
cases:9.40%
controls:0.99%
cases:11.91%
controls:0.10%
cases:3.46%
controls:0.00%
cases:15.17%
controls:0.12%
cases:30.22%
controls:0.99%
cases:35.94%
controls:3.17%
175
536
1932
20524
198
208
1909
20852
251
22
1856
21038
73
0
2034
21060
287
25
1605
20966
372
199
859
19889
184
480
328
14643
ursodeoxycholic acid; oral
A05AA02 [21600513]
3.0e+00
3.0e+00
3.7e+00
—
3.2e+00
3.5e+00
3.7e+00
cases:2.33%
controls:0.12%
cases:2.37%
controls:0.12%
cases:1.47%
controls:0.04%
—
—
cases:1.48%
controls:0.06%
cases:3.82%
controls:0.12%
cases:5.86%
controls:0.16%
49
25
2058
21035
50
26
2057
21034
31
8
2076
21052
—
28
13
1864
20978
47
24
1184
20064
30
24
482
15099
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.1e+00
2.1e+00
3.5e+00
1.0e+50
5.2e+00
4.4e+00
2.9e+00
cases:4.70%
controls:1.69%
cases:4.08%
controls:0.51%
cases:2.56%
controls:0.08%
cases:0.76%
controls:0.00%
cases:11.58%
controls:0.07%
cases:30.22%
controls:0.55%
cases:23.44%
controls:1.61%
99
355
2008
20705
86
107
2021
20953
54
17
2053
21043
16
0
2091
21060
219
15
1673
20976
372
111
859
19977
120
244
392
14879
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.8e-01
1.4e+00
3.4e+00
5.2e+00
3.6e+00
2.5e+00
1.8e+00
cases:38.40%
controls:25.88%
cases:41.05%
controls:14.34%
cases:42.52%
controls:2.30%
cases:13.62%
controls:0.09%
cases:46.19%
controls:2.20%
cases:68.16%
controls:14.36%
cases:73.44%
controls:32.22%
809
5450
1298
15610
865
3019
1242
18041
896
485
1211
20575
287
19
1820
21041
874
462
1018
20529
839
2885
392
17203
376
4872
136
10251
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
8.2e-01
1.4e+00
2.8e+00
4.2e+00
3.4e+00
3.1e+00
2.5e+00
cases:5.27%
controls:2.40%
cases:5.89%
controls:1.48%
cases:5.17%
controls:0.32%
cases:1.85%
controls:0.03%
cases:8.83%
controls:0.31%
cases:25.26%
controls:1.48%
cases:29.88%
controls:3.46%
111
505
1996
20555
124
312
1983
20748
109
67
1998
20993
39
6
2068
21054
167
66
1725
20925
311
298
920
19790
153
524
359
14599
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
2.4e+00
3.4e+00
5.1e+00
1.0e+50
—
4.2e+00
3.1e+00
cases:4.08%
controls:0.39%
cases:4.79%
controls:0.16%
cases:3.65%
controls:0.02%
cases:1.47%
controls:0.00%
—
—
cases:13.08%
controls:0.22%
cases:14.26%
controls:0.73%
86
83
2021
20977
101
34
2006
21026
77
5
2030
21055
31
0
2076
21060
—
161
44
1070
20044
73
111
439
15012
Upper gastrointestinal surgery
106 [44777669]
6.9e-01
1.9e+00
4.1e+00
—
4.8e+00
3.7e+00
2.8e+00
cases:19.98%
controls:11.10%
cases:21.03%
controls:3.89%
cases:25.44%
controls:0.56%
—
—
cases:37.74%
controls:0.50%
cases:58.25%
controls:3.39%
cases:67.97%
controls:11.29%
421
2338
1686
18722
443
820
1664
20240
536
117
1571
20943
—
714
106
1178
20885
717
681
514
19407
348
1708
164
13415
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
5.0e-01
1.3e+00
3.5e+00
5.4e+00
3.5e+00
2.2e+00
1.5e+00
cases:28.29%
controls:19.37%
cases:25.87%
controls:8.76%
cases:24.44%
controls:0.97%
cases:6.93%
controls:0.03%
cases:22.09%
controls:0.82%
cases:44.19%
controls:8.16%
cases:55.86%
controls:21.77%
596
4080
1511
16980
545
1844
1562
19216
515
204
1592
20856
146
7
1961
21053
418
172
1474
20819
544
1639
687
18449
286
3293
226
11830
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.5e-01
1.1e+00
3.4e+00
5.1e+00
3.5e+00
2.7e+00
1.6e+00
cases:16.94%
controls:11.48%
cases:12.96%
controls:4.57%
cases:13.81%
controls:0.54%
cases:5.08%
controls:0.03%
cases:13.58%
controls:0.49%
cases:37.04%
controls:3.91%
cases:42.19%
controls:12.80%
357
2417
1750
18643
273
962
1834
20098
291
114
1816
20946
107
7
2000
21053
257
103
1635
20888
456
786
775
19302
216
1936
296
13187
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.9e+00
3.1e+00
5.2e+00
1.0e+50
—
4.3e+00
3.0e+00
cases:5.60%
controls:0.90%
cases:5.55%
controls:0.26%
cases:4.03%
controls:0.02%
cases:3.70%
controls:0.00%
—
—
cases:13.48%
controls:0.20%
cases:16.60%
controls:0.97%
118
190
1989
20870
117
55
1990
21005
85
5
2022
21055
78
0
2029
21060
—
166
41
1065
20047
85
147
427
14976
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.8e+00
2.5e+00
4.5e+00
—
3.4e+00
2.9e+00
2.0e+00
cases:2.42%
controls:0.39%
cases:3.42%
controls:0.30%
cases:2.61%
controls:0.03%
—
—
cases:1.80%
controls:0.06%
cases:5.85%
controls:0.35%
cases:9.96%
controls:1.42%
51
83
2056
20977
72
63
2035
20997
55
6
2052
21054
—
34
13
1858
20978
72
71
1159
20017
51
214
461
14909
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
1.3e+00
2.2e+00
4.5e+00
—
4.3e+00
3.0e+00
1.8e+00
cases:6.93%
controls:1.91%
cases:6.41%
controls:0.76%
cases:5.08%
controls:0.06%
—
—
cases:5.44%
controls:0.08%
cases:10.89%
controls:0.63%
cases:10.74%
controls:1.92%
146
403
1961
20657
135
160
1972
20900
107
13
2000
21047
—
103
17
1789
20974
134
126
1097
19962
55
290
457
14833
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.3e+00
2.0e+00
4.3e+00
—
4.3e+00
3.0e+00
1.8e+00
cases:6.74%
controls:1.92%
cases:5.55%
controls:0.77%
cases:4.84%
controls:0.07%
—
—
cases:4.92%
controls:0.07%
cases:10.32%
controls:0.58%
cases:9.96%
controls:1.81%
142
405
1965
20655
117
162
1990
20898
102
15
2005
21045
—
93
14
1799
20977
127
116
1104
19972
51
274
461
14849
Oesophageal varices without bleeding
I85.9 [45581834]
4.1e+00
4.2e+00
—
1.0e+50
—
4.3e+00
4.0e+00
cases:4.98%
controls:0.09%
cases:4.41%
controls:0.07%
—
—
cases:1.23%
controls:0.00%
—
—
cases:4.63%
controls:0.06%
cases:7.03%
controls:0.13%
105
18
2002
21042
93
14
2014
21046
—
26
0
2081
21060
—
57
13
1174
20075
36
20
476
15103
General Surgery
2 [38004447]
4.1e-01
9.9e-01
2.8e+00
5.9e+00
3.1e+00
2.0e+00
1.4e+00
cases:22.73%
controls:16.39%
cases:11.87%
controls:4.76%
cases:10.58%
controls:0.69%
cases:8.35%
controls:0.02%
cases:11.63%
controls:0.59%
cases:25.91%
controls:4.50%
cases:37.89%
controls:13.53%
479
3451
1628
17609
250
1002
1857
20058
223
146
1884
20914
176
5
1931
21055
220
123
1672
20868
319
903
912
19185
194
2046
318
13077
Oncology Clinic/Center
261QX0200X [38004268]
3.7e+00
4.5e+00
—
—
1.0e+50
4.9e+00
3.5e+00
cases:10.73%
controls:0.29%
cases:7.64%
controls:0.09%
—
—
—
—
cases:16.81%
controls:0.00%
cases:9.83%
controls:0.08%
cases:10.55%
controls:0.35%
226
62
1881
20998
161
20
1946
21040
—
—
318
0
1574
20991
121
16
1110
20072
54
53
458
15070
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.7e+00
2.5e+00
4.2e+00
1.0e+50
3.8e+00
2.5e+00
1.7e+00
cases:5.93%
controls:1.17%
cases:5.03%
controls:0.44%
cases:2.47%
controls:0.04%
cases:0.33%
controls:0.00%
cases:2.11%
controls:0.05%
cases:4.14%
controls:0.35%
cases:6.25%
controls:1.24%
125
246
1982
20814
106
93
2001
20967
52
8
2055
21052
7
0
2100
21060
40
10
1852
20981
51
71
1180
20017
32
187
480
14936
Outpatient Hospital
22 [8756]
4.2e-01
9.5e-01
2.6e+00
6.2e+00
3.1e+00
2.0e+00
1.0e+00
cases:35.36%
controls:26.44%
cases:16.61%
controls:7.18%
cases:11.53%
controls:0.96%
cases:10.20%
controls:0.02%
cases:15.70%
controls:0.82%
cases:31.93%
controls:6.03%
cases:34.96%
controls:16.43%
745
5569
1362
15491
350
1513
1757
19547
243
203
1864
20857
215
5
1892
21055
297
172
1595
20819
393
1212
838
18876
179
2484
333
12639
Abdominal CT examination
JN3AD [2001305554]
6.0e-01
2.0e+00
4.3e+00
—
4.3e+00
3.0e+00
2.0e+00
cases:2.18%
controls:1.21%
cases:4.84%
controls:0.69%
cases:4.22%
controls:0.06%
—
—
cases:2.33%
controls:0.03%
cases:11.78%
controls:0.68%
cases:17.58%
controls:2.72%
46
255
2061
20805
102
145
2005
20915
89
12
2018
21048
—
44
7
1848
20984
145
136
1086
19952
90
412
422
14711
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
2.3e+00
4.4e+00
—
1.0e+50
—
5.5e+00
4.1e+00
cases:1.61%
controls:0.17%
cases:5.32%
controls:0.07%
—
—
cases:1.42%
controls:0.00%
—
—
cases:14.46%
controls:0.07%
cases:13.28%
controls:0.26%
34
36
2073
21024
112
15
1995
21045
—
30
0
2077
21060
—
178
14
1053
20074
68
40
444
15083
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
2.9e+00
4.0e+00
—
1.0e+50
1.0e+50
4.8e+00
4.5e+00
cases:1.38%
controls:0.08%
cases:1.95%
controls:0.04%
—
—
cases:0.81%
controls:0.00%
cases:1.22%
controls:0.00%
cases:4.55%
controls:0.04%
cases:8.40%
controls:0.11%
29
16
2078
21044
41
8
2066
21052
—
17
0
2090
21060
23
0
1869
20991
56
8
1175
20080
43
16
469
15107
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
1.1e+00
1.9e+00
4.0e+00
—
4.4e+00
2.9e+00
1.9e+00
cases:3.18%
controls:1.13%
cases:2.75%
controls:0.41%
cases:1.95%
controls:0.04%
—
—
cases:2.59%
controls:0.03%
cases:5.85%
controls:0.35%
cases:6.45%
controls:0.99%
67
238
2040
20822
58
87
2049
20973
41
8
2066
21052
—
49
7
1843
20984
72
71
1159
20017
33
149
479
14974
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
5.2e-01
1.4e+00
2.9e+00
1.0e+50
4.4e+00
4.4e+00
3.1e+00
cases:1.28%
controls:0.76%
cases:0.95%
controls:0.23%
cases:0.90%
controls:0.05%
cases:1.04%
controls:0.00%
cases:1.85%
controls:0.02%
cases:11.54%
controls:0.16%
cases:9.57%
controls:0.48%
27
161
2080
20899
20
49
2087
21011
19
11
2088
21049
22
0
2085
21060
35
5
1857
20986
142
33
1089
20055
49
73
463
15050
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
8.1e-01
1.7e+00
4.1e+00
—
4.2e+00
3.0e+00
2.3e+00
cases:14.29%
controls:6.92%
cases:16.42%
controls:3.31%
cases:20.60%
controls:0.44%
—
—
cases:19.87%
controls:0.39%
cases:36.64%
controls:2.84%
cases:45.31%
controls:7.89%
301
1458
1806
19602
346
697
1761
20363
434
92
1673
20968
—
376
81
1516
20910
451
571
780
19517
232
1193
280
13930
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
6.6e-01
1.3e+00
2.5e+00
2.9e+00
3.4e+00
2.8e+00
2.3e+00
cases:6.64%
controls:3.56%
cases:5.65%
controls:1.65%
cases:2.61%
controls:0.21%
cases:0.62%
controls:0.03%
cases:5.34%
controls:0.18%
cases:20.96%
controls:1.52%
cases:33.79%
controls:4.79%
140
750
1967
20310
119
347
1988
20713
55
45
2052
21015
13
7
2094
21053
101
38
1791
20953
258
305
973
19783
173
724
339
14399
Body CT examination
JN4AD [2001310897]
1.5e+00
2.6e+00
—
1.0e+50
4.4e+00
4.2e+00
3.3e+00
cases:2.09%
controls:0.48%
cases:4.13%
controls:0.33%
—
—
cases:3.75%
controls:0.00%
cases:2.70%
controls:0.03%
cases:17.30%
controls:0.32%
cases:26.17%
controls:1.30%
44
102
2063
20958
87
69
2020
20991
—
79
0
2028
21060
51
7
1841
20984
213
65
1018
20023
134
196
378
14927
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.1e+00
1.9e+00
4.3e+00
—
3.7e+00
2.9e+00
2.0e+00
cases:5.60%
controls:1.92%
cases:5.17%
controls:0.84%
cases:5.41%
controls:0.08%
—
—
cases:4.49%
controls:0.12%
cases:12.43%
controls:0.80%
cases:16.41%
controls:2.59%
118
404
1989
20656
109
177
1998
20883
114
17
1993
21043
—
85
25
1807
20966
153
160
1078
19928
84
392
428
14731
Palliative care
Z51.5 [45547323]
—
2.1e+00
—
1.0e+50
5.6e+00
4.7e+00
3.4e+00
—
—
cases:0.76%
controls:0.09%
—
—
cases:3.99%
controls:0.00%
cases:8.14%
controls:0.03%
cases:19.25%
controls:0.22%
cases:21.88%
controls:0.91%
—
16
20
2091
21040
—
84
0
2023
21060
154
7
1738
20984
237
45
994
20043
112
138
400
14985
INR in Blood by Coagulation assay
34714-6 [3032080]
5.2e-01
1.3e+00
2.7e+00
4.1e+00
2.7e+00
2.5e+00
1.8e+00
cases:26.63%
controls:17.68%
cases:28.48%
controls:10.20%
cases:35.55%
controls:3.67%
cases:12.91%
controls:0.26%
cases:36.42%
controls:3.61%
cases:57.03%
controls:10.23%
cases:61.72%
controls:20.50%
561
3724
1546
17336
600
2149
1507
18911
749
773
1358
20287
272
54
1835
21006
689
757
1203
20234
702
2055
529
18033
316
3100
196
12023
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
1.6e+00
2.7e+00
—
3.5e+00
3.4e+00
3.2e+00
cases:0.85%
controls:0.31%
cases:0.85%
controls:0.18%
cases:0.85%
controls:0.06%
—
—
cases:1.22%
controls:0.04%
cases:5.93%
controls:0.21%
cases:11.52%
controls:0.51%
18
65
2089
20995
18
38
2089
21022
18
12
2089
21048
—
23
8
1869
20983
73
42
1158
20046
59
77
453
15046
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.1e-01
9.1e-01
2.9e+00
4.6e+00
3.0e+00
2.1e+00
1.4e+00
cases:24.49%
controls:19.22%
cases:19.74%
controls:9.01%
cases:18.22%
controls:1.22%
cases:6.98%
controls:0.08%
cases:18.08%
controls:1.11%
cases:46.22%
controls:9.19%
cases:56.64%
controls:24.56%
516
4048
1591
17012
416
1897
1691
19163
384
257
1723
20803
147
16
1960
21044
342
234
1550
20757
569
1847
662
18241
290
3714
222
11409
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
7.9e-01
1.7e+00
2.9e+00
—
3.9e+00
3.5e+00
2.4e+00
cases:1.33%
controls:0.61%
cases:1.38%
controls:0.26%
cases:0.71%
controls:0.04%
—
—
cases:1.37%
controls:0.03%
cases:6.17%
controls:0.20%
cases:6.64%
controls:0.63%
28
128
2079
20932
29
54
2078
21006
15
8
2092
21052
—
26
6
1866
20985
76
41
1155
20047
34
95
478
15028
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
JKE98 [2001305336]
2.9e+00
3.8e+00
—
1.0e+50
1.0e+50
4.2e+00
4.2e+00
cases:1.42%
controls:0.08%
cases:1.76%
controls:0.04%
—
—
cases:1.19%
controls:0.00%
cases:0.90%
controls:0.00%
cases:2.84%
controls:0.04%
cases:5.08%
controls:0.08%
30
16
2077
21044
37
8
2070
21052
—
25
0
2082
21060
17
0
1875
20991
35
9
1196
20079
26
12
486
15111
Emergency Room and Inpatient Visit
ERIP [262]
4.9e-01
1.0e+00
2.7e+00
5.4e+00
2.6e+00
1.8e+00
9.6e-01
cases:11.49%
controls:7.34%
cases:12.06%
controls:4.58%
cases:8.54%
controls:0.63%
cases:7.93%
controls:0.04%
cases:8.09%
controls:0.62%
cases:25.67%
controls:5.25%
cases:33.40%
controls:16.15%
242
1545
1865
19515
254
965
1853
20095
180
132
1927
20928
167
8
1940
21052
153
130
1739
20861
316
1055
915
19033
171
2442
341
12681
Thorax X-ray examination
GD1AA [2001303617]
4.5e-01
1.1e+00
2.5e+00
4.9e+00
2.5e+00
2.1e+00
1.4e+00
cases:18.04%
controls:12.29%
cases:12.53%
controls:4.45%
cases:5.51%
controls:0.48%
cases:3.13%
controls:0.02%
cases:5.44%
controls:0.49%
cases:26.89%
controls:4.19%
cases:38.48%
controls:13.24%
380
2589
1727
18471
264
937
1843
20123
116
102
1991
20958
66
5
2041
21055
103
103
1789
20888
331
842
900
19246
197
2002
315
13121
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
8.0e-01
1.7e+00
3.8e+00
—
3.9e+00
2.7e+00
2.0e+00
cases:17.51%
controls:8.74%
cases:17.28%
controls:3.78%
cases:17.04%
controls:0.47%
—
—
cases:17.55%
controls:0.41%
cases:36.47%
controls:3.83%
cases:46.68%
controls:10.78%
369
1841
1738
19219
364
796
1743
20264
359
99
1748
20961
—
332
87
1560
20904
449
770
782
19318
239
1630
273
13493
Inpatient Hospital
21 [8717]
4.0e-01
8.9e-01
2.6e+00
5.5e+00
3.0e+00
1.7e+00
7.4e-01
cases:42.95%
controls:33.65%
cases:23.87%
controls:11.39%
cases:19.17%
controls:1.80%
cases:17.61%
controls:0.09%
cases:25.79%
controls:1.73%
cases:40.45%
controls:10.74%
cases:40.82%
controls:24.72%
905
7087
1202
13973
503
2399
1604
18661
404
380
1703
20680
371
19
1736
21041
488
364
1404
20627
498
2158
733
17930
209
3738
303
11385
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
2.8e+00
4.5e+00
1.0e+50
1.0e+50
—
4.6e+00
2.9e+00
cases:2.18%
controls:0.14%
cases:1.99%
controls:0.02%
cases:1.00%
controls:0.00%
cases:0.28%
controls:0.00%
—
—
cases:2.92%
controls:0.03%
cases:3.91%
controls:0.22%
46
30
2061
21030
42
5
2065
21055
21
0
2086
21060
6
0
2101
21060
—
36
6
1195
20082
20
34
492
15089
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.3e-01
1.0e+00
2.3e+00
3.9e+00
2.9e+00
2.3e+00
1.7e+00
cases:23.73%
controls:15.53%
cases:22.07%
controls:9.02%
cases:15.05%
controls:1.69%
cases:3.13%
controls:0.07%
cases:22.04%
controls:1.47%
cases:47.77%
controls:8.77%
cases:57.62%
controls:20.10%
500
3270
1607
17790
465
1899
1642
19161
317
356
1790
20704
66
14
2041
21046
417
308
1475
20683
588
1762
643
18326
295
3040
217
12083
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.3e+00
1.7e+00
2.5e+00
—
3.3e+00
2.9e+00
3.0e+00
cases:1.76%
controls:0.51%
cases:1.90%
controls:0.36%
cases:0.90%
controls:0.07%
—
—
cases:1.32%
controls:0.05%
cases:5.52%
controls:0.33%
cases:13.48%
controls:0.78%
37
107
2070
20953
40
76
2067
20984
19
15
2088
21045
—
25
10
1867
20981
68
67
1163
20021
69
118
443
15005
Cholangitis
K83.0 [45552955]
2.6e+00
3.4e+00
—
1.0e+50
—
4.3e+00
4.3e+00
cases:1.99%
controls:0.15%
cases:2.42%
controls:0.09%
—
—
cases:1.23%
controls:0.00%
—
—
cases:5.69%
controls:0.08%
cases:9.18%
controls:0.14%
42
32
2065
21028
51
18
2056
21042
—
26
0
2081
21060
—
70
16
1161
20072
47
21
465
15102
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
9.9e-01
1.6e+00
3.3e+00
—
4.0e+00
2.6e+00
2.0e+00
cases:5.89%
controls:2.26%
cases:5.36%
controls:1.13%
cases:4.03%
controls:0.15%
—
—
cases:4.70%
controls:0.09%
cases:13.24%
controls:1.08%
cases:18.75%
controls:3.17%
124
476
1983
20584
113
237
1994
20823
85
32
2022
21028
—
89
19
1803
20972
163
216
1068
19872
96
479
416
14644
Gastroenterology
10 [38004455]
1.3e+00
2.0e+00
3.1e+00
—
3.4e+00
2.5e+00
2.0e+00
cases:19.08%
controls:5.85%
cases:16.09%
controls:2.49%
cases:10.54%
controls:0.52%
—
—
cases:11.52%
controls:0.43%
cases:24.21%
controls:2.68%
cases:35.74%
controls:6.70%
402
1233
1705
19827
339
524
1768
20536
222
110
1885
20950
—
218
91
1674
20900
298
538
933
19550
183
1013
329
14110
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
5.8e-01
1.6e+00
3.3e+00
1.0e+50
3.3e+00
3.4e+00
2.7e+00
cases:1.14%
controls:0.64%
cases:1.23%
controls:0.25%
cases:0.62%
controls:0.02%
cases:0.52%
controls:0.00%
cases:0.74%
controls:0.03%
cases:5.36%
controls:0.19%
cases:6.64%
controls:0.46%
24
135
2083
20925
26
53
2081
21007
13
5
2094
21055
11
0
2096
21060
14
6
1878
20985
66
38
1165
20050
34
70
478
15053
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 [3021197]
1.6e+00
2.6e+00
—
—
—
4.7e+00
5.3e+00
cases:0.43%
controls:0.09%
cases:0.57%
controls:0.04%
—
—
—
—
—
—
cases:2.76%
controls:0.02%
cases:7.42%
controls:0.04%
9
19
2098
21041
12
9
2095
21051
—
—
—
34
5
1197
20083
38
6
474
15117
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.6e+00
2.2e+00
3.4e+00
—
3.3e+00
2.1e+00
1.6e+00
cases:6.64%
controls:1.47%
cases:5.93%
controls:0.66%
cases:2.75%
controls:0.09%
—
—
cases:2.22%
controls:0.09%
cases:4.71%
controls:0.58%
cases:7.62%
controls:1.72%
140
309
1967
20751
125
140
1982
20920
58
20
2049
21040
—
42
18
1850
20973
58
117
1173
19971
39
260
473
14863
tinzaparin; parenteral
B01AB10 [21600981]
9.2e-01
1.3e+00
3.3e+00
—
3.5e+00
3.2e+00
1.8e+00
cases:1.85%
controls:0.75%
cases:1.71%
controls:0.45%
cases:1.38%
controls:0.05%
—
—
cases:2.91%
controls:0.09%
cases:8.77%
controls:0.39%
cases:8.59%
controls:1.47%
39
157
2068
20903
36
95
2071
20965
29
11
2078
21049
—
55
19
1837
20972
108
78
1123
20010
44
223
468
14900
Cathetrisation of abdominal cavity with ultrasound guidance
JA3AT [2001304536]
2.8e+00
3.3e+00
—
1.0e+50
1.0e+50
4.5e+00
3.4e+00
cases:1.33%
controls:0.08%
cases:1.23%
controls:0.05%
—
—
cases:1.00%
controls:0.00%
cases:1.16%
controls:0.00%
cases:3.98%
controls:0.04%
cases:3.91%
controls:0.13%
28
17
2079
21043
26
10
2081
21050
—
21
0
2086
21060
22
0
1870
20991
49
9
1182
20079
20
20
492
15103
Emergency Room Visit
ER [9203]
3.6e-01
9.7e-01
2.7e+00
5.2e+00
2.4e+00
1.6e+00
8.7e-01
cases:46.27%
controls:37.57%
cases:27.76%
controls:12.75%
cases:20.74%
controls:1.70%
cases:13.05%
controls:0.09%
cases:13.95%
controls:1.51%
cases:39.64%
controls:12.11%
cases:52.54%
controls:31.69%
975
7913
1132
13147
585
2685
1522
18375
437
358
1670
20702
275
18
1832
21042
264
316
1628
20675
488
2433
743
17655
269
4793
243
10330
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.3e+00
1.5e+00
2.3e+00
—
3.2e+00
2.9e+00
2.8e+00
cases:0.76%
controls:0.22%
cases:0.57%
controls:0.13%
cases:0.38%
controls:0.04%
—
—
cases:0.58%
controls:0.02%
cases:2.44%
controls:0.13%
cases:6.25%
controls:0.40%
16
46
2091
21014
12
27
2095
21033
8
8
2099
21052
—
11
5
1881
20986
30
27
1201
20061
32
60
480
15063
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.9e-01
1.6e+00
3.8e+00
—
3.8e+00
2.5e+00
1.5e+00
cases:15.33%
controls:8.33%
cases:15.61%
controls:3.47%
cases:14.71%
controls:0.38%
—
—
cases:12.84%
controls:0.34%
cases:28.68%
controls:3.35%
cases:34.77%
controls:10.22%
323
1754
1784
19306
329
731
1778
20329
310
79
1797
20981
—
243
72
1649
20919
353
673
878
19415
178
1546
334
13577
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
1.3e+00
1.6e+00
3.6e+00
1.0e+50
3.0e+00
2.7e+00
1.8e+00
cases:2.18%
controls:0.61%
cases:1.14%
controls:0.24%
cases:0.85%
controls:0.02%
cases:0.28%
controls:0.00%
cases:0.63%
controls:0.03%
cases:3.33%
controls:0.23%
cases:4.69%
controls:0.80%
46
129
2061
20931
24
51
2083
21009
18
5
2089
21055
6
0
2101
21060
12
7
1880
20984
41
47
1190
20041
24
121
488
15002
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.4e-01
1.0e+00
2.2e+00
4.2e+00
2.7e+00
1.9e+00
1.5e+00
cases:18.65%
controls:12.90%
cases:16.37%
controls:6.49%
cases:8.59%
controls:1.05%
cases:3.51%
controls:0.06%
cases:12.74%
controls:0.96%
cases:33.06%
controls:7.04%
cases:47.85%
controls:17.59%
393
2716
1714
18344
345
1366
1762
19694
181
222
1926
20838
74
12
2033
21048
241
201
1651
20790
407
1415
824
18673
245
2660
267
12463
Endoscopic internal drainage of bile duct
JKE18 [2001305331]
2.4e+00
3.8e+00
1.0e+50
1.0e+50
1.0e+50
4.5e+00
3.1e+00
cases:0.38%
controls:0.03%
cases:1.42%
controls:0.03%
cases:1.52%
controls:0.00%
cases:1.09%
controls:0.00%
cases:1.16%
controls:0.00%
cases:2.52%
controls:0.03%
cases:1.95%
controls:0.09%
8
7
2099
21053
30
7
2077
21053
32
0
2075
21060
23
0
2084
21060
22
0
1870
20991
31
6
1200
20082
10
14
502
15109
HLA Ab [Presence] in Serum
44534-6 [3042733]
1.4e+00
2.8e+00
—
1.0e+50
2.6e+00
4.1e+00
4.2e+00
cases:0.38%
controls:0.09%
cases:1.04%
controls:0.07%
—
—
cases:0.24%
controls:0.00%
cases:0.32%
controls:0.02%
cases:2.76%
controls:0.04%
cases:3.52%
controls:0.05%
8
20
2099
21040
22
14
2085
21046
—
5
0
2102
21060
6
5
1886
20986
34
9
1197
20079
18
8
494
15115
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.0e+00
1.6e+00
3.4e+00
1.0e+50
3.4e+00
2.4e+00
1.8e+00
cases:7.93%
controls:2.93%
cases:4.79%
controls:1.00%
cases:2.85%
controls:0.10%
cases:0.76%
controls:0.00%
cases:2.38%
controls:0.08%
cases:8.77%
controls:0.83%
cases:13.67%
controls:2.57%
167
617
1940
20443
101
210
2006
20850
60
21
2047
21039
16
0
2091
21060
45
17
1847
20974
108
166
1123
19922
70
388
442
14735
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.4e-01
1.3e+00
3.4e+00
—
3.6e+00
2.9e+00
1.9e+00
cases:9.49%
controls:5.74%
cases:7.55%
controls:2.16%
cases:8.64%
controls:0.31%
—
—
cases:7.19%
controls:0.22%
cases:26.97%
controls:1.96%
cases:30.47%
controls:6.13%
200
1209
1907
19851
159
454
1948
20606
182
65
1925
20995
—
136
46
1756
20945
332
393
899
19695
156
927
356
14196
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
5.3e-01
1.2e+00
2.2e+00
3.1e+00
2.7e+00
2.4e+00
1.5e+00
cases:13.29%
controls:8.29%
cases:7.88%
controls:2.63%
cases:4.94%
controls:0.57%
cases:0.62%
controls:0.03%
cases:7.77%
controls:0.55%
cases:21.93%
controls:2.44%
cases:24.80%
controls:6.65%
280
1746
1827
19314
166
553
1941
20507
104
119
2003
20941
13
6
2094
21054
147
115
1745
20876
270
491
961
19597
127
1006
385
14117
MRI examination of upper part of abodmen with high intensity magnet
JN1BG [2001305523]
2.1e+00
3.2e+00
—
1.0e+50
—
4.4e+00
3.9e+00
cases:0.33%
controls:0.04%
cases:0.71%
controls:0.03%
—
—
cases:0.47%
controls:0.00%
—
—
cases:2.03%
controls:0.02%
cases:3.91%
controls:0.08%
7
9
2100
21051
15
6
2092
21054
—
10
0
2097
21060
—
25
5
1206
20083
20
12
492
15111
Treatment plan or consultation
WZC00 [2001310885]
6.7e-01
1.2e+00
2.4e+00
1.0e+50
4.1e+00
3.1e+00
2.1e+00
cases:8.69%
controls:4.63%
cases:4.65%
controls:1.49%
cases:1.42%
controls:0.13%
cases:2.14%
controls:0.00%
cases:8.99%
controls:0.16%
cases:25.51%
controls:1.46%
cases:31.84%
controls:5.41%
183
976
1924
20084
98
313
2009
20747
30
28
2077
21032
45
0
2062
21060
170
34
1722
20957
314
294
917
19794
163
818
349
14305
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
5.3e-01
1.3e+00
3.4e+00
—
3.7e+00
2.9e+00
1.7e+00
cases:12.67%
controls:7.87%
cases:9.87%
controls:2.90%
cases:11.49%
controls:0.41%
—
—
cases:9.99%
controls:0.27%
cases:31.03%
controls:2.53%
cases:34.38%
controls:8.61%
267
1657
1840
19403
208
610
1899
20450
242
87
1865
20973
—
189
57
1703
20934
382
509
849
19579
176
1302
336
13821
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.0e-01
8.7e-01
2.6e+00
4.0e+00
2.9e+00
1.8e+00
1.0e+00
cases:47.46%
controls:40.19%
cases:44.52%
controls:25.15%
cases:38.73%
controls:4.70%
cases:18.04%
controls:0.39%
cases:43.92%
controls:4.31%
cases:67.34%
controls:25.26%
cases:73.83%
controls:49.91%
1000
8465
1107
12595
938
5296
1169
15764
816
989
1291
20071
380
82
1727
20978
831
904
1061
20087
829
5075
402
15013
378
7548
134
7575
oxycodone; oral, parenteral
N02AA05 [21604260]
3.6e-01
1.4e+00
2.6e+00
—
3.9e+00
3.3e+00
2.2e+00
cases:2.80%
controls:1.97%
cases:4.27%
controls:1.10%
cases:3.89%
controls:0.31%
—
—
cases:13.11%
controls:0.30%
cases:27.78%
controls:1.38%
cases:27.73%
controls:4.03%
59
414
2048
20646
90
232
2017
20828
82
65
2025
20995
—
248
62
1644
20929
342
278
889
19810
142
609
370
14514
Abdominal ultrasound examination
JN3AE [2001305555]
1.1e+00
2.4e+00
—
1.0e+50
4.5e+00
3.2e+00
2.2e+00
cases:4.84%
controls:1.71%
cases:5.03%
controls:0.47%
—
—
cases:1.57%
controls:0.00%
cases:2.54%
controls:0.03%
cases:8.77%
controls:0.41%
cases:12.50%
controls:1.57%
102
360
2005
20700
106
98
2001
20962
—
33
0
2074
21060
48
6
1844
20985
108
82
1123
20006
64
238
448
14885
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
8.1e-01
1.1e+00
2.0e+00
4.8e+00
2.4e+00
1.4e+00
8.4e-01
cases:19.13%
controls:9.48%
cases:13.10%
controls:4.84%
cases:5.65%
controls:0.82%
cases:4.94%
controls:0.04%
cases:8.30%
controls:0.78%
cases:18.36%
controls:5.29%
cases:23.83%
controls:11.93%
403
1997
1704
19063
276
1019
1831
20041
119
173
1988
20887
104
9
2003
21051
157
163
1735
20828
226
1062
1005
19026
122
1804
390
13319
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.0e-01
9.7e-01
2.2e+00
3.7e+00
2.8e+00
1.9e+00
1.4e+00
cases:20.27%
controls:14.53%
cases:18.04%
controls:7.68%
cases:9.63%
controls:1.19%
cases:3.04%
controls:0.08%
cases:14.38%
controls:1.04%
cases:36.80%
controls:8.15%
cases:51.56%
controls:21.08%
427
3059
1680
18001
380
1618
1727
19442
203
250
1904
20810
64
16
2043
21044
272
218
1620
20773
453
1637
778
18451
264
3188
248
11935
pH of Serum or Plasma
2753-2 [3018418]
5.0e-01
1.0e+00
2.1e+00
3.9e+00
2.6e+00
1.7e+00
1.4e+00
cases:12.15%
controls:7.71%
cases:10.35%
controls:4.08%
cases:5.41%
controls:0.71%
cases:1.14%
controls:0.02%
cases:7.98%
controls:0.61%
cases:20.71%
controls:4.39%
cases:35.35%
controls:11.70%
256
1624
1851
19436
218
859
1889
20201
114
150
1993
20910
24
5
2083
21055
151
128
1741
20863
255
882
976
19206
181
1769
331
13354
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
2.4e+00
3.7e+00
1.0e+50
1.0e+50
—
4.3e+00
2.9e+00
cases:3.04%
controls:0.28%
cases:2.52%
controls:0.07%
cases:2.28%
controls:0.00%
cases:0.52%
controls:0.00%
—
—
cases:5.12%
controls:0.07%
cases:5.66%
controls:0.33%
64
58
2043
21002
53
14
2054
21046
48
0
2059
21060
11
0
2096
21060
—
63
15
1168
20073
29
50
483
15073
dexamethasone; oral, parenteral
H02AB02 [21602730]
7.5e-01
1.3e+00
2.4e+00
1.0e+50
4.1e+00
3.1e+00
1.6e+00
cases:3.08%
controls:1.48%
cases:2.52%
controls:0.70%
cases:0.85%
controls:0.08%
cases:0.24%
controls:0.00%
cases:5.60%
controls:0.10%
cases:14.62%
controls:0.74%
cases:12.50%
controls:2.79%
65
311
2042
20749
53
148
2054
20912
18
17
2089
21043
5
0
2102
21060
106
21
1786
20970
180
148
1051
19940
64
422
448
14701
Internal Medicine
11 [38004456]
5.3e-01
9.3e-01
2.4e+00
4.9e+00
2.2e+00
1.4e+00
8.1e-01
cases:37.59%
controls:26.22%
cases:23.07%
controls:10.58%
cases:14.90%
controls:1.59%
cases:10.01%
controls:0.08%
cases:13.00%
controls:1.63%
cases:31.36%
controls:10.23%
cases:41.60%
controls:24.08%
792
5522
1315
15538
486
2229
1621
18831
314
334
1793
20726
211
17
1896
21043
246
343
1646
20648
386
2056
845
18032
213
3642
299
11481
Hematology
82 [38004501]
1.2e+00
2.0e+00
2.8e+00
—
3.0e+00
2.3e+00
1.8e+00
cases:2.75%
controls:0.84%
cases:2.28%
controls:0.30%
cases:1.19%
controls:0.07%
—
—
cases:1.27%
controls:0.07%
cases:3.41%
controls:0.36%
cases:4.69%
controls:0.79%
58
176
2049
20884
48
64
2059
20996
25
15
2082
21045
—
24
14
1868
20977
42
73
1189
20015
24
119
488
15004
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
1.4e+00
2.9e+00
1.0e+50
1.0e+50
—
4.8e+00
4.0e+00
cases:1.23%
controls:0.29%
cases:1.57%
controls:0.09%
cases:1.38%
controls:0.00%
cases:0.81%
controls:0.00%
—
—
cases:4.47%
controls:0.04%
cases:6.25%
controls:0.13%
26
62
2081
20998
33
18
2074
21042
29
0
2078
21060
17
0
2090
21060
—
55
8
1176
20080
32
19
480
15104
Liver Pathology biopsy report
65752-8 [40768441]
3.2e+00
4.4e+00
—
1.0e+50
—
—
5.4e+00
cases:1.42%
controls:0.06%
cases:1.90%
controls:0.02%
—
—
cases:8.59%
controls:0.00%
—
—
—
—
cases:12.50%
controls:0.07%
30
13
2077
21047
40
5
2067
21055
—
181
0
1926
21060
—
—
64
10
448
15113
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
4.4e-01
7.8e-01
2.4e+00
4.0e+00
2.2e+00
1.9e+00
1.1e+00
cases:5.13%
controls:3.35%
cases:3.89%
controls:1.81%
cases:2.66%
controls:0.24%
cases:1.23%
controls:0.02%
cases:2.11%
controls:0.23%
cases:12.67%
controls:2.09%
cases:18.95%
controls:7.01%
108
705
1999
20355
82
382
2025
20678
56
50
2051
21010
26
5
2081
21055
40
48
1852
20943
156
419
1075
19669
97
1060
415
14063
Multidisciplinary treatment meeting
WZC20 [2001310890]
1.8e+00
3.0e+00
—
1.0e+50
—
4.6e+00
3.5e+00
cases:0.90%
controls:0.15%
cases:1.80%
controls:0.09%
—
—
cases:1.61%
controls:0.00%
—
—
cases:6.90%
controls:0.07%
cases:7.81%
controls:0.24%
19
31
2088
21029
38
20
2069
21040
—
34
0
2073
21060
—
85
15
1146
20073
40
37
472
15086
Hepatitis E virus IgM Ab [Presence] in Serum
14212-5 [3002222]
2.3e+00
3.5e+00
1.0e+50
—
—
4.2e+00
3.0e+00
cases:0.81%
controls:0.09%
cases:1.14%
controls:0.03%
cases:0.52%
controls:0.00%
—
—
—
—
cases:1.87%
controls:0.03%
cases:2.15%
controls:0.11%
17
18
2090
21042
24
7
2083
21053
11
0
2096
21060
—
—
23
6
1208
20082
11
17
501
15106
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
49693-5 [3029023]
2.3e+00
3.5e+00
1.0e+50
—
—
4.2e+00
3.0e+00
cases:0.81%
controls:0.09%
cases:1.14%
controls:0.03%
cases:0.52%
controls:0.00%
—
—
—
—
cases:1.87%
controls:0.03%
cases:2.15%
controls:0.11%
17
18
2090
21042
24
7
2083
21053
11
0
2096
21060
—
—
23
6
1208
20082
11
17
501
15106
Extensive body CT
JN4BD [2001310899]
1.7e+00
2.4e+00
—
1.0e+50
—
4.6e+00
4.2e+00
cases:3.08%
controls:0.59%
cases:2.04%
controls:0.18%
—
—
cases:1.38%
controls:0.00%
—
—
cases:10.97%
controls:0.12%
cases:18.55%
controls:0.34%
65
125
2042
20935
43
38
2064
21022
—
29
0
2078
21060
—
135
25
1096
20063
95
52
417
15071
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 [3027529]
1.6e+00
2.7e+00
—
—
1.0e+50
4.8e+00
3.6e+00
cases:0.71%
controls:0.14%
cases:0.95%
controls:0.06%
—
—
—
—
cases:0.69%
controls:0.00%
cases:3.01%
controls:0.02%
cases:2.93%
controls:0.08%
15
30
2092
21030
20
13
2087
21047
—
—
13
0
1879
20991
37
5
1194
20083
15
12
497
15111
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.5e-01
1.0e+00
1.7e+00
3.4e+00
2.4e+00
1.8e+00
1.9e+00
cases:6.17%
controls:3.33%
cases:5.51%
controls:2.07%
cases:2.71%
controls:0.49%
cases:0.81%
controls:0.03%
cases:4.39%
controls:0.41%
cases:11.78%
controls:2.20%
cases:23.83%
controls:4.58%
130
702
1977
20358
116
435
1991
20625
57
103
2050
20957
17
6
2090
21054
83
86
1809
20905
145
441
1086
19647
122
693
390
14430
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
5.4e-01
1.5e+00
2.6e+00
1.0e+50
2.9e+00
3.2e+00
2.6e+00
cases:1.00%
controls:0.58%
cases:1.14%
controls:0.26%
cases:0.38%
controls:0.03%
cases:0.47%
controls:0.00%
cases:0.58%
controls:0.03%
cases:4.39%
controls:0.18%
cases:5.47%
controls:0.44%
21
123
2086
20937
24
54
2083
21006
8
6
2099
21054
10
0
2097
21060
11
7
1881
20984
54
37
1177
20051
28
66
484
15057
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 [3014959]
1.6e+00
2.7e+00
—
—
1.0e+50
4.9e+00
3.6e+00
cases:0.71%
controls:0.15%
cases:0.95%
controls:0.06%
—
—
—
—
cases:0.69%
controls:0.00%
cases:3.09%
controls:0.02%
cases:2.93%
controls:0.09%
15
31
2092
21029
20
13
2087
21047
—
—
13
0
1879
20991
38
5
1193
20083
15
13
497
15110
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.1e+00
2.0e+00
3.0e+00
—
3.0e+00
2.0e+00
1.5e+00
cases:14.71%
controls:5.41%
cases:10.39%
controls:1.52%
cases:3.75%
controls:0.19%
—
—
cases:3.17%
controls:0.16%
cases:10.56%
controls:1.63%
cases:20.31%
controls:5.16%
310
1139
1797
19921
219
321
1888
20739
79
40
2028
21020
—
60
34
1832
20957
130
328
1101
19760
104
781
408
14342
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
5.2e-01
9.1e-01
2.4e+00
3.8e+00
2.3e+00
1.7e+00
9.8e-01
cases:6.22%
controls:3.77%
cases:5.17%
controls:2.16%
cases:3.08%
controls:0.29%
cases:1.28%
controls:0.03%
cases:2.80%
controls:0.29%
cases:11.86%
controls:2.36%
cases:16.60%
controls:6.98%
131
795
1976
20265
109
454
1998
20606
65
62
2042
20998
27
6
2080
21054
53
60
1839
20931
146
475
1085
19613
85
1055
427
14068
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.5e+00
2.9e+00
—
—
—
4.8e+00
3.4e+00
cases:1.09%
controls:0.25%
cases:1.19%
controls:0.07%
—
—
—
—
—
—
cases:9.67%
controls:0.08%
cases:7.42%
controls:0.28%
23
53
2084
21007
25
14
2082
21046
—
—
—
119
17
1112
20071
38
42
474
15081
Bacteria [Presence] in Urine
87829-8 [36304419]
3.7e-01
8.3e-01
2.3e+00
4.1e+00
2.2e+00
1.6e+00
1.1e+00
cases:9.92%
controls:7.08%
cases:8.21%
controls:3.74%
cases:4.79%
controls:0.52%
cases:1.76%
controls:0.03%
cases:4.39%
controls:0.49%
cases:17.22%
controls:3.87%
cases:25.98%
controls:10.69%
209
1491
1898
19569
173
788
1934
20272
101
110
2006
20950
37
6
2070
21054
83
103
1809
20888
212
778
1019
19310
133
1617
379
13506
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.8e-01
6.6e-01
2.5e+00
4.3e+00
2.8e+00
1.4e+00
6.3e-01
cases:52.44%
controls:47.99%
cases:52.49%
controls:36.42%
cases:43.81%
controls:5.75%
cases:14.29%
controls:0.22%
cases:47.04%
controls:5.27%
cases:69.21%
controls:36.51%
cases:75.20%
controls:61.67%
1105
10107
1002
10953
1106
7671
1001
13389
923
1212
1184
19848
301
46
1806
21014
890
1106
1002
19885
852
7335
379
12753
385
9327
127
5796
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
4.2e-01
1.3e+00
3.3e+00
—
3.6e+00
2.5e+00
1.5e+00
cases:6.60%
controls:4.45%
cases:5.36%
controls:1.59%
cases:4.79%
controls:0.19%
—
—
cases:4.60%
controls:0.13%
cases:14.78%
controls:1.47%
cases:18.36%
controls:4.88%
139
937
1968
20123
113
335
1994
20725
101
40
2006
21020
—
87
28
1805
20963
182
296
1049
19792
94
738
418
14385
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.6e-01
8.4e-01
2.2e+00
4.0e+00
2.3e+00
1.6e+00
1.0e+00
cases:10.35%
controls:7.43%
cases:8.69%
controls:3.96%
cases:5.03%
controls:0.57%
cases:1.85%
controls:0.03%
cases:4.86%
controls:0.53%
cases:18.52%
controls:4.21%
cases:27.73%
controls:11.86%
218
1564
1889
19496
183
833
1924
20227
106
120
2001
20940
39
7
2068
21053
92
112
1800
20879
228
845
1003
19243
142
1793
370
13330
Endoscopic retrograd cholangiopancreaticography
JL5SB [2001305388]
1.7e+00
3.5e+00
1.0e+50
1.0e+50
1.0e+50
4.0e+00
3.2e+00
cases:0.76%
controls:0.13%
cases:1.19%
controls:0.04%
cases:0.90%
controls:0.00%
cases:1.57%
controls:0.00%
cases:0.63%
controls:0.00%
cases:2.11%
controls:0.04%
cases:2.54%
controls:0.11%
16
28
2091
21032
25
8
2082
21052
19
0
2088
21060
33
0
2074
21060
12
0
1880
20991
26
8
1205
20080
13
16
499
15107
Left sided colitis
K51.5 [45533604]
1.1e+00
1.7e+00
2.6e+00
1.0e+50
2.6e+00
1.9e+00
2.4e+00
cases:1.09%
controls:0.35%
cases:1.14%
controls:0.21%
cases:0.57%
controls:0.04%
cases:0.28%
controls:0.00%
cases:0.63%
controls:0.05%
cases:1.38%
controls:0.20%
cases:3.32%
controls:0.32%
23
74
2084
20986
24
45
2083
21015
12
9
2095
21051
6
0
2101
21060
12
10
1880
20981
17
41
1214
20047
17
49
495
15074
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.3e-01
9.0e-01
2.3e+00
3.6e+00
2.3e+00
1.7e+00
9.2e-01
cases:5.98%
controls:3.60%
cases:5.41%
controls:2.27%
cases:2.99%
controls:0.32%
cases:1.23%
controls:0.03%
cases:3.12%
controls:0.31%
cases:12.51%
controls:2.60%
cases:17.97%
controls:8.00%
126
759
1981
20301
114
479
1993
20581
63
67
2044
20993
26
7
2081
21053
59
65
1833
20926
154
522
1077
19566
92
1210
420
13913
Bacterial infection, unspecified
A49.9 [45590816]
5.9e-01
1.5e+00
3.1e+00
—
2.6e+00
2.8e+00
1.6e+00
cases:2.47%
controls:1.38%
cases:2.66%
controls:0.59%
cases:1.52%
controls:0.07%
—
—
cases:1.27%
controls:0.10%
cases:9.67%
controls:0.68%
cases:11.33%
controls:2.49%
52
290
2055
20770
56
124
2051
20936
32
14
2075
21046
—
24
20
1868
20971
119
136
1112
19952
58
376
454
14747
General anesthesia, balanced
WX408 [2001310808]
4.4e-01
9.3e-01
2.4e+00
1.0e+50
3.5e+00
3.0e+00
2.0e+00
cases:6.03%
controls:3.97%
cases:1.99%
controls:0.80%
cases:0.95%
controls:0.09%
cases:1.04%
controls:0.00%
cases:1.64%
controls:0.05%
cases:8.69%
controls:0.48%
cases:10.94%
controls:1.59%
127
836
1980
20224
42
168
2065
20892
20
19
2087
21041
22
0
2085
21060
31
11
1861
20980
107
96
1124
19992
56
241
456
14882
Pathology report gross observation
24419-4 [3002256]
8.8e-01
9.4e-01
2.2e+00
1.0e+50
3.2e+00
2.9e+00
2.0e+00
cases:4.13%
controls:1.76%
cases:1.47%
controls:0.58%
cases:0.47%
controls:0.05%
cases:1.28%
controls:0.00%
cases:1.64%
controls:0.07%
cases:7.96%
controls:0.45%
cases:10.35%
controls:1.57%
87
370
2020
20690
31
122
2076
20938
10
11
2097
21049
27
0
2080
21060
31
14
1861
20977
98
91
1133
19997
53
238
459
14885
Fever, unspecified
R50.9 [45582716]
5.3e-01
1.4e+00
3.0e+00
1.0e+50
2.7e+00
2.8e+00
1.6e+00
cases:2.75%
controls:1.64%
cases:2.42%
controls:0.58%
cases:1.28%
controls:0.07%
cases:0.47%
controls:0.00%
cases:1.37%
controls:0.09%
cases:9.02%
controls:0.59%
cases:11.13%
controls:2.37%
58
345
2049
20715
51
122
2056
20938
27
14
2080
21046
10
0
2097
21060
26
19
1866
20972
111
118
1120
19970
57
358
455
14765
Intravenous
ZX120 [2001311495]
8.7e-01
1.3e+00
2.1e+00
—
2.8e+00
3.0e+00
2.1e+00
cases:2.47%
controls:1.04%
cases:1.52%
controls:0.40%
cases:0.57%
controls:0.07%
—
—
cases:1.06%
controls:0.07%
cases:5.77%
controls:0.31%
cases:6.25%
controls:0.81%
52
220
2055
20840
32
84
2075
20976
12
15
2095
21045
—
20
14
1872
20977
71
63
1160
20025
32
123
480
15000
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.4e+00
1.2e+00
1.7e+00
3.4e+00
2.0e+00
1.4e+00
1.0e+00
cases:5.89%
controls:1.56%
cases:3.18%
controls:1.01%
cases:1.42%
controls:0.25%
cases:1.00%
controls:0.03%
cases:1.64%
controls:0.22%
cases:4.39%
controls:1.11%
cases:6.05%
controls:2.30%
124
329
1983
20731
67
212
2040
20848
30
53
2077
21007
21
7
2086
21053
31
47
1861
20944
54
223
1177
19865
31
348
481
14775
Cathetrisation of artery
TPH07 [2001309747]
7.5e-01
1.1e+00
2.7e+00
1.0e+50
3.1e+00
2.6e+00
1.7e+00
cases:3.42%
controls:1.64%
cases:1.85%
controls:0.61%
cases:0.81%
controls:0.05%
cases:1.00%
controls:0.00%
cases:1.27%
controls:0.06%
cases:8.12%
controls:0.62%
cases:9.57%
controls:1.89%
72
346
2035
20714
39
128
2068
20932
17
11
2090
21049
21
0
2086
21060
24
12
1868
20979
100
125
1131
19963
49
286
463
14837
General Practice
1 [38004446]
3.7e-01
5.5e-01
1.8e+00
4.7e+00
2.6e+00
1.5e+00
5.9e-01
cases:25.30%
controls:19.03%
cases:14.38%
controls:8.86%
cases:7.88%
controls:1.35%
cases:5.22%
controls:0.05%
cases:15.12%
controls:1.32%
cases:30.46%
controls:9.06%
cases:37.11%
controls:24.59%
533
4007
1574
17053
303
1865
1804
19195
166
285
1941
20775
110
11
1997
21049
286
278
1606
20713
375
1820
856
18268
190
3719
322
11404
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
2.1e+00
4.1e+00
—
1.0e+50
—
3.3e+00
2.5e+00
cases:1.04%
controls:0.12%
cases:1.71%
controls:0.03%
—
—
cases:0.28%
controls:0.00%
—
—
cases:1.30%
controls:0.05%
cases:1.37%
controls:0.11%
22
26
2085
21034
36
6
2071
21054
—
6
0
2101
21060
—
16
10
1215
20078
7
17
505
15106
Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49376-7 [3029536]
2.3e+00
3.1e+00
—
—
—
3.8e+00
2.9e+00
cases:0.47%
controls:0.05%
cases:0.62%
controls:0.03%
—
—
—
—
—
—
cases:1.06%
controls:0.02%
cases:1.95%
controls:0.11%
10
10
2097
21050
13
6
2094
21054
—
—
—
13
5
1218
20083
10
17
502
15106
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
2.3e+00
3.5e+00
1.0e+50
1.0e+50
—
3.7e+00
2.5e+00
cases:4.98%
controls:0.52%
cases:4.89%
controls:0.15%
cases:3.42%
controls:0.00%
cases:0.66%
controls:0.00%
—
—
cases:5.69%
controls:0.15%
cases:6.84%
controls:0.58%
105
110
2002
20950
103
32
2004
21028
72
0
2035
21060
14
0
2093
21060
—
70
31
1161
20057
35
88
477
15035
Intravenous general anesthesia
WX404 [2001310807]
7.3e-01
1.1e+00
2.4e+00
1.0e+50
2.8e+00
2.6e+00
2.3e+00
cases:5.08%
controls:2.50%
cases:1.57%
controls:0.51%
cases:0.57%
controls:0.05%
cases:0.52%
controls:0.00%
cases:1.11%
controls:0.07%
cases:4.79%
controls:0.36%
cases:7.42%
controls:0.83%
107
527
2000
20533
33
108
2074
20952
12
11
2095
21049
11
0
2096
21060
21
14
1871
20977
59
72
1172
20016
38
126
474
14997
Thrombin time
3243-3 [3036489]
4.7e-01
1.6e+00
2.6e+00
1.0e+50
3.0e+00
2.8e+00
2.1e+00
cases:1.23%
controls:0.77%
cases:1.33%
controls:0.28%
cases:0.38%
controls:0.03%
cases:0.47%
controls:0.00%
cases:0.63%
controls:0.03%
cases:4.39%
controls:0.27%
cases:5.47%
controls:0.73%
26
163
2081
20897
28
60
2079
21000
8
6
2099
21054
10
0
2097
21060
12
7
1880
20984
54
55
1177
20033
28
111
484
15012
Hepatitis E virus Ab [Presence] in Serum
13294-4 [3006922]
2.4e+00
3.4e+00
1.0e+50
—
—
3.6e+00
2.5e+00
cases:0.85%
controls:0.08%
cases:1.14%
controls:0.04%
cases:0.52%
controls:0.00%
—
—
—
—
cases:1.79%
controls:0.05%
cases:2.15%
controls:0.17%
18
17
2089
21043
24
8
2083
21052
11
0
2096
21060
—
—
22
10
1209
20078
11
26
501
15097
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
2.3e+00
3.4e+00
—
1.0e+50
—
3.7e+00
2.5e+00
cases:4.98%
controls:0.54%
cases:4.75%
controls:0.16%
—
—
cases:0.71%
controls:0.00%
—
—
cases:5.52%
controls:0.14%
cases:6.84%
controls:0.61%
105
114
2002
20946
100
34
2007
21026
—
15
0
2092
21060
—
68
28
1163
20060
35
92
477
15031
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.4e-01
7.9e-01
2.2e+00
3.8e+00
2.1e+00
1.5e+00
1.1e+00
cases:14.33%
controls:10.69%
cases:10.73%
controls:5.18%
cases:6.31%
controls:0.73%
cases:2.37%
controls:0.06%
cases:5.50%
controls:0.71%
cases:20.71%
controls:5.34%
cases:33.79%
controls:14.33%
302
2251
1805
18809
226
1090
1881
19970
133
154
1974
20906
50
12
2057
21048
104
148
1788
20843
255
1072
976
19016
173
2167
339
12956
Bacteria identified in Isolate by Culture
43409-2 [3042936]
7.3e-01
1.2e+00
2.7e+00
—
3.3e+00
2.3e+00
1.6e+00
cases:7.21%
controls:3.60%
cases:4.03%
controls:1.30%
cases:2.23%
controls:0.16%
—
—
cases:2.43%
controls:0.10%
cases:11.05%
controls:1.19%
cases:17.38%
controls:3.98%
152
758
1955
20302
85
273
2022
20787
47
33
2060
21027
—
46
20
1846
20971
136
240
1095
19848
89
602
423
14521
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
1.4e+00
1.3e+00
1.4e+00
—
3.0e+00
3.4e+00
2.7e+00
cases:0.66%
controls:0.17%
cases:0.66%
controls:0.18%
cases:0.43%
controls:0.11%
—
—
cases:1.96%
controls:0.10%
cases:6.26%
controls:0.23%
cases:8.01%
controls:0.56%
14
36
2093
21024
14
38
2093
21022
9
23
2098
21037
—
37
21
1855
20970
77
46
1154
20042
41
84
471
15039
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
9.6e-01
1.4e+00
2.5e+00
—
3.0e+00
2.7e+00
1.1e+00
cases:3.37%
controls:1.32%
cases:2.04%
controls:0.50%
cases:0.81%
controls:0.07%
—
—
cases:1.80%
controls:0.09%
cases:8.61%
controls:0.63%
cases:7.23%
controls:2.43%
71
277
2036
20783
43
106
2064
20954
17
14
2090
21046
—
34
19
1858
20972
106
126
1125
19962
37
367
475
14756
Osmolality of Urine
2695-5 [3026782]
3.7e-01
6.9e-01
2.3e+00
3.9e+00
2.0e+00
1.3e+00
1.2e+00
cases:8.59%
controls:6.10%
cases:4.89%
controls:2.51%
cases:3.08%
controls:0.33%
cases:1.33%
controls:0.03%
cases:2.48%
controls:0.35%
cases:9.02%
controls:2.56%
cases:18.95%
controls:6.45%
181
1285
1926
19775
103
529
2004
20531
65
70
2042
20990
28
6
2079
21054
47
73
1845
20918
111
515
1120
19573
97
975
415
14148
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.2e-01
9.9e-01
2.1e+00
3.3e+00
2.0e+00
1.5e+00
1.2e+00
cases:15.33%
controls:8.90%
cases:12.72%
controls:5.14%
cases:6.74%
controls:0.92%
cases:0.85%
controls:0.03%
cases:5.44%
controls:0.80%
cases:20.39%
controls:5.24%
cases:31.05%
controls:11.51%
323
1875
1784
19185
268
1082
1839
19978
142
193
1965
20867
18
7
2089
21053
103
168
1789
20823
251
1052
980
19036
159
1741
353
13382
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
1.0e+00
1.5e+00
2.4e+00
—
2.9e+00
2.7e+00
1.2e+00
cases:3.32%
controls:1.25%
cases:2.09%
controls:0.49%
cases:0.66%
controls:0.06%
—
—
cases:1.59%
controls:0.09%
cases:8.12%
controls:0.62%
cases:6.84%
controls:2.18%
70
264
2037
20796
44
104
2063
20956
14
13
2093
21047
—
30
18
1862
20973
100
124
1131
19964
35
329
477
14794
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.4e-01
8.2e-01
2.2e+00
3.6e+00
2.1e+00
1.5e+00
9.8e-01
cases:11.96%
controls:8.79%
cases:9.97%
controls:4.66%
cases:5.89%
controls:0.67%
cases:2.14%
controls:0.06%
cases:5.34%
controls:0.68%
cases:20.31%
controls:5.15%
cases:30.66%
controls:14.24%
252
1851
1855
19209
210
981
1897
20079
124
141
1983
20919
45
13
2062
21047
101
142
1791
20849
250
1035
981
19053
157
2154
355
12969
Emergency Medicine
93 [38004510]
2.4e-01
7.2e-01
2.4e+00
4.7e+00
1.8e+00
1.2e+00
5.4e-01
cases:23.54%
controls:19.51%
cases:19.55%
controls:10.59%
cases:13.76%
controls:1.45%
cases:6.50%
controls:0.06%
cases:7.82%
controls:1.44%
cases:29.57%
controls:11.29%
cases:42.58%
controls:30.19%
496
4108
1611
16952
412
2231
1695
18829
290
305
1817
20755
137
13
1970
21047
148
303
1744
20688
364
2267
867
17821
218
4566
294
10557
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
9.6e-01
1.4e+00
2.6e+00
—
2.9e+00
2.6e+00
1.1e+00
cases:3.23%
controls:1.26%
cases:2.04%
controls:0.51%
cases:0.85%
controls:0.06%
—
—
cases:1.64%
controls:0.10%
cases:8.04%
controls:0.66%
cases:7.03%
controls:2.47%
68
265
2039
20795
43
108
2064
20952
18
13
2089
21047
—
31
20
1861
20971
99
132
1132
19956
36
373
476
14750
Cathetrisation of vein
TPH04 [2001309597]
5.9e-01
1.3e+00
2.7e+00
—
3.0e+00
2.3e+00
1.5e+00
cases:6.50%
controls:3.72%
cases:4.37%
controls:1.28%
cases:2.85%
controls:0.19%
—
—
cases:3.33%
controls:0.17%
cases:12.02%
controls:1.29%
cases:16.41%
controls:4.03%
137
784
1970
20276
92
270
2015
20790
60
40
2047
21020
—
63
35
1829
20956
148
259
1083
19829
84
609
428
14514
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.8e-01
5.7e-01
2.3e+00
4.0e+00
2.5e+00
1.3e+00
6.0e-01
cases:53.35%
controls:48.87%
cases:53.16%
controls:39.10%
cases:42.76%
controls:7.26%
cases:19.60%
controls:0.43%
cases:47.94%
controls:6.84%
cases:70.35%
controls:39.76%
cases:75.39%
controls:62.61%
1124
10293
983
10767
1120
8235
987
12825
901
1528
1206
19532
413
90
1694
20970
907
1435
985
19556
866
7986
365
12102
386
9468
126
5655
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
8.6e-01
1.8e+00
3.2e+00
1.0e+50
3.1e+00
1.6e+00
9.0e-01
cases:6.83%
controls:3.02%
cases:5.36%
controls:0.91%
cases:1.99%
controls:0.09%
cases:0.38%
controls:0.00%
cases:1.85%
controls:0.09%
cases:4.22%
controls:0.87%
cases:7.81%
controls:3.35%
144
636
1963
20424
113
192
1994
20868
42
18
2065
21042
8
0
2099
21060
35
18
1857
20973
52
175
1179
19913
40
506
472
14617
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
7.1e-01
1.0e+00
2.5e+00
—
3.3e+00
2.5e+00
1.4e+00
cases:5.17%
controls:2.62%
cases:2.37%
controls:0.87%
cases:1.23%
controls:0.10%
—
—
cases:2.06%
controls:0.08%
cases:9.91%
controls:0.92%
cases:12.70%
controls:3.36%
109
551
1998
20509
50
183
2057
20877
26
22
2081
21038
—
39
16
1853
20975
122
184
1109
19904
65
508
447
14615
Physiotherapist
Z3226 [2001311560]
3.8e-01
1.2e+00
2.7e+00
1.0e+50
3.7e+00
2.3e+00
1.6e+00
cases:3.08%
controls:2.13%
cases:1.71%
controls:0.53%
cases:0.90%
controls:0.06%
cases:0.71%
controls:0.00%
cases:1.27%
controls:0.03%
cases:3.90%
controls:0.39%
cases:6.25%
controls:1.39%
65
449
2042
20611
36
112
2071
20948
19
13
2088
21047
15
0
2092
21060
24
7
1868
20984
48
78
1183
20010
32
210
480
14913
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.3e-01
7.6e-01
2.2e+00
3.7e+00
2.0e+00
1.4e+00
9.1e-01
cases:12.96%
controls:9.67%
cases:10.82%
controls:5.37%
cases:6.74%
controls:0.77%
cases:2.23%
controls:0.06%
cases:5.76%
controls:0.78%
cases:20.71%
controls:6.01%
cases:32.23%
controls:16.01%
273
2037
1834
19023
228
1131
1879
19929
142
163
1965
20897
47
12
2060
21048
109
164
1783
20827
255
1207
976
18881
165
2421
347
12702
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
2.3e+00
4.0e+00
1.0e+50
1.0e+50
1.0e+50
—
5.1e+00
cases:1.66%
controls:0.17%
cases:2.47%
controls:0.05%
cases:1.57%
controls:0.00%
cases:1.09%
controls:0.00%
cases:0.95%
controls:0.00%
—
—
cases:12.11%
controls:0.09%
35
35
2072
21025
52
10
2055
21050
33
0
2074
21060
23
0
2084
21060
18
0
1874
20991
—
62
13
450
15110
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.7e-01
5.6e-01
2.3e+00
4.0e+00
2.5e+00
1.3e+00
5.9e-01
cases:53.49%
controls:49.22%
cases:53.49%
controls:39.62%
cases:43.00%
controls:7.35%
cases:19.41%
controls:0.44%
cases:47.99%
controls:6.96%
cases:70.43%
controls:40.19%
cases:75.39%
controls:62.92%
1127
10365
980
10695
1127
8344
980
12716
906
1547
1201
19513
409
92
1698
20968
908
1461
984
19530
867
8074
364
12014
386
9516
126
5607
Bacteria identified in Blood by Culture
600-7 [3023368]
5.4e-01
1.1e+00
3.0e+00
—
3.1e+00
2.3e+00
1.3e+00
cases:11.87%
controls:7.29%
cases:9.30%
controls:3.30%
cases:6.69%
controls:0.36%
—
—
cases:8.03%
controls:0.40%
cases:26.56%
controls:3.53%
cases:32.62%
controls:11.19%
250
1535
1857
19525
196
696
1911
20364
141
76
1966
20984
—
152
83
1740
20908
327
709
904
19379
167
1692
345
13431
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
6.8e-01
1.1e+00
2.5e+00
—
3.2e+00
2.8e+00
1.1e+00
cases:2.04%
controls:1.04%
cases:1.66%
controls:0.56%
cases:0.71%
controls:0.06%
—
—
cases:1.43%
controls:0.06%
cases:9.26%
controls:0.64%
cases:6.64%
controls:2.27%
43
220
2064
20840
35
117
2072
20943
15
13
2092
21047
—
27
12
1865
20979
114
129
1117
19959
34
344
478
14779
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
2.5e+00
—
—
1.0e+50
—
5.1e+00
3.7e+00
cases:1.00%
controls:0.08%
—
—
—
—
cases:0.57%
controls:0.00%
—
—
cases:5.61%
controls:0.03%
cases:4.69%
controls:0.13%
21
17
2086
21043
—
—
12
0
2095
21060
—
69
7
1162
20081
24
19
488
15104
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
3.9e-01
1.1e+00
2.7e+00
—
3.4e+00
2.5e+00
1.5e+00
cases:1.14%
controls:0.77%
cases:1.00%
controls:0.33%
cases:0.47%
controls:0.03%
—
—
cases:1.48%
controls:0.05%
cases:5.20%
controls:0.43%
cases:6.84%
controls:1.54%
24
163
2083
20897
21
69
2086
20991
10
7
2097
21053
—
28
10
1864
20981
64
87
1167
20001
35
233
477
14890
More than three and less than five hours
ZXE20 [2001311408]
4.3e-01
1.0e+00
2.3e+00
1.0e+50
3.0e+00
3.0e+00
2.0e+00
cases:2.71%
controls:1.78%
cases:1.19%
controls:0.43%
cases:0.38%
controls:0.04%
cases:0.52%
controls:0.00%
cases:0.74%
controls:0.04%
cases:4.96%
controls:0.25%
cases:5.27%
controls:0.77%
57
374
2050
20686
25
91
2082
20969
8
8
2099
21052
11
0
2096
21060
14
8
1878
20983
61
50
1170
20038
27
116
485
15007
enoxaparin; parenteral
B01AB05 [21600976]
3.2e-01
9.2e-01
2.5e+00
—
3.6e+00
2.6e+00
1.5e+00
cases:7.64%
controls:5.69%
cases:4.22%
controls:1.72%
cases:2.71%
controls:0.24%
—
—
cases:6.40%
controls:0.20%
cases:16.08%
controls:1.42%
cases:17.19%
controls:4.62%
161
1198
1946
19862
89
363
2018
20697
57
50
2050
21010
—
121
41
1771
20950
198
286
1033
19802
88
699
424
14424
Liver transplant status
Z94.4 [45566478]
—
1.7e+00
—
1.0e+50
—
5.3e+00
6.0e+00
—
—
cases:0.24%
controls:0.04%
—
—
cases:0.38%
controls:0.00%
—
—
cases:6.50%
controls:0.03%
cases:15.63%
controls:0.05%
—
5
9
2102
21051
—
8
0
2099
21060
—
80
7
1151
20081
80
7
432
15116
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
8.2e-01
1.3e+00
2.8e+00
—
2.7e+00
2.2e+00
1.5e+00
cases:2.33%
controls:1.04%
cases:2.23%
controls:0.62%
cases:1.80%
controls:0.11%
—
—
cases:2.17%
controls:0.14%
cases:6.58%
controls:0.81%
cases:9.57%
controls:2.39%
49
218
2058
20842
47
131
2060
20929
38
24
2069
21036
—
41
30
1851
20961
81
162
1150
19926
49
362
463
14761
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.6e-01
7.0e-01
2.1e+00
3.9e+00
1.9e+00
1.4e+00
9.2e-01
cases:25.77%
controls:21.11%
cases:19.17%
controls:10.58%
cases:11.39%
controls:1.59%
cases:3.89%
controls:0.08%
cases:9.83%
controls:1.55%
cases:33.31%
controls:10.75%
cases:47.85%
controls:26.68%
543
4445
1564
16615
404
2229
1703
18831
240
334
1867
20726
82
17
2025
21043
186
326
1706
20665
410
2159
821
17929
245
4035
267
11088
Blood transfusion
WW500 [2001310603]
1.2e+00
2.2e+00
—
—
—
4.6e+00
3.1e+00
cases:0.76%
controls:0.22%
cases:0.95%
controls:0.10%
—
—
—
—
—
—
cases:3.98%
controls:0.04%
cases:5.08%
controls:0.23%
16
47
2091
21013
20
22
2087
21038
—
—
—
49
8
1182
20080
26
35
486
15088
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
7.9e-01
1.3e+00
2.6e+00
—
3.4e+00
2.0e+00
1.1e+00
cases:4.94%
controls:2.31%
cases:3.42%
controls:0.94%
cases:1.23%
controls:0.09%
—
—
cases:2.27%
controls:0.08%
cases:5.44%
controls:0.75%
cases:7.03%
controls:2.45%
104
487
2003
20573
72
199
2035
20861
26
20
2081
21040
—
43
17
1849
20974
67
150
1164
19938
36
370
476
14753
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
5.6e-01
1.3e+00
2.3e+00
—
3.1e+00
2.6e+00
1.3e+00
cases:2.04%
controls:1.17%
cases:2.33%
controls:0.62%
cases:0.71%
controls:0.07%
—
—
cases:1.80%
controls:0.09%
cases:8.20%
controls:0.65%
cases:7.03%
controls:2.11%
43
247
2064
20813
49
130
2058
20930
15
15
2092
21045
—
34
18
1858
20973
101
130
1130
19958
36
319
476
14804
Outpatient Visit
OP [9202]
4.0e-01
5.6e-01
1.2e+00
4.0e+00
1.7e+00
1.5e+00
1.8e+00
cases:85.38%
controls:79.62%
cases:72.24%
controls:59.83%
cases:30.42%
controls:11.61%
cases:20.50%
controls:0.46%
cases:40.80%
controls:11.25%
cases:86.52%
controls:58.96%
cases:97.07%
controls:84.94%
1799
16768
308
4292
1522
12600
585
8460
641
2445
1466
18615
432
97
1675
20963
772
2362
1120
18629
1065
11844
166
8244
497
12846
15
2277
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.0e-01
9.6e-01
1.9e+00
3.2e+00
2.0e+00
1.4e+00
1.1e+00
cases:21.78%
controls:14.43%
cases:18.94%
controls:8.20%
cases:9.35%
controls:1.51%
cases:1.33%
controls:0.05%
cases:8.56%
controls:1.25%
cases:27.29%
controls:8.26%
cases:41.41%
controls:19.29%
459
3038
1648
18022
399
1727
1708
19333
197
319
1910
20741
28
11
2079
21049
162
262
1730
20729
336
1659
895
18429
212
2917
300
12206
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.0e-01
9.7e-01
1.9e+00
3.2e+00
2.0e+00
1.4e+00
1.1e+00
cases:21.03%
controls:13.88%
cases:18.60%
controls:7.97%
cases:9.02%
controls:1.47%
cases:1.28%
controls:0.05%
cases:8.25%
controls:1.22%
cases:26.81%
controls:7.98%
cases:40.82%
controls:18.75%
443
2923
1664
18137
392
1678
1715
19382
190
310
1917
20750
27
11
2080
21049
156
257
1736
20734
330
1603
901
18485
209
2835
303
12288
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.1e+00
1.5e+00
2.5e+00
—
2.5e+00
2.1e+00
1.4e+00
cases:8.92%
controls:3.07%
cases:8.26%
controls:2.01%
cases:3.99%
controls:0.33%
—
—
cases:3.86%
controls:0.33%
cases:14.95%
controls:2.14%
cases:20.12%
controls:5.93%
188
646
1919
20414
174
424
1933
20636
84
70
2023
20990
—
73
70
1819
20921
184
429
1047
19659
103
897
409
14226
Basophils [#/volume] in Blood
26444-0 [3006315]
5.0e-01
9.7e-01
1.9e+00
3.2e+00
2.0e+00
1.4e+00
1.1e+00
cases:21.12%
controls:13.95%
cases:18.60%
controls:7.98%
cases:9.07%
controls:1.48%
cases:1.28%
controls:0.05%
cases:8.25%
controls:1.24%
cases:26.97%
controls:8.04%
cases:41.02%
controls:18.85%
445
2938
1662
18122
392
1681
1715
19379
191
311
1916
20749
27
11
2080
21049
156
261
1736
20730
332
1615
899
18473
210
2850
302
12273
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.0e-01
9.5e-01
1.9e+00
3.2e+00
2.0e+00
1.5e+00
1.0e+00
cases:20.17%
controls:13.33%
cases:17.42%
controls:7.55%
cases:8.45%
controls:1.39%
cases:1.19%
controls:0.05%
cases:7.88%
controls:1.16%
cases:26.65%
controls:7.69%
cases:38.09%
controls:17.75%
425
2807
1682
18253
367
1590
1740
19470
178
293
1929
20767
25
10
2082
21050
149
244
1743
20747
328
1544
903
18544
195
2684
317
12439
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.3e-01
7.6e-01
2.1e+00
3.5e+00
1.9e+00
1.3e+00
1.2e+00
cases:7.83%
controls:5.74%
cases:5.41%
controls:2.60%
cases:2.99%
controls:0.39%
cases:0.90%
controls:0.03%
cases:2.70%
controls:0.40%
cases:9.91%
controls:2.87%
cases:21.09%
controls:7.80%
165
1209
1942
19851
114
548
1993
20512
63
82
2044
20978
19
6
2088
21054
51
83
1841
20908
122
577
1109
19511
108
1179
404
13944
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.4e-01
5.4e-01
2.4e+00
3.9e+00
2.5e+00
1.2e+00
5.2e-01
cases:54.86%
controls:51.47%
cases:56.62%
controls:43.11%
cases:50.31%
controls:8.65%
cases:19.60%
controls:0.47%
cases:50.90%
controls:8.07%
cases:71.24%
controls:43.59%
cases:75.98%
controls:65.17%
1156
10840
951
10220
1193
9079
914
11981
1060
1822
1047
19238
413
99
1694
20961
963
1693
929
19298
877
8757
354
11331
389
9856
123
5267
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.9e-01
5.6e-01
2.2e+00
3.9e+00
2.4e+00
1.1e+00
6.3e-01
cases:37.26%
controls:32.94%
cases:39.49%
controls:27.23%
cases:35.93%
controls:5.64%
cases:14.71%
controls:0.34%
cases:37.21%
controls:5.34%
cases:53.70%
controls:27.88%
cases:60.55%
controls:45.02%
785
6937
1322
14123
832
5735
1275
15325
757
1187
1350
19873
310
71
1797
20989
704
1120
1188
19871
661
5600
570
14488
310
6808
202
8315
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e-01
3.5e-02
1.3e+00
—
3.2e+00
3.4e+00
3.0e+00
cases:22.73%
controls:24.79%
cases:7.26%
controls:7.03%
cases:2.47%
controls:0.66%
—
—
cases:2.27%
controls:0.10%
cases:16.90%
controls:0.68%
cases:25.78%
controls:1.62%
479
5220
1628
15840
153
1481
1954
19579
52
139
2055
20921
—
43
20
1849
20971
208
136
1023
19952
132
245
380
14878
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.9e-01
9.6e-01
1.9e+00
3.1e+00
2.0e+00
1.4e+00
1.1e+00
cases:21.74%
controls:14.55%
cases:18.98%
controls:8.23%
cases:9.11%
controls:1.52%
cases:1.38%
controls:0.06%
cases:8.62%
controls:1.29%
cases:27.46%
controls:8.32%
cases:41.99%
controls:19.32%
458
3065
1649
17995
400
1734
1707
19326
192
320
1915
20740
29
13
2078
21047
163
270
1729
20721
338
1672
893
18416
215
2922
297
12201
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.0e-01
9.5e-01
1.9e+00
3.1e+00
2.0e+00
1.5e+00
1.1e+00
cases:19.79%
controls:13.04%
cases:17.13%
controls:7.38%
cases:8.35%
controls:1.37%
cases:1.14%
controls:0.05%
cases:7.72%
controls:1.15%
cases:26.24%
controls:7.46%
cases:37.50%
controls:17.16%
417
2746
1690
18314
361
1554
1746
19506
176
288
1931
20772
24
11
2083
21049
146
241
1746
20750
323
1498
908
18590
192
2595
320
12528
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.6e-01
1.3e+00
2.7e+00
—
2.8e+00
2.2e+00
1.2e+00
cases:6.03%
controls:2.92%
cases:5.03%
controls:1.43%
cases:2.80%
controls:0.19%
—
—
cases:3.70%
controls:0.23%
cases:13.00%
controls:1.71%
cases:16.80%
controls:5.57%
127
615
1980
20445
106
301
2001
20759
59
41
2048
21019
—
70
48
1822
20943
160
343
1071
19745
86
843
426
14280
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.9e-01
9.4e-01
1.9e+00
3.1e+00
2.0e+00
1.4e+00
1.1e+00
cases:19.55%
controls:13.01%
cases:16.94%
controls:7.36%
cases:8.26%
controls:1.35%
cases:1.19%
controls:0.05%
cases:7.61%
controls:1.14%
cases:25.51%
controls:7.44%
cases:37.50%
controls:17.09%
412
2739
1695
18321
357
1549
1750
19511
174
285
1933
20775
25
11
2082
21049
144
240
1748
20751
314
1494
917
18594
192
2584
320
12539
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
7.5e-01
1.5e+00
1.8e+00
—
3.3e+00
3.6e+00
2.6e+00
cases:1.09%
controls:0.52%
cases:0.71%
controls:0.16%
cases:0.24%
controls:0.04%
—
—
cases:1.11%
controls:0.04%
cases:6.99%
controls:0.21%
cases:7.03%
controls:0.57%
23
109
2084
20951
15
34
2092
21026
5
8
2102
21052
—
21
9
1871
20982
86
43
1145
20045
36
86
476
15037
MCH [Entitic mass]
28539-5 [3035941]
1.1e-01
5.1e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.00%
controls:53.26%
cases:57.19%
controls:44.60%
cases:50.97%
controls:9.24%
cases:22.97%
controls:0.56%
cases:53.12%
controls:8.55%
cases:71.73%
controls:45.35%
cases:76.17%
controls:66.63%
1180
11217
927
9843
1205
9392
902
11668
1074
1945
1033
19115
484
118
1623
20942
1005
1795
887
19196
883
9110
348
10978
390
10077
122
5046
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.1e-01
6.9e-01
2.4e+00
4.2e+00
2.1e+00
9.7e-01
5.4e-01
cases:14.52%
controls:13.24%
cases:11.20%
controls:5.95%
cases:7.40%
controls:0.70%
cases:3.27%
controls:0.05%
cases:5.29%
controls:0.69%
cases:14.87%
controls:6.21%
cases:25.98%
controls:17.03%
306
2788
1801
18272
236
1254
1871
19806
156
147
1951
20913
69
11
2038
21049
100
145
1792
20846
183
1248
1048
18840
133
2575
379
12548
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.1e-01
5.1e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.19%
controls:53.37%
cases:57.33%
controls:44.63%
cases:51.02%
controls:9.25%
cases:23.02%
controls:0.56%
cases:53.12%
controls:8.58%
cases:71.73%
controls:45.45%
cases:76.17%
controls:66.70%
1184
11240
923
9820
1208
9399
899
11661
1075
1949
1032
19111
485
118
1622
20942
1005
1800
887
19191
883
9129
348
10959
390
10087
122
5036
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.1e-01
5.1e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.10%
controls:53.33%
cases:57.19%
controls:44.63%
cases:50.97%
controls:9.25%
cases:22.97%
controls:0.56%
cases:53.12%
controls:8.57%
cases:71.73%
controls:45.40%
cases:76.17%
controls:66.64%
1182
11232
925
9828
1205
9399
902
11661
1074
1948
1033
19112
484
118
1623
20942
1005
1799
887
19192
883
9120
348
10968
390
10078
122
5045
Platelets [#/volume] in Blood
26515-7 [3007461]
1.1e-01
5.1e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.6e-01
cases:56.05%
controls:53.25%
cases:57.14%
controls:44.57%
cases:50.97%
controls:9.24%
cases:22.97%
controls:0.56%
cases:53.12%
controls:8.56%
cases:71.73%
controls:45.37%
cases:75.98%
controls:66.61%
1181
11214
926
9846
1204
9387
903
11673
1074
1945
1033
19115
484
118
1623
20942
1005
1797
887
19194
883
9114
348
10974
389
10073
123
5050
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.1e-01
5.1e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.00%
controls:53.35%
cases:57.24%
controls:44.66%
cases:50.97%
controls:9.25%
cases:22.97%
controls:0.56%
cases:53.07%
controls:8.58%
cases:71.73%
controls:45.43%
cases:76.17%
controls:66.66%
1180
11235
927
9825
1206
9405
901
11655
1074
1948
1033
19112
484
118
1623
20942
1004
1802
888
19189
883
9126
348
10962
390
10081
122
5042
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.7e-01
9.5e-01
1.9e+00
3.1e+00
2.0e+00
1.4e+00
1.1e+00
cases:19.27%
controls:12.96%
cases:16.99%
controls:7.34%
cases:8.35%
controls:1.36%
cases:1.14%
controls:0.05%
cases:7.66%
controls:1.13%
cases:25.35%
controls:7.47%
cases:37.30%
controls:17.21%
406
2730
1701
18330
358
1546
1749
19514
176
287
1931
20773
24
11
2083
21049
145
238
1747
20753
312
1501
919
18587
191
2602
321
12521
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.1e-01
5.0e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.15%
controls:53.41%
cases:57.19%
controls:44.72%
cases:51.02%
controls:9.29%
cases:23.26%
controls:0.57%
cases:53.12%
controls:8.59%
cases:71.73%
controls:45.48%
cases:76.17%
controls:66.71%
1183
11248
924
9812
1205
9418
902
11642
1075
1956
1032
19104
490
119
1617
20941
1005
1803
887
19188
883
9137
348
10951
390
10088
122
5035
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.1e-01
5.0e-01
2.3e+00
4.0e+00
2.5e+00
1.1e+00
4.7e-01
cases:56.15%
controls:53.34%
cases:57.19%
controls:44.65%
cases:50.97%
controls:9.27%
cases:23.07%
controls:0.57%
cases:53.07%
controls:8.56%
cases:71.73%
controls:45.40%
cases:76.17%
controls:66.66%
1183
11234
924
9826
1205
9404
902
11656
1074
1952
1033
19108
486
119
1621
20941
1004
1797
888
19194
883
9119
348
10969
390
10081
122
5042
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.7e-01
9.3e-01
1.9e+00
3.1e+00
2.0e+00
1.4e+00
1.0e+00
cases:19.41%
controls:13.05%
cases:16.66%
controls:7.34%
cases:8.21%
controls:1.33%
cases:1.19%
controls:0.05%
cases:7.93%
controls:1.13%
cases:25.02%
controls:7.57%
cases:36.72%
controls:17.40%
409
2748
1698
18312
351
1545
1756
19515
173
281
1934
20779
25
11
2082
21049
150
237
1742
20754
308
1520
923
18568
188
2632
324
12491
Endoscopic ligature of oesophageal varices
JCA22 [2001304605]
3.9e+00
3.6e+00
—
—
—
—
3.3e+00
cases:1.66%
controls:0.03%
cases:0.85%
controls:0.02%
—
—
—
—
—
—
—
—
cases:2.15%
controls:0.08%
35
7
2072
21053
18
5
2089
21055
—
—
—
—
11
12
501
15111
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.6e-01
5.5e-01
2.2e+00
3.7e+00
2.3e+00
1.1e+00
7.3e-01
cases:39.01%
controls:35.23%
cases:43.19%
controls:30.48%
cases:37.35%
controls:6.04%
cases:12.15%
controls:0.33%
cases:38.27%
controls:5.63%
cases:57.60%
controls:31.70%
cases:69.14%
controls:51.97%
822
7420
1285
13640
910
6419
1197
14641
787
1272
1320
19788
256
69
1851
20991
724
1181
1168
19810
709
6367
522
13721
354
7860
158
7263
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.6e-01
1.3e+00
2.3e+00
—
2.9e+00
2.5e+00
1.0e+00
cases:4.22%
controls:2.01%
cases:3.08%
controls:0.85%
cases:1.04%
controls:0.10%
—
—
cases:2.17%
controls:0.12%
cases:11.37%
controls:1.09%
cases:9.96%
controls:3.73%
89
424
2018
20636
65
179
2042
20881
22
22
2085
21038
—
41
25
1851
20966
140
219
1091
19869
51
564
461
14559
ERCP
UJK02 [2001305365]
1.4e+00
3.0e+00
1.0e+50
1.0e+50
—
3.7e+00
2.7e+00
cases:0.90%
controls:0.23%
cases:1.95%
controls:0.09%
cases:2.14%
controls:0.00%
cases:1.99%
controls:0.00%
—
—
cases:3.41%
controls:0.09%
cases:4.10%
controls:0.28%
19
49
2088
21011
41
20
2066
21040
45
0
2062
21060
42
0
2065
21060
—
42
18
1189
20070
21
43
491
15080
Teaching
WZC30 [2001310891]
4.4e-01
6.7e-01
1.9e+00
—
3.0e+00
2.9e+00
1.9e+00
cases:3.46%
controls:2.26%
cases:1.71%
controls:0.88%
cases:0.66%
controls:0.10%
—
—
cases:2.59%
controls:0.14%
cases:12.10%
controls:0.79%
cases:16.60%
controls:2.80%
73
475
2034
20585
36
186
2071
20874
14
22
2093
21038
—
49
29
1843
20962
149
158
1082
19930
85
423
427
14700
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.1e+00
1.4e+00
2.4e+00
—
2.4e+00
2.0e+00
1.4e+00
cases:9.02%
controls:3.29%
cases:8.35%
controls:2.20%
cases:3.84%
controls:0.35%
—
—
cases:3.75%
controls:0.36%
cases:14.87%
controls:2.30%
cases:21.68%
controls:6.38%
190
692
1917
20368
176
463
1931
20597
81
73
2026
20987
—
71
76
1821
20915
183
463
1048
19625
111
965
401
14158
loperamide oxide; oral
A07DA05 [21600648]
8.5e-01
1.1e+00
1.3e+00
—
3.0e+00
3.1e+00
2.6e+00
cases:2.23%
controls:0.96%
cases:1.71%
controls:0.56%
cases:0.38%
controls:0.10%
—
—
cases:2.33%
controls:0.12%
cases:10.40%
controls:0.50%
cases:13.67%
controls:1.18%
47
203
2060
20857
36
118
2071
20942
8
22
2099
21038
—
44
25
1848
20966
128
101
1103
19987
70
179
442
14944
loperamide; oral
A07DA03 [21600646]
8.5e-01
1.1e+00
1.3e+00
—
3.0e+00
3.1e+00
2.6e+00
cases:2.23%
controls:0.96%
cases:1.71%
controls:0.56%
cases:0.38%
controls:0.10%
—
—
cases:2.33%
controls:0.12%
cases:10.40%
controls:0.50%
cases:13.67%
controls:1.18%
47
203
2060
20857
36
118
2071
20942
8
22
2099
21038
—
44
25
1848
20966
128
101
1103
19987
70
179
442
14944
CBC panel - Blood by Automated count
58410-2 [40761511]
1.8e-01
4.8e-01
2.2e+00
3.9e+00
2.3e+00
9.9e-01
6.7e-01
cases:49.36%
controls:44.89%
cases:40.72%
controls:29.82%
cases:34.12%
controls:5.46%
cases:14.52%
controls:0.36%
cases:34.73%
controls:5.03%
cases:52.56%
controls:29.20%
cases:66.99%
controls:50.85%
1040
9453
1067
11607
858
6281
1249
14779
719
1149
1388
19911
306
75
1801
20985
657
1056
1235
19935
647
5866
584
14222
343
7690
169
7433
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.6e-01
7.4e-01
2.0e+00
3.5e+00
2.0e+00
1.1e+00
8.3e-01
cases:17.51%
controls:11.77%
cases:18.08%
controls:9.55%
cases:13.00%
controls:1.92%
cases:3.37%
controls:0.11%
cases:12.53%
controls:1.86%
cases:25.59%
controls:10.15%
cases:36.13%
controls:19.76%
369
2479
1738
18581
381
2012
1726
19048
274
404
1833
20656
71
23
2036
21037
237
390
1655
20601
315
2039
916
18049
185
2988
327
12135
Differential panel - Peritoneal fluid
29581-6 [3033799]
3.5e+00
3.6e+00
—
—
—
—
3.6e+00
cases:0.90%
controls:0.03%
cases:1.04%
controls:0.03%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.07%
19
6
2088
21054
22
6
2085
21054
—
—
—
—
12
10
500
15113
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
5.9e-01
9.3e-01
2.7e+00
—
3.1e+00
2.1e+00
1.2e+00
cases:5.22%
controls:2.96%
cases:3.32%
controls:1.34%
cases:2.99%
controls:0.21%
—
—
cases:3.28%
controls:0.15%
cases:9.42%
controls:1.25%
cases:10.55%
controls:3.27%
110
623
1997
20437
70
283
2037
20777
63
44
2044
21016
—
62
32
1830
20959
116
251
1115
19837
54
495
458
14628
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.1e+00
1.4e+00
2.5e+00
—
2.4e+00
2.0e+00
1.4e+00
cases:9.82%
controls:3.61%
cases:8.64%
controls:2.31%
cases:4.03%
controls:0.36%
—
—
cases:3.86%
controls:0.37%
cases:15.11%
controls:2.43%
cases:22.46%
controls:6.79%
207
761
1900
20299
182
487
1925
20573
85
75
2022
20985
—
73
77
1819
20914
186
488
1045
19600
115
1027
397
14096
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
6.2e-01
1.0e+00
2.4e+00
—
2.7e+00
2.6e+00
1.3e+00
cases:1.85%
controls:1.00%
cases:1.52%
controls:0.57%
cases:0.85%
controls:0.08%
—
—
cases:1.37%
controls:0.09%
cases:7.47%
controls:0.62%
cases:7.62%
controls:2.22%
39
211
2068
20849
32
119
2075
20941
18
16
2089
21044
—
26
19
1866
20972
92
124
1139
19964
39
335
473
14788
Ulcerative colitis, unspecified
K51.9 [45605941]
1.3e+00
1.5e+00
2.0e+00
—
2.7e+00
1.4e+00
1.7e+00
cases:1.09%
controls:0.29%
cases:0.76%
controls:0.18%
cases:0.28%
controls:0.04%
—
—
cases:0.42%
controls:0.03%
cases:0.73%
controls:0.17%
cases:1.37%
controls:0.26%
23
62
2084
20998
16
37
2091
21023
6
8
2101
21052
—
8
6
1884
20985
9
35
1222
20053
7
39
505
15084
Gas panel - Venous blood
24339-4 [3000991]
7.8e-01
1.3e+00
2.4e+00
—
2.4e+00
2.3e+00
1.5e+00
cases:3.80%
controls:1.77%
cases:3.42%
controls:0.95%
cases:1.95%
controls:0.18%
—
—
cases:2.54%
controls:0.24%
cases:10.64%
controls:1.18%
cases:12.50%
controls:3.23%
80
373
2027
20687
72
201
2035
20859
41
38
2066
21022
—
48
50
1844
20941
131
238
1100
19850
64
489
448
14634
ABO and Rh group [Type] in Blood
882-1 [3003694]
2.4e-01
1.1e+00
3.4e+00
—
3.5e+00
2.0e+00
7.1e-01
cases:6.93%
controls:5.55%
cases:5.32%
controls:1.89%
cases:3.70%
controls:0.13%
—
—
cases:4.70%
controls:0.15%
cases:9.42%
controls:1.43%
cases:10.74%
controls:5.59%
146
1168
1961
19892
112
398
1995
20662
78
28
2029
21032
—
89
32
1803
20959
116
288
1115
19800
55
845
457
14278
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
7.1e-01
1.1e+00
2.6e+00
—
2.6e+00
2.4e+00
1.1e+00
cases:3.56%
controls:1.79%
cases:2.47%
controls:0.85%
cases:1.52%
controls:0.11%
—
—
cases:2.11%
controls:0.15%
cases:10.24%
controls:1.02%
cases:9.57%
controls:3.31%
75
376
2032
20684
52
178
2055
20882
32
24
2075
21036
—
40
32
1852
20959
126
205
1105
19883
49
501
463
14622
Monitored bed care
WX892 [2001310850]
3.2e-01
1.1e+00
2.5e+00
1.0e+50
3.0e+00
2.2e+00
1.7e+00
cases:1.76%
controls:1.28%
cases:1.09%
controls:0.37%
cases:0.71%
controls:0.06%
cases:0.52%
controls:0.00%
cases:0.48%
controls:0.02%
cases:2.60%
controls:0.29%
cases:4.49%
controls:0.82%
37
269
2070
20791
23
78
2084
20982
15
12
2092
21048
11
0
2096
21060
9
5
1883
20986
32
58
1199
20030
23
124
489
14999
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
1.2e+00
2.7e+00
—
1.0e+50
—
3.7e+00
2.9e+00
cases:1.00%
controls:0.29%
cases:1.66%
controls:0.12%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.25%
controls:0.08%
cases:3.91%
controls:0.22%
21
61
2086
20999
35
25
2072
21035
—
5
0
2102
21060
—
40
16
1191
20072
20
33
492
15090
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
7.5e-01
1.0e+00
2.4e+00
—
3.1e+00
2.0e+00
1.3e+00
cases:2.94%
controls:1.41%
cases:1.76%
controls:0.66%
cases:0.81%
controls:0.08%
—
—
cases:1.32%
controls:0.06%
cases:4.47%
controls:0.61%
cases:9.18%
controls:2.62%
62
296
2045
20764
37
138
2070
20922
17
16
2090
21044
—
25
13
1867
20978
55
123
1176
19965
47
396
465
14727
Inpatient Visit
IP [9201]
3.8e-01
8.7e-01
2.2e+00
—
3.3e+00
2.4e+00
1.4e+00
cases:12.24%
controls:8.68%
cases:8.45%
controls:3.72%
cases:4.51%
controls:0.52%
—
—
cases:9.57%
controls:0.40%
cases:30.79%
controls:3.85%
cases:35.94%
controls:12.11%
258
1827
1849
19233
178
784
1929
20276
95
110
2012
20950
—
181
84
1711
20907
379
774
852
19314
184
1832
328
13291
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
4.0e-01
1.3e+00
2.6e+00
1.0e+50
3.2e+00
2.3e+00
1.1e+00
cases:1.47%
controls:0.99%
cases:1.80%
controls:0.47%
cases:0.52%
controls:0.04%
cases:0.33%
controls:0.00%
cases:0.58%
controls:0.02%
cases:3.82%
controls:0.41%
cases:5.86%
controls:2.08%
31
208
2076
20852
38
100
2069
20960
11
8
2096
21052
7
0
2100
21060
11
5
1881
20986
47
82
1184
20006
30
314
482
14809
Respiratory and circulatory monitoring
WX700 [2001310817]
4.5e-01
7.7e-01
2.4e+00
1.0e+50
3.1e+00
2.5e+00
1.2e+00
cases:4.51%
controls:2.93%
cases:1.95%
controls:0.91%
cases:0.76%
controls:0.07%
cases:0.81%
controls:0.00%
cases:1.96%
controls:0.09%
cases:7.31%
controls:0.64%
cases:7.81%
controls:2.48%
95
617
2012
20443
41
191
2066
20869
16
14
2091
21046
17
0
2090
21060
37
18
1855
20973
90
129
1141
19959
40
375
472
14748
Coloscopy
UJF32 [2001305029]
8.1e-01
1.4e+00
2.6e+00
1.0e+50
2.6e+00
1.8e+00
1.3e+00
cases:10.16%
controls:4.79%
cases:4.27%
controls:1.11%
cases:1.52%
controls:0.11%
cases:0.71%
controls:0.00%
cases:2.01%
controls:0.15%
cases:5.61%
controls:1.02%
cases:13.67%
controls:4.12%
214
1009
1893
20051
90
234
2017
20826
32
24
2075
21036
15
0
2092
21060
38
31
1854
20960
69
205
1162
19883
70
623
442
14500
Stomach Pathology biopsy report
66114-0 [40768797]
8.4e-01
1.5e+00
2.6e+00
—
3.2e+00
1.4e+00
1.1e+00
cases:7.40%
controls:3.32%
cases:4.41%
controls:1.06%
cases:1.33%
controls:0.10%
—
—
cases:1.43%
controls:0.06%
cases:3.82%
controls:0.98%
cases:8.40%
controls:3.09%
156
700
1951
20360
93
223
2014
20837
28
22
2079
21038
—
27
13
1865
20978
47
196
1184
19892
43
468
469
14655
Bacteria identified in Urine by Culture
630-4 [3026008]
4.7e-01
7.4e-01
2.1e+00
3.6e+00
1.9e+00
1.2e+00
5.8e-01
cases:11.91%
controls:7.80%
cases:7.69%
controls:3.83%
cases:4.32%
controls:0.57%
cases:1.00%
controls:0.03%
cases:3.65%
controls:0.59%
cases:12.84%
controls:4.35%
cases:19.53%
controls:11.93%
251
1643
1856
19417
162
807
1945
20253
91
120
2016
20940
21
6
2086
21054
69
124
1823
20867
158
874
1073
19214
100
1804
412
13319
Oxygen saturation in Arterial blood
2708-6 [3016502]
6.9e-01
1.2e+00
2.3e+00
—
2.8e+00
2.4e+00
9.4e-01
cases:4.51%
controls:2.32%
cases:3.08%
controls:0.97%
cases:1.28%
controls:0.13%
—
—
cases:2.27%
controls:0.14%
cases:12.19%
controls:1.24%
cases:9.96%
controls:4.14%
95
489
2012
20571
65
204
2042
20856
27
27
2080
21033
—
43
29
1849
20962
150
249
1081
19839
51
626
461
14497
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
2.2e+00
2.4e+00
—
—
1.0e+50
3.1e+00
2.7e+00
cases:1.00%
controls:0.11%
cases:0.66%
controls:0.06%
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.73%
controls:0.03%
cases:1.56%
controls:0.11%
21
24
2086
21036
14
13
2093
21047
—
—
6
0
1886
20991
9
7
1222
20081
8
16
504
15107
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
1.3e+00
2.7e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:1.14%
controls:0.31%
cases:1.76%
controls:0.12%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.41%
controls:0.10%
cases:4.10%
controls:0.26%
24
65
2083
20995
37
26
2070
21034
—
5
0
2102
21060
—
42
21
1189
20067
21
39
491
15084
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
1.3e+00
2.6e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:1.14%
controls:0.31%
cases:1.76%
controls:0.13%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.41%
controls:0.10%
cases:3.91%
controls:0.24%
24
66
2083
20994
37
27
2070
21033
—
5
0
2102
21060
—
42
21
1189
20067
20
37
492
15086
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.1e-01
8.2e-01
2.3e+00
—
3.4e+00
2.2e+00
1.2e+00
cases:10.39%
controls:7.82%
cases:7.50%
controls:3.43%
cases:4.03%
controls:0.40%
—
—
cases:8.77%
controls:0.33%
cases:24.05%
controls:3.47%
cases:28.71%
controls:10.56%
219
1646
1888
19414
158
723
1949
20337
85
85
2022
20975
—
166
69
1726
20922
296
697
935
19391
147
1597
365
13526
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
2.2e-01
8.0e-01
2.6e+00
—
3.5e+00
2.2e+00
1.2e+00
cases:5.70%
controls:4.61%
cases:4.22%
controls:1.94%
cases:2.33%
controls:0.19%
—
—
cases:6.45%
controls:0.21%
cases:16.90%
controls:2.11%
cases:19.53%
controls:6.94%
120
970
1987
20090
89
409
2018
20651
49
39
2058
21021
—
122
45
1770
20946
208
423
1023
19665
100
1049
412
14074
General anaesthesia
WX402 [2001310806]
4.1e-01
1.3e+00
2.5e+00
—
2.4e+00
2.6e+00
1.5e+00
cases:3.46%
controls:2.33%
cases:4.18%
controls:1.15%
cases:1.95%
controls:0.17%
—
—
cases:1.96%
controls:0.19%
cases:13.65%
controls:1.20%
cases:15.43%
controls:3.97%
73
490
2034
20570
88
243
2019
20817
41
35
2066
21025
—
37
39
1855
20952
168
242
1063
19846
79
600
433
14523
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
1.3e+00
2.6e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:1.00%
controls:0.27%
cases:1.66%
controls:0.13%
—
—
cases:0.28%
controls:0.00%
—
—
cases:3.33%
controls:0.10%
cases:3.91%
controls:0.26%
21
56
2086
21004
35
27
2072
21033
—
6
0
2101
21060
—
41
21
1190
20067
20
39
492
15084
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
1.3e+00
2.5e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:0.95%
controls:0.26%
cases:1.52%
controls:0.13%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.49%
controls:0.10%
cases:3.91%
controls:0.24%
20
55
2087
21005
32
27
2075
21033
—
5
0
2102
21060
—
43
21
1188
20067
20
37
492
15086
Other transluminal endoscopic operation on stomach or duodenum
JDW98 [2001304774]
1.9e+00
2.4e+00
—
—
—
3.2e+00
2.7e+00
cases:1.00%
controls:0.16%
cases:0.52%
controls:0.05%
—
—
—
—
—
—
cases:0.81%
controls:0.03%
cases:1.76%
controls:0.12%
21
33
2086
21027
11
10
2096
21050
—
—
—
10
7
1221
20081
9
18
503
15105
Urology
34 [38004474]
4.4e-01
9.0e-01
1.9e+00
3.7e+00
1.5e+00
1.1e+00
5.8e-01
cases:13.48%
controls:9.16%
cases:8.83%
controls:3.80%
cases:3.75%
controls:0.59%
cases:1.14%
controls:0.03%
cases:3.01%
controls:0.67%
cases:10.15%
controls:3.69%
cases:16.41%
controls:9.91%
284
1929
1823
19131
186
800
1921
20260
79
125
2028
20935
24
6
2083
21054
57
140
1835
20851
125
741
1106
19347
84
1499
428
13624
Tissue Pathology biopsy report
66121-5 [40768804]
5.4e-01
9.6e-01
2.3e+00
1.0e+50
3.0e+00
1.9e+00
1.3e+00
cases:13.62%
controls:8.44%
cases:6.60%
controls:2.62%
cases:2.61%
controls:0.26%
cases:6.22%
controls:0.00%
cases:5.29%
controls:0.29%
cases:13.00%
controls:2.14%
cases:22.85%
controls:7.18%
287
1778
1820
19282
139
552
1968
20508
55
54
2052
21006
131
0
1976
21060
100
60
1792
20931
160
430
1071
19658
117
1086
395
14037
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
3.5e-01
9.8e-01
2.4e+00
—
2.5e+00
2.2e+00
1.9e+00
cases:3.23%
controls:2.29%
cases:2.28%
controls:0.86%
cases:1.28%
controls:0.12%
—
—
cases:1.32%
controls:0.10%
cases:6.42%
controls:0.74%
cases:12.89%
controls:2.16%
68
482
2039
20578
48
182
2059
20878
27
25
2080
21035
—
25
22
1867
20969
79
148
1152
19940
66
327
446
14796
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
5.9e-01
1.1e+00
1.7e+00
3.0e+00
1.7e+00
1.2e+00
7.6e-01
cases:16.37%
controls:9.80%
cases:15.47%
controls:5.88%
cases:4.70%
controls:0.86%
cases:0.47%
controls:0.02%
cases:4.28%
controls:0.83%
cases:18.20%
controls:6.37%
cases:30.08%
controls:16.75%
345
2063
1762
18997
326
1239
1781
19821
99
182
2008
20878
10
5
2097
21055
81
174
1811
20817
224
1279
1007
18809
154
2533
358
12590
pH of Arterial blood
2744-1 [3019977]
5.9e-01
1.1e+00
2.3e+00
—
2.6e+00
2.4e+00
1.1e+00
cases:4.75%
controls:2.70%
cases:3.46%
controls:1.20%
cases:1.47%
controls:0.15%
—
—
cases:2.33%
controls:0.17%
cases:12.51%
controls:1.34%
cases:12.11%
controls:4.46%
100
568
2007
20492
73
252
2034
20808
31
32
2076
21028
—
44
36
1848
20955
154
270
1077
19818
62
675
450
14448
Pain localized to upper abdomen
R10.1 [45568111]
3.7e-01
1.4e+00
3.9e+00
1.0e+50
2.4e+00
1.5e+00
8.2e-01
cases:3.46%
controls:2.41%
cases:3.08%
controls:0.81%
cases:2.66%
controls:0.06%
cases:0.90%
controls:0.00%
cases:0.69%
controls:0.06%
cases:3.09%
controls:0.69%
cases:5.66%
controls:2.57%
73
508
2034
20552
65
171
2042
20889
56
12
2051
21048
19
0
2088
21060
13
13
1879
20978
38
138
1193
19950
29
388
483
14735
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
8.2e-01
1.6e+00
3.3e+00
—
2.9e+00
1.3e+00
4.5e-01
cases:8.54%
controls:3.96%
cases:6.64%
controls:1.35%
cases:2.56%
controls:0.09%
—
—
cases:2.17%
controls:0.12%
cases:4.55%
controls:1.31%
cases:6.84%
controls:4.47%
180
833
1927
20227
140
284
1967
20776
54
20
2053
21040
—
41
25
1851
20966
56
264
1175
19824
35
676
477
14447
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
5.9e-01
1.1e+00
2.3e+00
—
2.7e+00
2.4e+00
1.0e+00
cases:4.84%
controls:2.73%
cases:3.46%
controls:1.20%
cases:1.42%
controls:0.15%
—
—
cases:2.33%
controls:0.17%
cases:12.59%
controls:1.35%
cases:11.72%
controls:4.52%
102
575
2005
20485
73
253
2034
20807
30
32
2077
21028
—
44
35
1848
20956
155
271
1076
19817
60
684
452
14439
Other and unspecified abdominal pain
R10.4 [45568113]
4.1e-01
1.1e+00
3.5e+00
—
2.6e+00
1.4e+00
8.5e-01
cases:7.69%
controls:5.25%
cases:4.75%
controls:1.63%
cases:4.84%
controls:0.15%
—
—
cases:2.11%
controls:0.16%
cases:5.85%
controls:1.46%
cases:12.11%
controls:5.58%
162
1105
1945
19955
100
343
2007
20717
102
31
2005
21029
—
40
33
1852
20958
72
294
1159
19794
62
844
450
14279
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
5.9e-01
1.1e+00
2.2e+00
—
2.7e+00
2.4e+00
1.0e+00
cases:4.84%
controls:2.73%
cases:3.46%
controls:1.21%
cases:1.42%
controls:0.16%
—
—
cases:2.33%
controls:0.17%
cases:12.59%
controls:1.35%
cases:11.72%
controls:4.53%
102
575
2005
20485
73
254
2034
20806
30
33
2077
21027
—
44
35
1848
20956
155
271
1076
19817
60
685
452
14438
Base excess in Arterial blood by calculation
1925-7 [3003396]
6.1e-01
1.1e+00
2.2e+00
—
2.6e+00
2.3e+00
1.1e+00
cases:4.89%
controls:2.72%
cases:3.51%
controls:1.20%
cases:1.38%
controls:0.16%
—
—
cases:2.33%
controls:0.17%
cases:12.35%
controls:1.36%
cases:12.11%
controls:4.44%
103
573
2004
20487
74
253
2033
20807
29
33
2078
21027
—
44
36
1848
20955
152
274
1079
19814
62
671
450
14452
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.8e-01
6.3e-01
1.8e+00
3.7e+00
1.5e+00
1.2e+00
8.5e-01
cases:26.72%
controls:23.42%
cases:20.46%
controls:12.02%
cases:9.54%
controls:1.74%
cases:2.71%
controls:0.07%
cases:7.40%
controls:1.68%
cases:30.14%
controls:11.89%
cases:48.24%
controls:28.39%
563
4933
1544
16127
431
2532
1676
18528
201
367
1906
20693
57
14
2050
21046
140
352
1752
20639
371
2389
860
17699
247
4293
265
10830
Short blood count panel - Blood
55429-5 [40758558]
6.3e-01
1.1e+00
2.4e+00
—
2.7e+00
1.8e+00
1.2e+00
cases:10.96%
controls:6.17%
cases:8.64%
controls:2.99%
cases:5.70%
controls:0.54%
—
—
cases:7.45%
controls:0.53%
cases:15.84%
controls:3.15%
cases:24.02%
controls:8.70%
231
1300
1876
19760
182
630
1925
20430
120
113
1987
20947
—
141
112
1751
20879
195
633
1036
19455
123
1316
389
13807
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
4.2e-01
9.6e-01
3.0e+00
—
2.9e+00
1.9e+00
1.0e+00
cases:1.23%
controls:0.81%
cases:1.52%
controls:0.59%
cases:1.28%
controls:0.06%
—
—
cases:1.06%
controls:0.06%
cases:4.55%
controls:0.71%
cases:7.03%
controls:2.70%
26
171
2081
20889
32
124
2075
20936
27
13
2080
21047
—
20
12
1872
20979
56
143
1175
19945
36
409
476
14714
Medical doctor
Z2221 [2001311556]
5.7e-01
1.1e+00
2.6e+00
1.0e+50
2.6e+00
1.7e+00
1.3e+00
cases:7.12%
controls:4.17%
cases:2.85%
controls:1.01%
cases:1.90%
controls:0.15%
cases:0.85%
controls:0.00%
cases:1.74%
controls:0.14%
cases:4.06%
controls:0.75%
cases:7.81%
controls:2.17%
150
879
1957
20181
60
213
2047
20847
40
31
2067
21029
18
0
2089
21060
33
29
1859
20962
50
150
1181
19938
40
328
472
14795
Thorax CT examination
GD1AD [2001303618]
2.9e-01
1.0e+00
2.9e+00
1.0e+50
3.0e+00
1.8e+00
1.0e+00
cases:0.76%
controls:0.57%
cases:0.66%
controls:0.24%
cases:0.62%
controls:0.03%
cases:0.43%
controls:0.00%
cases:0.48%
controls:0.02%
cases:1.54%
controls:0.26%
cases:2.73%
controls:0.99%
16
120
2091
20940
14
50
2093
21010
13
7
2094
21053
9
0
2098
21060
9
5
1883
20986
19
53
1212
20035
14
149
498
14974
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-3.8e-04
3.6e-01
2.1e+00
3.9e+00
2.2e+00
8.7e-01
3.4e-01
cases:39.16%
controls:39.16%
cases:38.44%
controls:30.40%
cases:33.70%
controls:6.06%
cases:15.80%
controls:0.37%
cases:35.47%
controls:5.74%
cases:51.02%
controls:30.38%
cases:56.45%
controls:47.92%
825
8248
1282
12812
810
6403
1297
14657
710
1276
1397
19784
333
78
1774
20982
671
1205
1221
19786
628
6102
603
13986
289
7247
223
7876
Base excess in Venous blood by calculation
1927-3 [3002032]
7.2e-01
1.1e+00
2.5e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:4.75%
controls:2.36%
cases:3.89%
controls:1.32%
cases:2.80%
controls:0.23%
—
—
cases:2.70%
controls:0.26%
cases:9.50%
controls:1.53%
cases:13.09%
controls:4.87%
100
498
2007
20562
82
277
2025
20783
59
48
2048
21012
—
51
54
1841
20937
117
307
1114
19781
67
736
445
14387
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
7.3e-01
1.1e+00
2.5e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:4.75%
controls:2.35%
cases:3.94%
controls:1.33%
cases:2.90%
controls:0.24%
—
—
cases:2.75%
controls:0.25%
cases:9.67%
controls:1.55%
cases:13.09%
controls:5.00%
100
495
2007
20565
83
281
2024
20779
61
51
2046
21009
—
52
53
1840
20938
119
312
1112
19776
67
756
445
14367
Essential (primary) hypertension
I10 [45591453]
3.5e-01
5.2e-01
1.6e+00
4.4e+00
1.9e+00
8.7e-01
2.5e-01
cases:36.69%
controls:29.02%
cases:22.64%
controls:14.79%
cases:11.30%
controls:2.45%
cases:9.07%
controls:0.12%
cases:14.53%
controls:2.43%
cases:29.65%
controls:14.94%
cases:41.60%
controls:35.63%
773
6112
1334
14948
477
3114
1630
17946
238
516
1869
20544
191
25
1916
21035
275
510
1617
20481
365
3002
866
17086
213
5389
299
9734
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
1.2e-01
6.8e-01
1.9e+00
3.8e+00
1.6e+00
1.2e+00
5.1e-01
cases:7.02%
controls:6.27%
cases:5.98%
controls:3.11%
cases:2.66%
controls:0.40%
cases:1.04%
controls:0.02%
cases:1.74%
controls:0.36%
cases:9.91%
controls:3.20%
cases:13.09%
controls:8.26%
148
1320
1959
19740
126
655
1981
20405
56
84
2051
20976
22
5
2085
21055
33
75
1859
20916
122
642
1109
19446
67
1249
445
13874
pH of Venous blood
2746-6 [3012544]
6.8e-01
1.1e+00
2.5e+00
—
2.5e+00
1.9e+00
1.1e+00
cases:4.84%
controls:2.52%
cases:3.94%
controls:1.36%
cases:2.99%
controls:0.25%
—
—
cases:2.80%
controls:0.25%
cases:9.50%
controls:1.58%
cases:13.28%
controls:5.02%
102
530
2005
20530
83
286
2024
20774
63
52
2044
21008
—
53
52
1839
20939
117
318
1114
19770
68
759
444
14364
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.2e+00
2.4e+00
—
1.0e+50
—
3.4e+00
2.7e+00
cases:1.09%
controls:0.35%
cases:1.66%
controls:0.15%
—
—
cases:0.28%
controls:0.00%
—
—
cases:3.41%
controls:0.12%
cases:4.49%
controls:0.32%
23
73
2084
20987
35
32
2072
21028
—
6
0
2101
21060
—
42
24
1189
20064
23
49
489
15074
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.7e-01
4.5e-01
2.0e+00
4.0e+00
2.2e+00
9.1e-01
4.8e-01
cases:6.83%
controls:5.84%
cases:3.75%
controls:2.42%
cases:2.09%
controls:0.30%
cases:1.33%
controls:0.02%
cases:3.07%
controls:0.33%
cases:4.63%
controls:1.92%
cases:6.05%
controls:3.84%
144
1230
1963
19830
79
509
2028
20551
44
63
2063
20997
28
5
2079
21055
58
70
1834
20921
57
386
1174
19702
31
580
481
14543
Physiotherapy
R4110 [2001310233]
3.5e-01
8.7e-01
1.8e+00
—
2.8e+00
2.3e+00
1.5e+00
cases:7.88%
controls:5.66%
cases:4.89%
controls:2.11%
cases:1.99%
controls:0.33%
—
—
cases:3.38%
controls:0.22%
cases:15.68%
controls:1.84%
cases:18.55%
controls:5.04%
166
1193
1941
19867
103
445
2004
20615
42
70
2065
20990
—
64
46
1828
20945
193
369
1038
19719
95
762
417
14361
Clinic/Center
261Q00000X [38004207]
8.5e-01
1.4e+00
—
—
2.9e+00
2.6e+00
1.8e+00
cases:1.80%
controls:0.78%
cases:0.90%
controls:0.23%
—
—
—
—
cases:0.58%
controls:0.03%
cases:2.84%
controls:0.22%
cases:3.32%
controls:0.54%
38
164
2069
20896
19
48
2088
21012
—
—
11
7
1881
20984
35
44
1196
20044
17
82
495
15041
lactulose; oral
A06AD11 [21600571]
8.5e-01
1.3e+00
1.7e+00
2.0e+00
2.2e+00
2.1e+00
1.3e+00
cases:6.93%
controls:3.10%
cases:5.93%
controls:1.70%
cases:2.47%
controls:0.47%
cases:0.24%
controls:0.03%
cases:4.12%
controls:0.45%
cases:13.24%
controls:1.86%
cases:14.84%
controls:4.34%
146
652
1961
20408
125
359
1982
20701
52
99
2055
20961
5
7
2102
21053
78
95
1814
20896
163
374
1068
19714
76
657
436
14466
Laparoscopy
JAH01 [2001304475]
8.9e-01
3.2e+00
—
1.0e+50
1.0e+50
3.7e+00
2.5e+00
cases:0.43%
controls:0.18%
cases:0.57%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
cases:0.26%
controls:0.00%
cases:1.22%
controls:0.03%
cases:1.56%
controls:0.13%
9
37
2098
21023
12
5
2095
21055
—
5
0
2102
21060
5
0
1887
20991
15
6
1216
20082
8
19
504
15104
hydroxyzine; oral, parenteral
N05BB01 [21604590]
6.5e-01
9.0e-01
2.2e+00
—
2.4e+00
1.8e+00
1.5e+00
cases:3.61%
controls:1.92%
cases:1.95%
controls:0.80%
cases:1.09%
controls:0.13%
—
—
cases:1.74%
controls:0.16%
cases:4.55%
controls:0.77%
cases:8.01%
controls:1.90%
76
404
2031
20656
41
168
2066
20892
23
27
2084
21033
—
33
34
1859
20957
56
154
1175
19934
41
287
471
14836
Laboratory Visit
OMOP4822461 [32036]
8.3e-02
3.7e-01
1.9e+00
3.9e+00
2.0e+00
8.8e-01
4.0e-01
cases:58.90%
controls:56.87%
cases:60.94%
controls:51.92%
cases:56.53%
controls:16.06%
cases:34.69%
controls:1.07%
cases:57.19%
controls:15.78%
cases:73.35%
controls:53.32%
cases:77.15%
controls:69.42%
1241
11977
866
9083
1284
10935
823
10125
1191
3382
916
17678
731
226
1376
20834
1082
3313
810
17678
903
10711
328
9377
395
10498
117
4625
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
6.6e-01
8.1e-01
2.5e+00
—
2.5e+00
1.9e+00
1.0e+00
cases:4.13%
controls:2.17%
cases:3.08%
controls:1.39%
cases:2.04%
controls:0.17%
—
—
cases:1.90%
controls:0.16%
cases:9.42%
controls:1.50%
cases:14.26%
controls:5.56%
87
458
2020
20602
65
293
2042
20767
43
36
2064
21024
—
36
34
1856
20957
116
301
1115
19787
73
841
439
14282
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
8.3e-01
1.8e+00
—
1.0e+50
—
4.7e+00
2.9e+00
cases:0.85%
controls:0.38%
cases:0.81%
controls:0.13%
—
—
cases:0.43%
controls:0.00%
—
—
cases:6.66%
controls:0.06%
cases:4.69%
controls:0.27%
18
79
2089
20981
17
28
2090
21032
—
9
0
2098
21060
—
82
13
1149
20075
24
41
488
15082
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
5.8e-01
7.4e-01
2.4e+00
—
2.5e+00
1.9e+00
1.3e+00
cases:2.94%
controls:1.66%
cases:1.42%
controls:0.68%
cases:1.00%
controls:0.09%
—
—
cases:1.16%
controls:0.10%
cases:4.31%
controls:0.69%
cases:7.42%
controls:2.10%
62
350
2045
20710
30
144
2077
20916
21
19
2086
21041
—
22
21
1870
20970
53
138
1178
19950
38
317
474
14806
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
1.5e+00
2.6e+00
—
—
—
4.3e+00
2.5e+00
cases:0.38%
controls:0.09%
cases:0.66%
controls:0.05%
—
—
—
—
—
—
cases:2.44%
controls:0.03%
cases:1.37%
controls:0.12%
8
18
2099
21042
14
10
2093
21050
—
—
—
30
7
1201
20081
7
18
505
15105
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
6.8e-01
9.0e-01
2.7e+00
—
—
3.1e+00
2.0e+00
cases:1.52%
controls:0.78%
cases:0.90%
controls:0.37%
cases:0.71%
controls:0.05%
—
—
—
—
cases:5.12%
controls:0.25%
cases:6.05%
controls:0.84%
32
164
2075
20896
19
78
2088
20982
15
10
2092
21050
—
—
63
51
1168
20037
31
127
481
14996
tacrolimus; oral, parenteral
L04AD02 [21603925]
9.5e-01
8.2e-01
—
—
2.0e+00
3.2e+00
4.1e+00
cases:0.33%
controls:0.13%
cases:0.33%
controls:0.15%
—
—
—
—
cases:0.48%
controls:0.06%
cases:3.98%
controls:0.17%
cases:9.96%
controls:0.18%
7
27
2100
21033
7
31
2100
21029
—
—
9
13
1883
20978
49
34
1182
20054
51
27
461
15096
Infectious Disease
44 [38004484]
6.4e-01
7.9e-01
2.2e+00
—
2.3e+00
1.9e+00
1.5e+00
cases:3.23%
controls:1.72%
cases:1.52%
controls:0.69%
cases:0.90%
controls:0.10%
—
—
cases:1.27%
controls:0.12%
cases:4.79%
controls:0.78%
cases:8.79%
controls:2.06%
68
363
2039
20697
32
146
2075
20914
19
21
2088
21039
—
24
26
1868
20965
59
157
1172
19931
45
312
467
14811
Oral Surgery
19 [38004464]
1.0e+00
1.6e+00
2.0e+00
—
—
2.5e+00
2.2e+00
cases:1.76%
controls:0.62%
cases:1.04%
controls:0.22%
cases:0.28%
controls:0.04%
—
—
—
—
cases:2.36%
controls:0.20%
cases:5.08%
controls:0.58%
37
131
2070
20929
22
46
2085
21014
6
8
2101
21052
—
—
29
40
1202
20048
26
87
486
15036
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
3.0e-01
4.9e-01
2.7e+00
1.0e+50
3.0e+00
2.3e+00
1.3e+00
cases:4.37%
controls:3.26%
cases:1.66%
controls:1.02%
cases:1.19%
controls:0.08%
cases:1.23%
controls:0.00%
cases:1.85%
controls:0.10%
cases:9.50%
controls:1.02%
cases:11.72%
controls:3.40%
92
687
2015
20373
35
215
2072
20845
25
17
2082
21043
26
0
2081
21060
35
20
1857
20971
117
205
1114
19883
60
514
452
14609
spironolactone; oral
C03DA01 [21601534]
1.3e+00
1.5e+00
1.6e+00
1.5e+00
1.7e+00
1.8e+00
1.4e+00
cases:10.06%
controls:3.10%
cases:11.25%
controls:2.74%
cases:4.18%
controls:0.88%
cases:0.28%
controls:0.06%
cases:5.13%
controls:0.98%
cases:15.68%
controls:2.95%
cases:16.41%
controls:4.48%
212
652
1895
20408
237
577
1870
20483
88
185
2019
20875
6
13
2101
21047
97
205
1795
20786
193
592
1038
19496
84
678
428
14445
Pleural effusion, not elsewhere classified
J90 [45605897]
9.8e-01
1.0e+00
2.1e+00
—
2.8e+00
1.8e+00
1.6e+00
cases:0.81%
controls:0.30%
cases:0.33%
controls:0.12%
cases:0.38%
controls:0.05%
—
—
cases:0.53%
controls:0.03%
cases:0.89%
controls:0.14%
cases:2.15%
controls:0.43%
17
64
2090
20996
7
25
2100
21035
8
10
2099
21050
—
10
7
1882
20984
11
29
1220
20059
11
65
501
15058
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
7.9e-01
1.2e+00
2.3e+00
—
3.0e+00
2.0e+00
7.4e-01
cases:1.99%
controls:0.91%
cases:0.90%
controls:0.28%
cases:0.33%
controls:0.03%
—
—
cases:0.79%
controls:0.04%
cases:2.19%
controls:0.31%
cases:2.34%
controls:1.14%
42
192
2065
20868
19
60
2088
21000
7
7
2100
21053
—
15
8
1877
20983
27
62
1204
20026
12
172
500
14951
Office Visit
OMOP4822458 [581477]
4.2e-01
6.5e-01
2.6e+00
—
3.0e+00
1.7e+00
9.2e-01
cases:12.72%
controls:8.76%
cases:3.99%
controls:2.13%
cases:3.08%
controls:0.23%
—
—
cases:4.65%
controls:0.25%
cases:10.07%
controls:2.06%
cases:13.09%
controls:5.67%
268
1845
1839
19215
84
448
2023
20612
65
48
2042
21012
—
88
53
1804
20938
124
413
1107
19675
67
857
445
14266
Scheduled procedure
ZXD10 [2001311387]
3.4e-01
7.0e-01
1.6e+00
1.0e+50
2.7e+00
2.4e+00
1.4e+00
cases:8.97%
controls:6.55%
cases:2.99%
controls:1.51%
cases:0.85%
controls:0.18%
cases:1.14%
controls:0.00%
cases:2.64%
controls:0.18%
cases:9.99%
controls:0.97%
cases:11.72%
controls:3.08%
189
1379
1918
19681
63
317
2044
20743
18
37
2089
21023
24
0
2083
21060
50
37
1842
20954
123
194
1108
19894
60
466
452
14657
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
6.0e-01
1.1e+00
2.4e+00
—
2.5e+00
1.9e+00
7.3e-01
cases:3.08%
controls:1.72%
cases:1.95%
controls:0.68%
cases:0.85%
controls:0.08%
—
—
cases:1.06%
controls:0.09%
cases:5.36%
controls:0.81%
cases:5.47%
controls:2.72%
65
363
2042
20697
41
143
2066
20917
18
17
2089
21043
—
20
18
1872
20973
66
163
1165
19925
28
411
484
14712
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.2e-01
6.6e-01
1.7e+00
3.5e+00
1.6e+00
1.0e+00
4.7e-01
cases:17.13%
controls:14.24%
cases:14.43%
controls:8.03%
cases:6.74%
controls:1.28%
cases:1.95%
controls:0.06%
cases:5.34%
controls:1.18%
cases:21.61%
controls:9.17%
cases:33.79%
controls:24.12%
361
2999
1746
18061
304
1692
1803
19368
142
270
1965
20790
41
12
2066
21048
101
247
1791
20744
266
1843
965
18245
173
3648
339
11475
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
7.6e-01
9.2e-01
1.1e+00
—
2.0e+00
3.2e+00
4.0e+00
cases:0.28%
controls:0.13%
cases:0.33%
controls:0.13%
cases:0.24%
controls:0.08%
—
—
cases:0.42%
controls:0.06%
cases:3.41%
controls:0.15%
cases:9.57%
controls:0.19%
6
28
2101
21032
7
28
2100
21032
5
17
2102
21043
—
8
12
1884
20979
42
30
1189
20058
49
29
463
15094
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
6.5e-01
7.8e-01
2.5e+00
—
2.3e+00
1.9e+00
1.0e+00
cases:4.18%
controls:2.22%
cases:2.90%
controls:1.35%
cases:1.95%
controls:0.17%
—
—
cases:1.59%
controls:0.16%
cases:9.26%
controls:1.49%
cases:13.48%
controls:5.19%
88
468
2019
20592
61
284
2046
20776
41
36
2066
21024
—
30
33
1862
20958
114
299
1117
19789
69
785
443
14338
Psoriasis vulgaris
L40.0 [45543370]
7.5e-01
1.2e+00
2.3e+00
—
2.2e+00
1.3e+00
1.3e+00
cases:1.61%
controls:0.77%
cases:1.23%
controls:0.37%
cases:0.62%
controls:0.06%
—
—
cases:0.63%
controls:0.07%
cases:1.38%
controls:0.36%
cases:2.34%
controls:0.66%
34
162
2073
20898
26
78
2081
20982
13
13
2094
21047
—
12
15
1880
20976
17
73
1214
20015
12
100
500
15023
magnesium hydroxide; oral
G04BX01 [21602658]
1.2e+00
1.3e+00
1.1e+00
—
1.4e+00
2.0e+00
2.1e+00
cases:1.95%
controls:0.61%
cases:1.57%
controls:0.45%
cases:0.66%
controls:0.22%
—
—
cases:0.90%
controls:0.21%
cases:3.57%
controls:0.48%
cases:7.81%
controls:1.06%
41
128
2066
20932
33
94
2074
20966
14
47
2093
21013
—
17
45
1875
20946
44
97
1187
19991
40
160
472
14963
magnesium hydroxide; oral
A02AA04 [21600052]
1.2e+00
1.3e+00
1.1e+00
—
1.4e+00
2.0e+00
2.1e+00
cases:1.95%
controls:0.61%
cases:1.57%
controls:0.45%
cases:0.66%
controls:0.22%
—
—
cases:0.90%
controls:0.21%
cases:3.57%
controls:0.48%
cases:7.81%
controls:1.06%
41
128
2066
20932
33
94
2074
20966
14
47
2093
21013
—
17
45
1875
20946
44
97
1187
19991
40
160
472
14963
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
1.4e+00
3.2e+00
—
—
1.0e+50
2.6e+00
1.8e+00
cases:1.04%
controls:0.25%
cases:1.66%
controls:0.07%
—
—
—
—
cases:0.53%
controls:0.00%
cases:1.14%
controls:0.08%
cases:2.15%
controls:0.37%
22
52
2085
21008
35
14
2072
21046
—
—
10
0
1882
20991
14
17
1217
20071
11
56
501
15067
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.0e-01
6.5e-01
1.7e+00
3.7e+00
1.6e+00
1.0e+00
4.7e-01
cases:16.99%
controls:14.33%
cases:14.38%
controls:8.06%
cases:6.60%
controls:1.29%
cases:1.99%
controls:0.05%
cases:5.39%
controls:1.15%
cases:21.69%
controls:9.19%
cases:33.59%
controls:24.08%
358
3018
1749
18042
303
1697
1804
19363
139
271
1968
20789
42
11
2065
21049
102
241
1790
20750
267
1847
964
18241
172
3642
340
11481
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
1.4e+00
3.1e+00
—
—
—
2.7e+00
1.9e+00
cases:0.95%
controls:0.25%
cases:1.52%
controls:0.07%
—
—
—
—
—
—
cases:1.22%
controls:0.08%
cases:2.34%
controls:0.36%
20
52
2087
21008
32
14
2075
21046
—
—
—
15
17
1216
20071
12
55
500
15068
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2.8e-01
9.3e-01
2.6e+00
1.0e+50
2.7e+00
2.1e+00
7.6e-01
cases:1.28%
controls:0.97%
cases:1.23%
controls:0.49%
cases:0.76%
controls:0.06%
cases:0.24%
controls:0.00%
cases:0.69%
controls:0.05%
cases:4.22%
controls:0.55%
cases:4.69%
controls:2.25%
27
204
2080
20856
26
103
2081
20957
16
12
2091
21048
5
0
2102
21060
13
10
1879
20981
52
111
1179
19977
24
341
488
14782
Atherosclerosis of arteries of extremities
I70.2 [45538421]
5.3e-01
8.3e-01
1.4e+00
4.0e+00
1.5e+00
7.7e-01
1.9e-01
cases:5.08%
controls:3.04%
cases:3.80%
controls:1.69%
cases:1.71%
controls:0.44%
cases:1.33%
controls:0.02%
cases:2.01%
controls:0.46%
cases:3.74%
controls:1.76%
cases:5.08%
controls:4.23%
107
641
2000
20419
80
355
2027
20705
36
93
2071
20967
28
5
2079
21055
38
97
1854
20894
46
353
1185
19735
26
639
486
14484
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
2.8e-01
9.6e-01
2.7e+00
—
2.6e+00
2.1e+00
7.4e-01
cases:1.28%
controls:0.97%
cases:1.38%
controls:0.53%
cases:0.81%
controls:0.06%
—
—
cases:0.69%
controls:0.05%
cases:4.63%
controls:0.62%
cases:4.88%
controls:2.38%
27
205
2080
20855
29
112
2078
20948
17
12
2090
21048
—
13
11
1879
20980
57
124
1174
19964
25
360
487
14763
12 lead EKG panel
34534-8 [3044889]
9.8e-02
4.5e-01
1.6e+00
3.2e+00
2.2e+00
9.7e-01
6.4e-01
cases:29.76%
controls:27.75%
cases:20.93%
controls:14.48%
cases:8.21%
controls:1.78%
cases:1.33%
controls:0.06%
cases:11.73%
controls:1.51%
cases:30.54%
controls:14.26%
cases:48.05%
controls:32.72%
627
5844
1480
15216
441
3049
1666
18011
173
374
1934
20686
28
12
2079
21048
222
316
1670
20675
376
2864
855
17224
246
4948
266
10175
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
2.1e-01
6.2e-01
1.4e+00
3.8e+00
1.4e+00
1.0e+00
7.0e-01
cases:10.58%
controls:8.74%
cases:8.50%
controls:4.77%
cases:3.37%
controls:0.83%
cases:1.04%
controls:0.02%
cases:3.07%
controls:0.75%
cases:12.75%
controls:5.05%
cases:23.05%
controls:12.93%
223
1840
1884
19220
179
1005
1928
20055
71
174
2036
20886
22
5
2085
21055
58
158
1834
20833
157
1015
1074
19073
118
1956
394
13167
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.9e-01
6.4e-01
1.7e+00
3.5e+00
1.6e+00
1.0e+00
4.9e-01
cases:16.33%
controls:13.87%
cases:14.00%
controls:7.93%
cases:6.60%
controls:1.27%
cases:1.95%
controls:0.06%
cases:5.23%
controls:1.14%
cases:21.28%
controls:8.96%
cases:33.59%
controls:23.67%
344
2922
1763
18138
295
1670
1812
19390
139
267
1968
20793
41
12
2066
21048
99
239
1793
20752
262
1800
969
18288
172
3579
340
11544
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
6.9e-01
2.3e+00
—
—
1.0e+50
3.5e+00
3.1e+00
cases:0.38%
controls:0.19%
cases:0.38%
controls:0.04%
—
—
—
—
cases:0.32%
controls:0.00%
cases:0.97%
controls:0.03%
cases:2.34%
controls:0.11%
8
40
2099
21020
8
8
2099
21052
—
—
6
0
1886
20991
12
6
1219
20082
12
16
500
15107
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.5e+00
2.3e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:2.04%
controls:0.47%
cases:1.71%
controls:0.17%
—
—
cases:0.24%
controls:0.00%
—
—
cases:3.66%
controls:0.17%
cases:3.91%
controls:0.52%
43
100
2064
20960
36
36
2071
21024
—
5
0
2102
21060
—
45
35
1186
20053
20
79
492
15044
Implantation of vascular injection port
TPX10 [2001309608]
1.5e+00
1.3e+00
—
—
—
3.9e+00
3.5e+00
cases:0.52%
controls:0.11%
cases:0.28%
controls:0.08%
—
—
—
—
—
—
cases:3.25%
controls:0.07%
cases:3.13%
controls:0.10%
11
24
2096
21036
6
16
2101
21044
—
—
—
40
14
1191
20074
16
15
496
15108
pH of Urine
2756-5 [3015736]
1.8e-01
6.1e-01
1.8e+00
3.6e+00
1.6e+00
9.4e-01
3.7e-01
cases:13.53%
controls:11.55%
cases:10.30%
controls:5.90%
cases:4.94%
controls:0.85%
cases:1.52%
controls:0.04%
cases:3.86%
controls:0.83%
cases:15.43%
controls:6.68%
cases:23.83%
controls:17.74%
285
2432
1822
18628
217
1242
1890
19818
104
178
2003
20882
32
9
2075
21051
73
175
1819
20816
190
1341
1041
18747
122
2683
390
12440
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
1.7e-01
6.1e-01
2.0e+00
3.5e+00
1.8e+00
9.6e-01
2.2e-01
cases:6.55%
controls:5.58%
cases:5.89%
controls:3.29%
cases:3.04%
controls:0.43%
cases:0.95%
controls:0.03%
cases:2.17%
controls:0.38%
cases:9.59%
controls:3.92%
cases:13.87%
controls:11.44%
138
1175
1969
19885
124
693
1983
20367
64
90
2043
20970
20
6
2087
21054
41
79
1851
20912
118
787
1113
19301
71
1730
441
13393
One hour or less
ZXE00 [2001311394]
4.7e-01
6.7e-01
1.9e+00
1.0e+50
2.5e+00
1.9e+00
1.5e+00
cases:10.35%
controls:6.75%
cases:3.27%
controls:1.70%
cases:1.14%
controls:0.18%
cases:0.85%
controls:0.00%
cases:1.80%
controls:0.16%
cases:7.47%
controls:1.19%
cases:13.28%
controls:3.45%
218
1421
1889
19639
69
357
2038
20703
24
37
2083
21023
18
0
2089
21060
34
33
1858
20958
92
239
1139
19849
68
522
444
14601
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
4.9e-01
5.2e-01
2.8e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:3.75%
controls:2.34%
cases:1.19%
controls:0.71%
cases:0.52%
controls:0.03%
—
—
cases:0.53%
controls:0.07%
cases:3.09%
controls:0.51%
cases:6.84%
controls:1.36%
79
493
2028
20567
25
150
2082
20910
11
7
2096
21053
—
10
14
1882
20977
38
103
1193
19985
35
206
477
14917
FEV1/FVC --post bronchodilation
69970-2 [42868459]
4.9e-01
5.2e-01
2.8e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:3.75%
controls:2.34%
cases:1.19%
controls:0.71%
cases:0.52%
controls:0.03%
—
—
cases:0.53%
controls:0.07%
cases:3.09%
controls:0.51%
cases:6.84%
controls:1.36%
79
493
2028
20567
25
150
2082
20910
11
7
2096
21053
—
10
14
1882
20977
38
103
1193
19985
35
206
477
14917
FEV1 percent change
69983-5 [42868472]
4.9e-01
5.2e-01
2.8e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:3.75%
controls:2.34%
cases:1.19%
controls:0.71%
cases:0.52%
controls:0.03%
—
—
cases:0.53%
controls:0.07%
cases:3.09%
controls:0.51%
cases:6.84%
controls:1.36%
79
493
2028
20567
25
150
2082
20910
11
7
2096
21053
—
10
14
1882
20977
38
103
1193
19985
35
206
477
14917
FEV1 --post bronchodilation
20155-8 [3023550]
4.9e-01
5.2e-01
2.8e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:3.75%
controls:2.34%
cases:1.19%
controls:0.71%
cases:0.52%
controls:0.03%
—
—
cases:0.53%
controls:0.07%
cases:3.09%
controls:0.51%
cases:6.84%
controls:1.36%
79
493
2028
20567
25
150
2082
20910
11
7
2096
21053
—
10
14
1882
20977
38
103
1193
19985
35
206
477
14917
FVC percent change Respiratory system
69982-7 [42868471]
4.9e-01
5.2e-01
2.8e+00
—
2.1e+00
1.8e+00
1.7e+00
cases:3.75%
controls:2.34%
cases:1.19%
controls:0.71%
cases:0.52%
controls:0.03%
—
—
cases:0.53%
controls:0.07%
cases:3.09%
controls:0.51%
cases:6.84%
controls:1.36%
79
493
2028
20567
25
150
2082
20910
11
7
2096
21053
—
10
14
1882
20977
38
103
1193
19985
35
206
477
14917
Chronic kidney disease, unspecified
N18.9 [45553438]
5.5e-01
7.6e-01
1.2e+00
3.4e+00
1.4e+00
7.2e-01
7.7e-01
cases:2.18%
controls:1.27%
cases:2.09%
controls:0.99%
cases:0.95%
controls:0.29%
cases:1.00%
controls:0.03%
cases:1.11%
controls:0.28%
cases:2.44%
controls:1.20%
cases:5.47%
controls:2.60%
46
267
2061
20793
44
209
2063
20851
20
61
2087
20999
21
7
2086
21053
21
58
1871
20933
30
242
1201
19846
28
393
484
14730
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
9.9e-02
6.2e-01
1.7e+00
3.4e+00
1.5e+00
9.8e-01
6.0e-01
cases:8.40%
controls:7.67%
cases:6.79%
controls:3.77%
cases:2.85%
controls:0.55%
cases:0.71%
controls:0.02%
cases:2.01%
controls:0.46%
cases:10.32%
controls:4.16%
cases:18.55%
controls:11.08%
177
1615
1930
19445
143
795
1964
20265
60
116
2047
20944
15
5
2092
21055
38
96
1854
20895
127
835
1104
19253
95
1675
417
13448
Extensive abdominal CT
JN3BD [2001305556]
9.8e-01
1.8e+00
—
1.0e+50
—
3.5e+00
2.5e+00
cases:3.56%
controls:1.37%
cases:1.85%
controls:0.32%
—
—
cases:1.23%
controls:0.00%
—
—
cases:5.85%
controls:0.18%
cases:8.79%
controls:0.80%
75
289
2032
20771
39
67
2068
20993
—
26
0
2081
21060
—
72
37
1159
20051
45
121
467
15002
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
4.8e-01
5.1e-01
—
—
2.3e+00
2.5e+00
3.9e+00
cases:0.24%
controls:0.15%
cases:0.24%
controls:0.14%
—
—
—
—
cases:0.53%
controls:0.05%
cases:1.95%
controls:0.16%
cases:6.45%
controls:0.14%
5
31
2102
21029
5
30
2102
21030
—
—
10
11
1882
20980
24
33
1207
20055
33
21
479
15102
Pneumonia, unspecified
J18.9 [45601123]
2.7e-01
4.9e-01
1.9e+00
3.8e+00
1.5e+00
9.9e-01
2.6e-01
cases:6.45%
controls:4.99%
cases:3.23%
controls:1.99%
cases:1.85%
controls:0.28%
cases:1.28%
controls:0.03%
cases:1.32%
controls:0.30%
cases:5.93%
controls:2.28%
cases:11.13%
controls:8.79%
136
1050
1971
20010
68
420
2039
20640
39
59
2068
21001
27
6
2080
21054
25
63
1867
20928
73
459
1158
19629
57
1330
455
13793
Anaemia, unspecified
D64.9 [45600610]
9.7e-01
1.6e+00
2.4e+00
1.0e+50
2.3e+00
1.4e+00
5.1e-01
cases:4.51%
controls:1.77%
cases:3.56%
controls:0.74%
cases:1.57%
controls:0.14%
cases:0.81%
controls:0.00%
cases:1.27%
controls:0.12%
cases:3.82%
controls:1.00%
cases:4.88%
controls:3.00%
95
372
2012
20688
75
155
2032
20905
33
30
2074
21030
17
0
2090
21060
24
26
1868
20965
47
201
1184
19887
25
454
487
14669
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
5.6e-01
1.1e+00
2.3e+00
—
2.2e+00
1.6e+00
8.9e-01
cases:11.20%
controls:6.75%
cases:6.03%
controls:2.06%
cases:1.85%
controls:0.19%
—
—
cases:2.06%
controls:0.22%
cases:9.42%
controls:2.09%
cases:15.43%
controls:6.96%
236
1422
1871
19638
127
433
1980
20627
39
40
2068
21020
—
39
47
1853
20944
116
419
1115
19669
79
1053
433
14070
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
2.8e-01
6.2e-01
1.7e+00
3.6e+00
1.6e+00
9.5e-01
2.2e-01
cases:8.31%
controls:6.39%
cases:6.88%
controls:3.82%
cases:3.08%
controls:0.60%
cases:1.00%
controls:0.03%
cases:2.80%
controls:0.59%
cases:10.24%
controls:4.22%
cases:13.48%
controls:11.08%
175
1345
1932
19715
145
804
1962
20256
65
126
2042
20934
21
6
2086
21054
53
124
1839
20867
126
848
1105
19240
69
1676
443
13447
Asthma, unspecified
J45.9 [45562456]
2.8e-01
5.3e-01
1.4e+00
4.0e+00
1.9e+00
8.0e-01
5.8e-02
cases:5.51%
controls:4.21%
cases:3.32%
controls:1.98%
cases:1.33%
controls:0.32%
cases:1.28%
controls:0.02%
cases:1.90%
controls:0.30%
cases:4.39%
controls:2.03%
cases:5.47%
controls:5.18%
116
887
1991
20173
70
417
2037
20643
28
67
2079
20993
27
5
2080
21055
36
62
1856
20929
54
407
1177
19681
28
783
484
14340
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
1.0e+00
1.1e+00
2.1e+00
—
2.2e+00
1.3e+00
9.9e-01
cases:7.07%
controls:2.72%
cases:4.22%
controls:1.45%
cases:2.04%
controls:0.27%
—
—
cases:2.59%
controls:0.29%
cases:6.09%
controls:1.76%
cases:11.13%
controls:4.46%
149
572
1958
20488
89
306
2018
20754
43
56
2064
21004
—
49
61
1843
20930
75
353
1156
19735
57
674
455
14449
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
8.3e-01
1.2e+00
2.2e+00
—
2.5e+00
1.9e+00
6.5e-01
cases:1.90%
controls:0.84%
cases:0.85%
controls:0.26%
cases:0.28%
controls:0.03%
—
—
cases:0.48%
controls:0.04%
cases:1.71%
controls:0.26%
cases:1.76%
controls:0.93%
40
176
2067
20884
18
54
2089
21006
6
7
2101
21053
—
9
8
1883
20983
21
53
1210
20035
9
140
503
14983
EKG study
11524-6 [3013512]
1.1e-01
3.8e-01
1.8e+00
3.7e+00
1.9e+00
8.4e-01
2.9e-01
cases:13.19%
controls:11.95%
cases:9.49%
controls:6.71%
cases:4.56%
controls:0.80%
cases:1.38%
controls:0.03%
cases:4.86%
controls:0.79%
cases:14.62%
controls:6.91%
cases:21.09%
controls:16.66%
278
2517
1829
18543
200
1413
1907
19647
96
168
2011
20892
29
7
2078
21053
92
166
1800
20825
180
1389
1051
18699
108
2520
404
12603
Urgent procedure
ZXD05 [2001311386]
2.3e-01
8.7e-01
2.3e+00
1.0e+50
2.8e+00
1.5e+00
1.2e+00
cases:5.98%
controls:4.81%
cases:2.56%
controls:1.09%
cases:0.90%
controls:0.09%
cases:0.57%
controls:0.00%
cases:1.43%
controls:0.09%
cases:3.74%
controls:0.86%
cases:9.57%
controls:3.14%
126
1014
1981
20046
54
229
2053
20831
19
20
2088
21040
12
0
2095
21060
27
19
1865
20972
46
173
1185
19915
49
475
463
14648
Metabolic syndrome
E66.00 [2000501500]
1.3e+00
1.2e+00
2.5e+00
—
2.0e+00
1.6e+00
6.8e-02
cases:2.66%
controls:0.74%
cases:1.00%
controls:0.30%
cases:0.57%
controls:0.05%
—
—
cases:0.63%
controls:0.09%
cases:1.62%
controls:0.33%
cases:0.98%
controls:0.91%
56
156
2051
20904
21
63
2086
20997
12
10
2095
21050
—
12
19
1880
20972
20
66
1211
20022
5
138
507
14985
Melaena
K92.1 [45533624]
1.0e+00
1.5e+00
3.1e+00
1.0e+50
—
1.9e+00
1.1e+00
cases:2.09%
controls:0.78%
cases:1.23%
controls:0.28%
cases:0.71%
controls:0.03%
cases:0.38%
controls:0.00%
—
—
cases:1.22%
controls:0.19%
cases:2.93%
controls:0.98%
44
164
2063
20896
26
60
2081
21000
15
7
2092
21053
8
0
2099
21060
—
15
38
1216
20050
15
148
497
14975
X-ray examination of the lungs in one projection
GD1PA [2001303645]
6.7e-01
7.3e-01
1.9e+00
1.0e+50
2.3e+00
2.2e+00
7.6e-01
cases:2.90%
controls:1.51%
cases:1.28%
controls:0.62%
cases:0.76%
controls:0.11%
cases:0.81%
controls:0.00%
cases:0.74%
controls:0.08%
cases:5.93%
controls:0.73%
cases:5.27%
controls:2.54%
61
318
2046
20742
27
131
2080
20929
16
23
2091
21037
17
0
2090
21060
14
16
1878
20975
73
146
1158
19942
27
384
485
14739
Intravenous administration of medicine
SPAT1255 [2001700356]
7.4e-01
1.3e+00
—
—
2.8e+00
2.1e+00
1.5e+00
cases:2.04%
controls:0.99%
cases:1.09%
controls:0.30%
—
—
—
—
cases:0.48%
controls:0.03%
cases:3.41%
controls:0.41%
cases:4.69%
controls:1.06%
43
208
2064
20852
23
63
2084
20997
—
—
9
6
1883
20985
42
83
1189
20005
24
161
488
14962

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
791
331
37.55
307.65
4.5
1.9
1329.43
395.88
u/ml
0.83
717
265
421
403
12.79
307.65
1.5
1.1
105.16
104.05
titre
0.01
31
37
292
203
16.52
307.65
1.3
1.1
1.66
1.55
g/l
2.33
277
179
478
47
131.06
307.65
1.7
1.5
—
—
—
0
0
502
199
32.75
307.65
4.1
1.9
987.51
32.58
u/ml
2.75
470
183
873
1400
9.91
307.65
5.4
2.0
0.17
0.19
g/l
16.64
822
1264
415
414
12.22
307.65
1.5
1.1
556.67
1630.00
titre
—
6
14
508
417
15.71
307.65
1.6
1.3
—
—
—
0
0
511
415
15.91
307.65
5.0
2.5
43.28
35.73
umol/l
2.19
480
365
1200
904
29.34
307.65
4.8
1.4
33.86
2.79
ug/l
2.13
1065
675
844
1712
7.54
307.65
10.6
2.2
23.35
8.13
umol/l
13.97
803
1504
613
1302
6.22
288.98
1.7
1.5
—
—
—
0
0
146
20
78.33
272.75
4.1
2.5
1992.23
5.80
ug/l
1.70
146
20
573
1211
6.12
270.16
1.7
1.6
—
—
—
0
0
685
1774
5.23
255.46
11.2
6.8
8.70
11.60
mmol/l
16.77
663
1678
1004
3946
3.94
208.08
15.2
3.8
74.70
82.07
%
16.74
984
3852
139
50
29.68
207.86
2.1
2.8
6100.58
482.51
e6/l
0.53
101
37
1549
8278
4.25
200.10
26.1
3.9
25.49
12.83
umol/l
24.51
1525
7786
1461
7532
4.03
198.32
15.4
4.0
31.44
35.15
g/l
92.85
1420
6949
388
814
5.61
179.97
1.8
1.4
1.45
1.15
g/l
2.61
353
748
1109
5027
3.53
177.85
11.7
2.6
65.77
38.81
u/l
6.24
1078
4705
116
40
30.62
175.61
2.0
2.7
2458.22
54541.41
e6/l
0.56
65
22
1133
5289
3.46
171.60
5.5
2.4
57.58
61.16
u/l
0.80
1097
4855
743
2690
3.71
167.83
5.7
2.6
0.76
0.82
mmol/l
29.92
718
2475
113
42
28.36
166.80
2.0
2.0
—
—
—
0
0
113
43
27.70
165.44
2.1
1.4
—
—
—
0
0
411
1021
4.75
155.14
2.3
2.3
12.97
11.01
g/l
9.83
378
939
332
730
5.21
144.60
1.4
1.4
—
—
—
0
0
1485
8806
3.30
139.35
22.9
20.2
1.29
1.39
inr
13.33
1290
7441
479
1444
3.99
138.84
5.1
2.3
35.00
39.24
u/l
0.53
423
1180
97
42
24.16
135.23
4.2
2.2
0.59
0.59
mmol/l
0.21
97
42
1047
5244
2.97
130.36
6.7
4.1
—
—
—
0
0
993
4848
2.97
129.35
4.3
2.2
—
—
—
0
0
94
46
21.34
124.65
1.4
4.2
—
—
—
0
0
86
35
25.57
122.62
1.0
1.0
—
—
—
0
0
85
35
25.26
120.66
1.0
1.0
—
—
—
0
0
80
28
29.65
120.14
1.2
1.3
41.65
25.51
g/l
0.34
51
23
212
369
6.27
118.24
4.8
2.3
2.90
3.49
g/l
4.89
206
350
114
92
13.04
117.04
2.3
2.2
32.14
44.49
iu/ml
0.26
16
16
113
90
13.21
116.94
1.2
1.1
—
—
—
0
0
656
2680
3.10
115.50
3.0
2.8
23.24
22.45
%
0.60
639
2463
91
50
18.97
114.59
1.6
2.0
10.13
13.64
g/l
1.42
67
34
88
50
18.32
109.05
43.2
37.3
6.75
7.30
ug/l
1.22
79
44
673
2905
2.93
106.04
3.0
2.7
2.30
2.24
g/l
1.31
636
2651
121
129
9.89
102.99
1.3
1.2
157.65
136.09
titre
0.09
17
23
1194
6995
2.62
101.20
4.9
2.5
—
—
estimate
—
0
0
102
87
12.27
101.07
1.1
1.0
—
—
—
0
0
150
216
7.40
99.95
1.3
1.4
146.68
155.39
au/ml
0.28
34
77
651
2841
2.86
99.60
3.3
1.9
31.64
29.93
s
7.48
640
2765
691
3112
2.81
99.57
3.0
2.7
12.63
12.51
umol/l
0.15
663
2862
105
96
11.46
99.46
1.1
1.1
—
—
—
0
0
260
632
4.55
98.91
2.8
1.5
0.26
0.34
mg/l
1.46
96
285
158
254
6.64
94.97
1.4
1.3
—
—
—
0
0
1352
8625
2.57
92.43
18.9
6.1
4.39
4.47
e9/l
0.48
1215
7298
159
266
6.38
91.88
1.2
1.2
—
—
—
0
0
146
224
6.93
91.70
1.4
1.2
322.21
279.40
u/ml
0.68
98
126
354
1157
3.47
88.26
1.5
1.1
—
—
—
0
0
206
455
4.91
87.90
6.8
3.0
1.67
1.78
mg/l
0.90
193
386
84
67
13.01
86.65
1.3
1.1
—
—
—
0
0
157
303
5.52
78.00
1.4
1.2
—
—
—
0
0
542
2435
2.65
75.60
2.8
2.0
—
—
—
0
0
67
51
13.53
70.96
33.1
28.3
131.15
133.38
ug/l
0.06
52
39
522
2375
2.59
70.36
8.3
5.6
1.06
1.04
mmol/l
0.94
497
2168
413
1672
2.83
70.14
14.7
8.3
—
—
—
0
0
96
126
7.93
69.13
1.0
1.0
280.09
283.68
mg/l
0.13
86
113
118
195
6.35
68.81
1.2
1.1
—
—
—
0
0
52
27
19.72
66.88
1.1
1.1
—
—
—
0
0
420
1757
2.73
66.71
12.5
7.1
1.76
1.45
mmol/l
3.40
409
1714
336
1262
2.98
65.21
14.6
9.1
94.69
93.37
%
3.96
336
1256
808
4584
2.23
65.17
2.6
1.6
—
—
—
0
0
118
209
5.92
64.11
1.1
1.0
—
—
—
0
0
863
5064
2.19
63.62
5.9
3.5
7.40
7.40
ph
3.19
671
3673
1270
8758
2.12
60.24
12.1
6.3
1.19
1.21
mmol/l
7.78
1121
7519
1175
7873
2.11
60.13
11.8
6.0
1.19
1.21
mmol/l
6.63
1137
7140
1368
9745
2.14
59.01
11.8
3.2
221.61
52.21
u/l
65.82
1317
8940
321
1243
2.87
58.57
15.0
9.1
0.60
0.64
%
1.24
321
1236
453
2114
2.45
56.54
12.5
7.0
96.48
94.70
%
8.78
443
2041
323
1286
2.78
55.77
14.8
8.8
1.39
1.33
%
0.63
323
1276
483
2333
2.39
55.74
12.0
6.9
7.41
7.42
ph
0.12
223
1355
423
1926
2.49
55.61
13.1
7.5
116.52
122.29
g/l
6.88
415
1892
484
2344
2.38
55.50
12.0
6.9
12.51
11.29
kpa
6.95
469
2250
483
2344
2.37
55.08
12.0
6.9
4.98
5.05
kpa
0.88
468
2252
877
5414
2.06
54.38
7.0
2.1
2.34
2.35
mmol/l
0.84
839
4737
431
2010
2.44
53.60
1.5
1.3
370.98
518.12
titre
1.34
102
467
478
2340
2.35
53.24
12.0
6.9
0.27
1.03
mmol/l
3.96
401
1906
864
5349
2.04
52.73
8.2
5.3
—
—
—
0
0
281
1076
2.86
52.05
13.6
9.6
15.53
15.97
%
1.70
273
1049
1401
10329
2.05
51.66
12.8
4.9
7.48
6.93
mmol/l
12.60
1369
9843
121
273
4.64
49.92
2.0
1.5
132.75
25.24
u/ml
1.95
116
259
357
1574
2.53
49.85
1.6
1.6
—
—
—
0
0
176
530
3.53
48.83
3.7
1.8
22.89
20.70
s
8.73
171
476
434
2127
2.31
47.68
5.6
3.5
5.52
5.85
kpa
8.25
429
2060
426
2079
2.31
47.23
5.7
3.5
1.03
1.78
mmol/l
3.65
347
1789
435
2154
2.28
46.53
5.6
3.5
7.38
7.38
ph
0.37
285
1259
789
4899
1.97
46.28
4.1
3.2
0.94
0.48
e6/l
2.83
620
3619
281
1143
2.68
46.09
16.1
9.0
23.77
24.18
mmol/l
1.40
276
1106
599
3389
2.07
45.51
6.4
2.2
2.51
2.45
mmol/l
23.33
565
2965
220
791
2.99
45.48
2.2
1.7
2.26
1.95
ug/l
0.29
208
686
1573
12392
2.05
44.37
29.1
5.7
178.73
78.02
u/l
91.98
1541
11539
1073
7471
1.88
43.73
8.9
5.6
22.84
26.01
%
15.54
1030
6981
510
2761
2.12
43.29
3.6
3.1
1.62
1.90
e6/l
0.48
282
1369
494
2642
2.13
43.29
1.7
1.3
3.93
2.79
g/l
14.69
387
1502
1061
7378
1.88
43.25
9.0
5.7
9.55
9.20
%
2.88
1007
6804
1054
7338
1.87
42.56
8.7
5.6
61.11
58.63
%
7.83
1011
6928
1145
8219
1.86
41.58
8.7
5.5
1.56
1.81
e9/l
11.45
1020
7065
1048
7367
1.84
40.24
9.0
5.6
2.60
3.02
%
7.81
996
6790
1126
8107
1.83
39.82
8.7
5.4
0.04
0.04
e9/l
3.74
975
6813
1121
8064
1.83
39.72
8.7
5.4
0.64
0.63
e9/l
0.47
972
6771
865
5752
1.85
39.57
4.3
3.3
189.19
76.35
e6/l
0.41
700
4422
1045
7379
1.82
39.17
9.1
5.7
0.59
0.65
%
2.62
990
6800
428
2242
2.14
39.16
1.4
1.3
—
—
—
0
0
535
3052
2.01
38.82
3.4
3.0
1.01
1.27
e6/l
0.82
305
1673
573
3373
1.96
37.84
3.6
2.8
539.89
540.17
mosm/kgh2o
0.01
522
2931
1140
8348
1.79
37.05
9.2
5.5
0.18
0.21
e9/l
10.29
1001
7123
99
254
4.04
34.52
7.8
6.0
12.38
12.34
mg/l
0.02
91
235
735
4833
1.80
33.51
3.0
2.4
3.58
2.80
mg/l
11.13
653
4114
900
6348
1.73
31.63
5.1
3.9
84.15
118.87
e6/l
0.94
710
4545
415
6759
0.52
30.83
2.3
1.9
1.54
1.31
mmol/l
5.88
372
5594
612
3910
1.79
30.12
1.6
1.3
—
—
—
0
0
134
466
3.00
29.17
1.5
1.5
224.49
286.72
ug/g
2.61
79
298
696
4678
1.73
28.37
12.9
4.7
—
—
—
0
0
616
4022
1.75
27.73
3.3
2.6
5.96
4.59
e6/l
1.91
577
3646
87
239
3.75
27.57
2.0
1.6
0.94
0.98
g/l
0.11
69
189
1328
10780
1.62
24.35
5.6
4.7
1109.71
2576.94
e6/l
0.88
28
200
323
1797
1.94
24.07
4.9
3.0
4.58
4.45
kpa
0.60
318
1733
394
2369
1.81
22.95
2.9
2.0
2.06
1.74
%
5.16
356
2080
713
5121
1.59
21.01
3.5
3.3
—
—
—
0
0
253
1370
1.96
20.24
3.2
1.9
410.32
368.15
nmol/l
2.22
235
1244
68
196
3.55
20.12
3.9
2.2
2.00
1.42
%
0.53
62
163
32
20
16.23
20.11
1.3
1.1
—
—
—
0
0
39
73
5.42
19.98
1.6
1.2
—
—
—
0
0
277
1573
1.88
19.16
1.6
1.3
—
—
—
0
0
53
136
3.97
18.54
1.9
1.5
19.72
22.54
ng/l
0.61
53
136
905
7013
1.51
18.20
4.0
3.1
205.78
143.84
ug/l
6.53
847
6434
1362
15512
0.66
17.69
5.8
5.6
4.17
4.35
mmol/l
8.11
1238
14288
274
1592
1.83
17.55
2.1
1.7
65.64
66.47
g/l
0.82
248
1420
1351
15388
0.66
17.23
5.7
5.5
1.27
1.39
mmol/l
22.51
1215
14057
40
88
4.61
17.06
1.1
1.1
—
—
—
0
0
890
6948
1.48
16.85
23.1
10.5
0.00
0.00
e9/l
0.50
713
5610
234
1312
1.88
16.76
4.9
3.1
1.21
1.22
mmol/l
1.23
215
1106
238
1344
1.87
16.67
4.8
3.7
1.26
0.75
%
1.84
128
307
36
74
4.93
16.64
5.2
1.4
47.55
6.23
umol/l
3.27
31
42
1408
15863
0.66
16.42
6.3
6.5
2.40
2.50
mmol/l
4.21
1270
14572
129
599
2.23
15.48
3.7
2.9
635.94
408.49
mg/l
0.31
84
228
297
1831
1.72
15.44
3.0
2.0
76.99
66.53
e9/l
3.66
216
1356
1384
15570
0.68
15.03
6.0
5.7
6.61
6.14
mmol/l
21.91
1253
14065
90
363
2.54
14.81
4.5
4.6
2.17
2.79
mmol/l
1.53
60
238
175
929
1.96
14.73
1.8
1.6
1.44
1.54
g/l
0.60
143
802
454
3147
1.56
14.73
5.7
4.2
—
—
—
0
0
221
1275
1.82
14.40
5.3
4.1
—
—
—
0
0
226
1328
1.79
13.84
7.3
6.1
23.45
24.42
mmol/l
3.03
216
1285
195
1099
1.85
13.69
4.1
2.7
1.21
1.16
%
0.35
195
1094
193
1087
1.85
13.58
4.1
2.7
0.67
0.61
%
1.87
193
1082
355
5110
0.63
13.54
4.2
3.7
—
—
—
0
0
219
1289
1.78
13.33
4.9
3.6
0.75
0.60
%
0.62
117
303
84
346
2.49
13.26
1.4
1.4
51.47
60.08
mmol/l
0.97
53
276
300
1929
1.65
13.21
1.9
1.4
—
—
—
0
0
623
4716
1.45
12.98
4.0
2.7
374.53
367.77
umol/l
0.72
553
4025
1314
14788
0.71
12.78
5.1
4.7
1.41
1.28
mmol/l
7.80
1178
13364
1375
15345
0.70
12.62
10.0
7.4
43.37
40.74
mmol/mol
14.32
1265
14199
217
1310
1.73
12.07
5.1
3.7
0.15
0.07
%
0.78
109
275
173
987
1.82
11.67
5.2
4.3
36.86
36.90
°c
0.83
173
974
15
5
30.19
11.64
3.6
5.6
1242.65
278.80
u/l
—
15
5
175
1012
1.79
11.29
4.4
3.0
23.86
25.11
mmol/l
3.91
169
969
90
412
2.24
11.24
3.7
4.0
—
—
—
0
0
216
1329
1.70
11.20
5.3
3.9
0.27
0.01
%
0.67
98
252
26
57
4.61
11.18
1.2
1.2
—
—
—
0
0
44
141
3.17
11.13
2.7
2.6
—
—
—
0
0
31
79
3.97
11.03
2.1
1.5
5.46
113.10
u/l
—
6
20
574
7287
0.71
10.85
3.9
4.0
22.62
24.51
%
1.69
267
3594
51
182
2.85
10.72
1.7
1.4
29423.03
64037.77
e6/l
0.47
32
105
44
148
3.01
10.28
3.9
2.4
59.22
59.55
%
0.03
37
119
294
2024
1.53
9.53
1.9
1.8
—
—
—
0
0
461
3480
1.42
9.29
2.5
1.6
2.78
1.37
mg/l
5.49
395
2751
131
737
1.83
9.27
1.2
1.2
—
—
—
0
0
93
470
2.02
9.06
4.3
3.6
2.02
1.65
index
0.28
62
241
45
165
2.76
9.05
1.8
1.4
—
—
—
0
0
37
122
3.07
8.98
1.3
1.2
—
—
—
0
0
100
522
1.96
8.90
2.2
2.2
168.38
96.21
ug/min
0.56
60
313
38
128
3.00
8.90
1.0
1.1
—
—
—
0
0
53
214
2.51
8.82
1.8
1.4
1252.30
1325.22
e6/l
0.05
40
154
144
853
1.74
8.58
6.3
4.2
0.86
0.85
%
0.14
135
816
46
176
2.65
8.54
1.2
1.1
—
—
—
0
0
153
929
1.70
8.34
6.2
4.1
1.67
1.61
%
0.37
146
891
171
2629
0.62
8.23
1.3
1.3
48.37
38.09
iu/ml
0.22
58
758
1327
14558
0.76
7.95
5.2
4.9
2.44
2.04
mu/l
6.78
1203
13182
45
177
2.58
7.93
2.0
1.5
—
—
—
0
0
49
201
2.47
7.92
1.6
1.4
—
—
—
0
0
49
201
2.47
7.92
1.6
1.4
—
—
—
0
0
49
201
2.47
7.92
1.6
1.4
—
—
—
0
0
49
201
2.47
7.92
1.6
1.4
—
—
—
0
0
45
180
2.53
7.68
1.9
1.4
—
—
—
0
0
790
6636
1.30
7.65
3.3
3.4
1472.87
1663.83
ng/l
0.52
704
5792
60
274
2.22
7.63
3.2
2.9
56.47
59.63
%
0.91
60
274
25
72
3.50
7.54
2.2
2.5
33.49
41.83
%
1.59
25
72
402
5159
0.73
7.45
2.8
3.0
0.74
0.74
ug/l
0.01
269
3525
202
1355
1.54
7.35
2.0
1.5
—
—
—
0
0
52
229
2.30
7.22
3.2
3.1
4.06
4.58
e9/l
0.66
52
229
204
1379
1.53
7.17
4.2
4.0
89.45
95.85
ng/l
0.59
181
1175
104
593
1.79
7.10
4.3
4.0
3.96
3.95
mmol/l
0.12
104
587
164
2453
0.64
6.93
1.2
1.3
16.59
14.89
u/ml
0.09
59
897
100
575
1.78
6.66
7.3
5.0
1.85
1.37
mmol/l
1.24
85
515
39
157
2.51
6.61
2.0
2.3
888.41
610.69
ml
2.29
22
93
130
807
1.65
6.56
2.0
1.4
4.13
3.79
g/l
1.81
115
710
481
3841
1.33
6.55
4.5
4.5
373.65
473.06
ng/l
0.32
421
3333
130
810
1.64
6.47
2.0
1.4
4.36
4.16
g/l
1.77
115
715
778
8982
0.79
6.30
4.5
4.3
2.17
2.10
ug/l
0.20
663
8088
6
0
+∞
6.25
15.2
0.0
8.87
—
ug/l
—
6
0
115
701
1.68
6.24
1.4
1.2
—
—
—
0
0
68
359
1.92
5.96
1.2
1.2
—
—
—
0
0
19
54
3.54
5.88
1.3
1.3
16.73
34.28
u/l
1.59
12
37
108
660
1.67
5.82
2.1
1.6
39.00
35.18
mg/l
0.67
90
558
108
661
1.67
5.79
2.1
1.6
55.98
50.84
mg/l
0.42
88
559
115
717
1.64
5.74
2.0
1.4
11.63
10.32
g/l
1.62
97
617
99
594
1.70
5.72
2.2
1.5
1.52
1.66
ratio
0.34
53
346
853
7440
1.25
5.57
4.8
4.3
41.24
110.68
ng/l
1.87
732
5844
15
28
5.39
5.53
1.9
3.1
42.13
24.57
%
2.12
15
28
70
383
1.86
5.53
8.9
5.6
12.60
11.65
mmol/l
1.05
63
353
70
383
1.86
5.53
9.0
5.6
105.29
104.95
mmol/l
0.29
63
353
38
166
2.31
5.45
3.9
3.4
19.57
11.64
index
1.10
28
83
171
1185
1.48
5.37
4.6
3.8
—
—
—
0
0
799
6940
1.24
5.36
4.7
4.2
13.51
8.44
mg/mmol
2.09
563
4493
23
79
2.93
5.30
1.3
4.5
55.72
61.42
mg/l
0.23
18
57
247
1837
1.39
5.28
2.9
3.4
216.78
256.44
ng/l
0.93
231
1708
43
203
2.14
5.15
1.2
1.2
191.88
190.90
miu/ml
—
8
73
65
358
1.84
5.06
1.2
1.4
0.76
0.88
nmol/l
0.72
53
294
53
274
1.96
4.99
1.4
1.5
10.50
7.09
u/l
0.93
33
218
79
466
1.72
4.90
4.8
4.2
—
—
—
0
0
1609
16940
0.79
4.87
60.1
24.5
7.25
6.89
e9/l
5.45
1562
16380
1609
16940
0.79
4.87
60.6
24.7
123.38
136.01
g/l
146.51
1575
16660
1609
16939
0.79
4.86
60.0
24.5
4.15
4.48
e12/l
90.18
1561
16379
1609
16939
0.79
4.86
62.5
25.0
37.27
40.44
%
101.06
1574
16643
1609
16938
0.79
4.85
59.8
24.4
30.33
30.55
pg
3.68
1575
16650
1609
16937
0.79
4.84
59.9
24.5
91.63
91.74
fl
0.36
1577
16646
185
1329
1.43
4.83
4.4
3.8
7.42
7.41
ph
0.22
156
1102
1609
16936
0.79
4.83
60.1
24.5
213.56
235.54
e9/l
19.26
1564
16457
27
108
2.52
4.71
1.6
1.6
12.81
15.55
umol/l
1.14
27
94
7
269
0.26
4.71
1.0
1.2
1.26
1.49
g/l
—
7
269
1079
11814
0.82
4.67
4.4
3.8
14.81
15.03
pmol/l
2.06
973
10635
120
799
1.53
4.59
1.4
1.6
6.07
24.61
iu/ml
—
9
21
34
699
0.48
4.57
1.6
1.9
3.38
3.44
mmol/l
0.11
28
540
187
1364
1.41
4.50
4.4
3.8
4.90
5.19
kpa
5.01
175
1294
385
3141
1.28
4.32
1.3
1.3
1.42
1.75
u/ml
0.47
75
823
52
282
1.87
4.29
1.9
1.6
1.11
0.88
%
1.17
42
188
24
544
0.43
4.22
1.0
1.1
—
—
—
0
0
1603
16813
0.81
4.14
52.9
22.0
87.05
85.96
umol/l
0.41
1575
16533
25
104
2.42
4.06
1.5
1.3
19.12
14.71
u/l
1.31
25
97
7
7
10.03
4.01
3.6
2.3
145.90
46.76
pmol/l
—
7
7
7
8
8.77
3.77
2.0
1.0
—
—
—
0
0
776
6902
1.20
3.76
3.9
3.5
6.99
7.59
mmol/l
3.90
655
5796
30
141
2.14
3.71
1.6
1.2
—
—
—
0
0
14
45
3.13
3.65
1.2
1.2
2.02
7.56
ug/l
—
5
18
39
709
0.54
3.64
1.2
1.3
—
—
—
0
0
14
372
0.37
3.63
1.1
1.7
—
—
—
0
0
30
143
2.11
3.59
1.6
1.2
0.46
0.43
g/l
0.13
18
108
30
143
2.11
3.59
1.6
1.2
7.26
7.30
g/l
0.02
18
109
30
143
2.11
3.59
1.6
1.2
3.77
3.08
g/l
0.67
18
108
34
171
2.00
3.54
1.5
1.2
—
—
—
0
0
439
3715
1.23
3.54
1.9
1.8
1142.40
1160.36
nmol/l
0.14
335
2802
245
1938
1.30
3.50
2.5
2.5
6.71
7.96
ug/l
0.45
211
1684
96
649
1.50
3.49
2.7
1.8
—
—
—
0
0
39
208
1.89
3.45
1.8
1.8
2.03
1.55
g/24h
0.35
24
109
67
419
1.62
3.43
1.2
1.1
—
—
—
0
0
211
1645
1.31
3.36
2.9
2.4
196.18
177.01
ug/g
0.32
179
1311
16
59
2.72
3.32
1.0
1.1
1656.63
1580.29
miu/ml
0.09
16
59
15
54
2.79
3.25
1.1
1.6
—
—
—
0
0
20
84
2.39
3.23
1.1
1.4
7.44
7.44
ph
0.01
12
57
211
1662
1.30
3.13
5.4
3.8
7.37
7.36
ph
0.55
191
1112
6
8
7.52
3.05
2.2
1.4
—
—
—
0
0
6
8
7.52
3.05
1.0
1.1
74.67
22.75
u/l
—
6
8
34
182
1.88
3.01
1.1
1.4
278.48
273.35
mosm/kgh2o
0.45
23
132
26
127
2.06
2.97
1.2
1.1
—
—
—
0
0
123
901
1.39
2.97
2.4
2.5
—
—
—
0
0
16
63
2.55
2.95
2.4
3.5
24.93
29.48
mu/l
0.15
16
56
9
22
4.10
2.88
1.9
1.5
—
—
—
0
0
22
102
2.17
2.87
1.9
2.0
500.19
494.23
min
0.12
16
71
12
38
3.17
2.85
1.1
1.0
—
—
—
0
0
70
1028
0.67
2.79
2.4
2.5
23.50
18.84
au/ml
—
6
73
750
6784
1.16
2.78
3.9
3.5
67.73
49.84
mg/l
1.40
551
4541
62
929
0.66
2.74
1.2
1.3
46.43
61.06
au/ml
—
7
68
127
952
1.36
2.68
4.4
3.4
1.02
1.02
ratio
1.48
115
865
776
7065
1.16
2.60
4.3
3.5
6.27
6.26
ph
0.13
408
3856
37
215
1.73
2.56
2.2
2.9
—
—
—
0
0
124
938
1.34
2.49
5.0
4.0
—
—
—
0
0
1589
16486
0.85
2.48
34.2
10.8
42.26
25.72
u/l
62.05
1561
15796
16
70
2.30
2.41
1.4
1.4
58.44
103.74
umol/l
—
9
43
7
17
4.13
2.36
1.3
1.1
—
—
—
0
0
11
39
2.83
2.34
4.8
1.4
1.56
1.87
umol/l
0.39
11
34
954
8888
1.13
2.17
4.9
3.8
11.56
2.56
estimate
0.57
235
1786
60
858
0.69
2.15
1.8
1.9
—
—
—
0
0
455
4033
1.16
2.14
1.8
1.8
43784234.19
38827147.65
pmol/l
0.04
370
3307
564
5079
1.15
2.14
5.2
3.9
0.00
0.00
estimate
0.50
187
1559
493
4405
1.16
2.08
4.7
3.4
0.00
0.19
estimate
0.51
176
1338
940
8772
1.13
2.05
4.9
3.8
0.00
0.00
estimate
0.50
224
1744
956
8935
1.13
2.02
4.9
3.9
4.84
0.02
estimate
0.50
210
1631
11
44
2.51
2.01
1.7
2.0
—
—
—
0
0
14
63
2.23
2.01
3.1
2.3
29.18
45.75
%
—
9
33
475
4246
1.15
1.99
4.2
3.7
0.00
0.10
—
5
48
228
1918
1.21
1.97
5.2
2.8
6.58
4.70
e9/l
0.87
206
1590
182
2194
0.81
1.93
4.6
5.4
33.18
32.87
%
0.12
130
1417
489
4395
1.15
1.89
3.4
3.0
0.00
0.04
0.78
12
131
20
356
0.56
1.87
1.3
1.7
—
—
—
0
0
93
708
1.33
1.86
3.4
3.2
4.13
4.45
pmol/l
2.55
81
618
1602
16517
0.88
1.85
49.5
21.0
4.03
4.02
mmol/l
0.67
1570
16109
30
182
1.66
1.85
1.3
1.4
25.54
26.04
iu/l
0.02
19
147
38
248
1.54
1.76
1.1
1.1
202.61
75.57
iu/ml
—
8
45
5
13
3.85
1.71
1.2
1.2
—
—
—
0
0
1602
16494
0.88
1.71
49.4
20.9
137.85
139.78
mmol/l
102.86
1573
16112
68
910
0.74
1.69
1.2
1.3
295.71
271.38
u/ml
0.10
62
846
10
41
2.45
1.64
1.1
1.3
—
—
—
0
0
92
720
1.29
1.55
5.4
4.3
24.15
24.76
mmol/l
0.82
84
649
12
59
2.04
1.43
4.9
1.3
25.08
28.60
umol/l
0.57
12
54
1224
12738
0.91
1.43
52.8
21.6
330.96
332.46
g/l
6.35
1214
12647
24
150
1.61
1.38
2.4
2.3
—
—
—
0
0
8
34
2.36
1.29
1.1
1.5
—
—
—
0
0
9
45
2.00
1.23
1.4
1.4
29.56
28.62
s
—
9
45
64
496
1.30
1.21
2.1
2.2
121.43
132.26
g/l
2.59
51
398
8
38
2.11
1.18
1.3
1.4
—
—
—
0
0
37
265
1.40
1.16
8.5
8.6
9.46
7.49
mmol/l
1.49
28
223
27
182
1.49
1.16
1.3
1.4
—
—
nmol/l
—
0
0
703
6630
1.09
1.10
5.1
3.9
0.13
0.09
estimate
0.13
187
1419
7
31
2.26
1.10
1.6
1.4
—
—
—
0
0
13
219
0.59
1.09
1.5
1.2
—
—
—
0
0
1598
15606
1.10
1.08
41.9
16.5
35.24
26.96
mg/l
18.04
1555
12872
30
210
1.43
1.08
1.2
1.4
1.23
9.09
nmol/l
0.45
30
202
23
338
0.68
1.07
1.6
1.9
2.28
20.57
iu/l
—
5
137
1289
12495
1.08
1.00
51.9
19.9
15.12
13.73
%
123.59
1279
12265
20
133
1.51
0.94
1.7
1.7
15.05
16.58
%
1.57
20
133
48
375
1.29
0.91
1.3
1.2
—
—
—
0
0
25
176
1.43
0.90
1.0
1.3
—
84.75
—
0
8
54
429
1.27
0.90
1.6
1.6
0.24
0.23
g/l
0.11
49
406
761
7259
1.08
0.88
3.0
2.4
75.07
77.93
nmol/l
1.70
698
6375
49
612
0.80
0.84
15.3
11.0
—
—
—
0
0
1558
15884
0.93
0.82
34.5
15.1
—
—
—
0
0
11
66
1.67
0.78
1.3
1.4
0.10
0.22
nmol/l
—
6
53
28
208
1.35
0.77
1.3
1.2
2.35
7.60
u/ml
1.78
20
103
32
243
1.32
0.77
2.7
2.8
—
—
—
0
0
26
348
0.74
0.76
1.0
1.1
—
—
—
0
0
22
159
1.39
0.72
1.2
1.2
317.94
334.39
nmol/l
0.13
16
126
5
27
1.85
0.68
2.4
1.4
—
—
—
0
0
5
27
1.85
0.68
1.2
1.3
—
70.40
—
0
5
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
25
188
1.33
0.66
1.2
1.1
—
—
—
0
0
5
28
1.79
0.66
8.4
9.2
5.08
5.20
mmol/l
—
5
28
156
1407
1.12
0.65
1.6
1.5
—
—
—
0
0
42
515
0.81
0.65
1.5
1.5
19698.62
13774.25
e6/l
0.42
29
374
19
138
1.38
0.62
1.8
1.5
8.46
7.82
mmol/l
0.33
19
138
74
637
1.17
0.62
1.1
1.2
—
—
—
0
0
875
8469
1.06
0.61
2.3
2.3
88.37
92.79
pmol/l
1.94
456
4575
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
28
220
1.28
0.57
1.3
1.4
181.39
74.80
mu/l
0.43
28
198
8
55
1.46
0.56
1.1
1.3
—
0.06
—
0
7
13
183
0.71
0.55
1.0
1.1
0.36
1.67
u/ml
—
7
102
1234
12079
1.05
0.54
5.5
4.4
22.75
12.76
mm/h
43.54
1131
11186
6
40
1.50
0.51
1.7
1.7
0.00
0.15
estimate
—
6
40
6
40
1.50
0.51
1.0
1.2
293.50
241.40
pmol/l
—
6
25
21
270
0.78
0.51
1.7
2.4
—
—
—
0
0
123
1115
1.11
0.51
1.2
1.2
—
—
—
0
0
46
542
0.85
0.51
1.7
1.9
59.76
43.97
nmol/l
2.96
41
517
19
146
1.30
0.47
1.5
1.3
—
—
—
0
0
30
364
0.82
0.46
1.2
1.4
—
—
—
0
0
20
157
1.28
0.43
1.8
2.0
1.73
1.10
u/field
0.78
11
89
10
140
0.71
0.43
1.0
1.1
4.15
1.96
u/ml
—
5
74
11
151
0.73
0.42
1.0
1.1
4.12
5.64
u/ml
—
5
76
0
15
0.00
0.41
0.0
1.5
—
364.73
—
0
15
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
13.3
—
0.21
—
0
17
0
17
0.00
0.40
0.0
1.2
—
330.12
—
0
5
15
114
1.32
0.40
1.1
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
9
68
1.32
0.37
1.2
1.2
39.06
38.86
g/l
—
9
68
9
69
1.31
0.37
1.4
1.1
507.00
256.91
iu/ml
—
9
69
6
42
1.43
0.35
3.3
1.9
0.53
1.53
ug/l
—
6
36
13
99
1.32
0.35
1.8
1.7
534.83
271.43
mu/l
—
6
75
9
125
0.72
0.35
1.7
1.5
130.34
163.30
pmol/l
—
9
125
6
47
1.28
0.32
1.0
1.5
—
—
—
0
0
10
130
0.77
0.29
1.2
1.3
91.70
99.32
pmol/l
—
10
130
9
116
0.77
0.27
2.6
1.8
69.22
97.23
umol/l
—
9
116
22
187
1.18
0.26
1.3
1.2
—
—
—
0
0
13
104
1.25
0.26
2.6
1.9
17.67
17.24
nmol/l
—
7
92
137
1441
0.95
0.23
2.2
2.3
12.34
15.30
nmol/l
2.91
117
1290
58
534
1.09
0.23
1.6
1.6
23.13
22.32
u/ml
0.04
11
104
12
97
1.24
0.23
1.8
1.4
—
—
—
0
0
21
242
0.87
0.22
2.9
2.1
-0.54
0.17
mmol/l
0.21
21
233
18
210
0.86
0.22
1.8
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
0.03
—
0
11
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
18
209
0.86
0.21
1.8
1.3
—
—
—
0
0
8
105
0.76
0.21
1.1
1.7
—
—
—
0
0
15
126
1.19
0.21
1.1
1.2
—
—
—
0
0
16
187
0.85
0.20
1.3
1.2
20355.91
152014.08
e6/l
1.89
11
130
41
374
1.10
0.20
1.9
1.9
12.99
12.55
mg/l
0.10
35
347
6
51
1.18
0.19
11.2
7.4
6.43
5.32
kpa
—
6
51
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
18
207
0.87
0.19
1.8
1.3
—
—
—
0
0
13
109
1.19
0.18
2.8
3.0
—
—
—
0
0
18
206
0.87
0.18
1.8
1.3
—
—
—
0
0
52
558
0.93
0.17
1.3
1.5
—
—
—
0
0
5
68
0.73
0.17
1.0
1.2
—
38.32
—
0
33
48
515
0.93
0.16
2.7
3.3
0.84
0.82
nmol/l
0.09
39
414
14
162
0.86
0.16
1.3
1.4
16.20
24.86
%
—
8
108
8
72
1.11
0.16
1.4
1.1
—
—
—
0
0
13
111
1.17
0.15
1.0
1.2
—
—
—
0
0
17
149
1.14
0.15
1.1
1.1
—
—
—
0
0
100
1039
0.96
0.13
1.2
1.3
—
—
—
0
0
22
201
1.10
0.11
1.0
1.1
—
20.92
—
0
34
85
818
1.04
0.11
2.6
2.0
0.00
1.11
estimate
0.50
23
227
18
198
0.91
0.10
1.8
1.3
—
—
—
0
0
14
125
1.12
0.10
1.1
1.3
—
—
—
0
0
411
4161
0.98
0.09
5.4
4.0
1.02
1.02
kg/l
0.47
295
2733
6
56
1.07
0.08
11.2
7.4
6.00
6.02
kpa
—
6
51
6
56
1.07
0.08
1.2
1.5
7.93
8.30
mmol/l
—
6
56
5
62
0.81
0.08
1.4
1.4
151.80
171.59
mmol/24h
—
5
62
64
663
0.96
0.08
1.5
1.7
5.28
6.52
iu/ml
0.24
12
155
569
5642
1.01
0.07
1.9
1.7
17.87
19.51
nmol/l
2.23
518
4734
6
74
0.81
0.07
2.3
1.8
—
—
—
0
0
6
74
0.81
0.07
1.5
1.2
—
—
—
0
0
42
402
1.05
0.07
4.0
3.6
30.93
30.56
mg/l
0.03
34
290
8
90
0.89
0.06
2.4
3.5
—
—
—
0
0
34
354
0.96
0.05
1.3
1.3
98.00
765.02
e6/l
1.11
25
289
17
159
1.07
0.05
1.1
1.3
—
—
—
0
0
609
6057
1.01
0.05
2.2
2.3
185.29
242.04
u/l
1.57
579
5684
15
140
1.07
0.04
3.5
2.7
—
—
—
0
0
16
150
1.07
0.04
1.1
1.1
—
—
—
0
0
132
1336
0.99
0.03
3.2
2.7
5.90
6.05
ph
1.28
108
937
13
138
0.94
0.02
1.1
1.1
—
—
—
0
0
13
138
0.94
0.02
1.8
2.2
6.18
3.04
ug/l
0.36
13
128
34
349
0.97
0.02
1.2
1.3
2.00
32.68
e6/l
1.10
23
271
25
242
1.03
0.02
1.3
1.1
—
—
—
0
0
19
197
0.96
0.01
1.3
1.3
—
—
—
0
0
167
1661
1.01
0.01
2.6
2.0
0.00
0.01
estimate
0.50
36
306
18
182
0.99
0.00
4.9
2.9
53.90
32.55
mg/l
0.27
13
141
21
215
0.98
0.00
1.3
1.5
49.58
63.08
%
0.62
12
138
11
112
0.98
0.00
1.9
1.9
81.63
125.43
ng/l
1.34
11
112
72
716
1.01
0.00
1.2
1.2
29.88
108.11
u/ml
4.06
16
265
16
156
1.03
0.00
1.1
1.2
—
—
—
0
0
10
97
1.03
0.00
1.1
1.2
109.50
141.42
nmol/l
—
10
97
19
188
1.01
0.00
1.4
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
166.83
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
4.7
7.3
26.84
24.84
mmol/l
—
7
66
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
83
0.96
-0.00
2.4
3.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
92.86
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE – Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).